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ABSTRACT 
Barry J Harnick 
 
 
RIGHT-SIZED RISK-BASED DEPLOYMENT OF A COTS CHROMATOGRAPHY 
DATA SYSTEM 
 
 
As technology advances, computer software has taken a large position in the modern 
laboratory. The exponential growth of data produced in biopharmaceutical laboratories 
today has forced the need for moving from capturing data on paper or storing it in 
spreadsheets and small, non-robust databases to the need for having an automated and 
secure data management platform.  In the November edition of the 2003 Scientific 
Computing & Instrumentation LIMS Guide, M. Elliott (2003) pointed out that 
traditionally laboratories have looked to Laboratory Information Management Systems 
(LIMS) to assist in managing the ever increasing information workload.  In the not so 
distant past, these LIMS and other systems were custom systems that largely delivered 
every user requirement, specific to each company’s internal processes.  However, new 
regulations and reporting requirements have stretched this model and the reality of long-
term maintenance costs have brought about the integration of systems within laboratories, 
not only to collect data but also manage these systems in a way that insures long-term 
preservation and knowledge retention.  This integration is not without its challenges, 
especially when it occurs in a heavily regulated industry such as pharmaceuticals.  While 
there are certainly technical challenges associated with this integration, this strict 
regulatory environment particularly requires expensive, tedious validation of most 
software.  Into the software validation mine field has entered the risk-based verbiage 
recently espoused by the United States Food and Drug Administration (FDA).  This 
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verbiage might either be the bane or panacea for an industry that is trying hard to focus 
on making the next block-buster drug, not on developing internal software.   
So, how does a large pharmaceutical company meet tightening FDA guidelines and 
accomplish their true drug discovery goal?  The solution might be in another type of 
integration- namely integrating laboratory processes, risk-based software validation, and 
a Commercial-off-the-shelf (COTS) system.  The resulting blend will nearly certainly 
hold more initial deployment pain for the laboratory, as the COTS system cannot be 
modified to completely fit the current laboratory processes.  Often, however, the 
validation and compliance benefits might greatly outweigh the initial costs. 
The thesis project consisted of developing a right-sized, risk-based validation 
package for a COTS chromatography data system (CDS) and the subsequent deployment 
of the validated software.  Validation included first developing a detailed risk assessment 
to guide right-sizing the validation effort, taking current regulatory guidance on risk-
based software validation into account.  This is the approach of a large pharmaceutical 
company that is seeking to minimize direct involvement in software development, while 
minimizing the significant risks that come from software, whether developed internally or 
by an outside vendor. This project explored the various ways risk-based validation and 
COTS software vendor management can reduce validation, deployment and maintenance 
costs, especially those associated with the testing and on-going maintenance of a COTS 
package. 
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1.  INTRODUCTION 
A. Introduction of subject 
While computer systems regulation for laboratory work was originally regulated at only 
the most basic level, in terms of location and suitability per 21 CFR Part 58 [1], more 
regulation was seen needed by the FDA as computers became ubiquitous and critical to 
operations in the pharmaceutical laboratory setting.  An excellent historical summary of 
this progression from regulatory apathy to regulatory scrutiny is provided by Ludwig 
Huber, detailing the progression from Part 58 compliance to modern day software 
validation [2].  Dr. Huber concludes the first guidance that clearly spelled out FDA 
expectations for software validation came in 1997 when the US Food and Drug 
Administration released a new regulation on electronic records and signatures, 21 CFR 
Part 11 [3].  This regulation also defined a much broader scope than before, requiring 
some type of validation or justification for all computers used to generate data in support 
of FDA submissions.  After a two year wait to permit industry to prepare, the FDA began 
enforcement of the regulation, often based on the interpretation of a particular FDA 
inspector.  The original regulation had no verbiage about legacy versus new systems and 
did not provide important distinctions between types of records and their criticality.  
Some inspectors would site firms for word processing software, while others were 
interpreting the regulation more narrowly.  As more and more firms received audit 
findings, the complexity of implementing and enforcing this regulation became clearer.  
A scramble to comply ensued, with the sudden genesis of a cottage industry supporting 
computer validation suddenly springing up.  A litany of FDA draft guidance [4-8] and an 
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enforcement guide [9] did not help the process as was intended.  Many industry leaders 
viewed these FDA draft guidance documents as equally hard to interpret [10].  
The process culminated when the FDA pulled all their draft guidance in February 2003.  
Significantly, the FDA wrote in the pull-back that it was concerned that some 
interpretations would: 
 “(1) unnecessarily restrict the use of electronic technology in a manner 
that is inconsistent with FDA’s stated intent in issuing the rule, (2) 
significantly increase the costs of compliance to an extent that was not 
contemplated at the time the rule was drafted, and (3) discourage 
innovation and technology advances without providing a significant public 
health benefit” [11]  
Consistent with their statements around “significant health benefit”, the FDA has moved 
toward a risk-based approach, refocusing on its original regulatory purpose of protecting 
the public from risks that might exist during the manufacturing and processing of food 
and drug products.  For Part 11 compliance, the culmination of this thinking was 
documented in a draft guidance issued by the FDA in February 2003 [12].  The final 
guidance was issued in August 2003 [13].   This new guidance focused heavily on risk-
based validation of systems and provided a clearer framework for narrowing computer 
validation based on risk, rather than the prior vague guidance that drove firms to huge 
validation efforts. 
While European regulatory bodies are also concerned with computer validation 
[14], the focus of this project will be on right-sizing the validation and deploying an 
electronic laboratory system in compliance with 21 CFR Part 11 in light of the current 
Guidance document dated August 2003 [13].  This right-sized, risk-based validation and 
deployment will account for the COTS status of the software, in contrast to activities 
expected for a custom coded application.  In particular, the system validation 
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documentation will be written to facilitate the deployment and maintenance of a large 
footprint COTS CDS within the existing workflow of a typical pharmaceutical testing 
laboratory.  
Chromatography Data Systems 
A CDS has the somewhat unique critical role of collecting a large quantity of 
truly raw, un-processed analog or digital data directly from laboratory instruments.  The 
CDS then must facilitate data processing, storage, and retrieval in a timely manner, 
usually under stiff performance requirements in order to meet critical manufacturing 
timelines.  Where LIMS, SDMS or ELN might aggregate raw or processed data, a CDS 
typically is a high-volume, high-criticality source system, often for a large portion of 
laboratory data within a typical pharmaceutical testing laboratory.  A CDS is often at the 
cross-roads of a process automation system and a laboratory system and has the inherent 
risks associated with both types of systems.  This type of system can undergo extensive 
regulatory scrutiny during audit, since it manipulates raw data.  The risk of fraud, often 
mitigated through many layers of system and process procedures, is relatively high at this 
level of systems interaction.  People can, and have, fraudulently performed 
chromatography assays [15]. 
Commercial off the Shelf 
Any discussion of the acronym of COTS often includes wrangling around the 
ideas of “customization” versus “configuration.” A typical definition of customization is 
any code that modifies the system behavior.  Configuration typically offers expansion of 
and control over the software without requiring code to be written.  A COTS system is 
typically assumed to include no customization, but it can have embedded functionality to 
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permit significant configuration.  Configuration capabilities within COTS systems is so 
ubiquitous that even notable validation experts interchangeably use the acronym COTS 
as “configurable off the shelf” software [16].  A COTS system can lend itself to reduced 
validation if the software supplier is found to be sufficiently reliable for software quality 
management. 
Risk-based 
Per the ISO/IEC Guide 51:1999, risk is “A combination of occurrence of harm, 
and the severity of that harm.”  Translated into the world of systems in the 
pharmaceutical industry, the FDA now requires an impact/risk assessment for systems 
that might impact “the accuracy, reliability, integrity, availability, and authenticity of 
required records and signatures” [11].  This requirement is enforced by regulation with 
extensive compliance activities. 
With such scrutiny, a validation effort around a critical system, such as a CDS, 
might seem to require a very robust effort.  Validation is certainly required to be 
complete and comprehensive for an enterprise-size CDS validation package; however, 
regulatory bodies are logical entities that understand the costs and benefits of a complete 
validation effort that might extend beyond the requirements to perceptively reduce risks.  
This understanding is certainly accommodated in the recent FDA guidance emphasizing a 
risk-based approach to validation.  For a firm deploying a large CDS, prudent balancing 
of costs and benefits would support the right-sizing of a software deployment and 
validation, based on a documented risk assessment. 
Right-Sizing  
Right-sizing is a term used to describe modifying a project’s approach to include 
consideration for external and internal influences.  When discussing risks and validation, 
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Walker Royce and Per Kroll, software developers from IBM and certainly no strangers to 
software validation, suggest: 
 “More process, such as usage of more artifacts, production of more 
detailed documentation, development and maintenance of more models 
that need to be synchronized and more formal reviews, is not necessarily 
better. Rather, you need to right-size (emphasis added) the process to 
project needs” [17] 
So, Royce and Kroll would emphasize that more is not always better.  A firm 
might greatly benefit from focusing efforts on those deliverables that are required by the 
FDA, rather attempting to create a large validation package that will difficult to maintain.  
That sort of validation may even pose more risk, since the firm might find it difficult to 
remain in compliance with its own processes, thus exposing the firm in an audit situation. 
B. Importance of subject 
Maybe risk-based, right-sized validation is a potential panacea for large 
pharmaceutical companies which are facing daily increases in pressure to deliver new 
drugs while tightly containing costs.  Since there is little public dissemination of true 
validation packages, the public debate has only been permitted to occur within select 
forums and limited context.  Most public discussion has been from a regulatory body to 
firms during calls for public comments, with little discussion of actual example 
deliverables that interpret the regulation and guidance.  Perhaps a public issuance of 
actual deliverables might lead others to understand how to apply complicated regulation 
and take full credit for choosing a COTS system versus a custom built solution.  The 
ability for review of risk-based right-sized COTS validation versus a more traditional 
non-risked based validation would be an important research goal. 
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C. Knowledge gap 
There is little available material of actual complete software validation 
documents, ready to be modified for a specific company’s use or at least discussed in 
public venue.  The dissemination of this project’s risk-based deliverables will provide a 
source of several very common validation documents without the need for an individual 
or company incurring the costs that would typically be required to purchase such 
deliverables from a third party or develop them in-house.  More importantly, the 
discussion of the merits of traditional versus risk based validation and COTS versus 
custom systems will also be advanced through creation of a tangible validation package. 
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2.  BACKGROUND 
A. Validation 
Software validation is the process by which system development and use are 
documented to a rigor that the FDA and other regulatory bodies find sufficient to ensure 
minimization of risks to the products generated by the manufacturing organization.  For 
decades, various professional bodies had documented approaches to validate software 
and systems [18-24].  While for many years, the FDA was focusing on computers almost 
as equipment and covered under Part 58, in June 1997 the Quality System Regulation 
took effect, including a Draft guidance, “General Principles of Software Validation, 
Version 1.1”.  This Guidance was finalized on January 11, 2002 as “General Principles of 
Software Validation; Final Guidance for Industry and FDA Staff.”  This guidance states: 
 “Validation requirements apply to software used as components in 
medical devices, to software that is itself a medical device, and to software 
used in production of the device or in implementation of the device 
manufacturer's quality system.”[25] 
A particular concern stated by the FDA in this guidance is the ease and speed at 
which software can be changed.  The agency fears that this will lead management to 
assume there does not need to be a tightly controlled process around something that is so 
easily fixed.  The guidance states: 
 “In fact, the opposite is true. Because of its complexity, the 
development process for software should be even more tightly 
controlled than for hardware, in order to prevent problems that 
cannot be easily detected later in the development process.”  
And 
 “For these and other reasons, software engineering needs an even 
greater level of managerial scrutiny and control than does hardware 
engineering.” 
 {Emphasis is from original text}[25] 
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It is readily apparent that the FDA sees software validation as a key component of 
a complete Quality System when producing pharmaceutical products and/or medical 
devices.  In the same Guidance, the Agency states this validation should include “an 
integration of software life cycle management and risk management activities”.  It also 
states “Validation coverage should be based on the software's complexity and safety risk 
- not on firm size or resource constraints” [25]. The smallest company has to comply with 
the same vigor as the largest company in a well defined way. 
A firm would be wise to ensure validation is complete, since the FDA assumes 
validation to be a necessary pre-requisite to use software for any data that is submitted to 
the agency for consideration.  Software validation has direct and significant impact on the 
willingness of the FDA to accept any data generated or manipulated by the system.  
Improper validation or lack of adherence to the system’s validation can lead to regulatory 
action, including dismissal of valuable data, intensive future government oversight, or 
even direction to immediately cease and desist using the system [26].  All these actions 
could prove significantly more expensive than a validation effort. 
B. What is the scope of validation? 
Validation deliverables should be defined within the context of a defined 
Software Development Life Cycle (SDLC).  Activities in such a SDLC would typically 
include: Quality Planning; System Requirements Definition; Detailed Software 
Requirements Specification; Software Design Specification; Construction or Coding; 
Testing; Installation Operation and Support; Maintenance; Retirement [25].  Validation 
deliverables should address all of these areas to ensure proper application of the SDLC to 
all system development and maintenance activities.  If one validation deliverable is not 
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addressed, a gap might create unexpected exposure to risks.  This exposure is particularly 
important in the pharmaceutical testing environment, given that the product being tested 
is often going directly into a human patient that intimately and completely trusts the 
safety of the product. 
It is exactly this sort of risk where the FDA is now focusing software validation 
compliance verification efforts.  Per the new guidance from the FDA, the scope of 
validation should be set at the time of the initial risk assessment.  The FDA focuses on 
the importance of this risk assessment as a vehicle to ensure all risks to patient safety are 
addressed.  As another benefit, industry might find a properly used risk assessment 
prevents excessive validation deliverables and extended effort in areas that might not 
provide sufficient risk mitigation to warrant the effort. 
As a practical example of over-validating, a validation effort could spend 
significant time around logical security for a system being deployed, drafting extensive 
scenarios and mitigation strategies, only to find later that a corporate firewall provides 
sufficient logical security so that the validation could just point to the pre-existing 
processes and procedures around that firewall.  A risk assessment effort would have 
scoped the validation early on to not include such effort around logical security 
mitigation measures.  
Proper understanding of the validation scope in terms of all the policies, 
procedures, and systems that surround and support a system validation and deployment is 
the only way to truly deliver a right-sized, risk-based validation package.  For this 
project, the focus of the risk assessment is on a CDS, as noted in the dashed line in Figure 
1 below: 
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Figure 1, Scope of Risk Assessment and Validation 
C. Risk Assessment Process 
Given the expense of software development, deployment, and support, firms 
would be well-served to focus time and effort on the risk management effort early in the 
validation planning activities around any system.  The purpose of risk management is 
making informed decisions by the appropriate people in order to focus on the most 
critical aspects of a process and, in this case, to focus the computer system validation 
effort on those critical functions.  Risk management is an iterative process and should be 
updated as necessary throughout the system life cycle. 
The results from this risk management/assessment activity will be used as input to 
determine the extent of validation for the Chromatography Data System (CDS) and to 
focus the validation effort on those areas that will have the most impact on ensuring 
product quality and record integrity.  This risk assessment will permit a firm to 
adequately assess what true risks the system exposes to the firm’s products, as well as aid 
a firm in managing system development, deployment and post-deployment support. 
 11
It is worth a firm’s time and effort to ensure all risks are identified and addressed 
during system development.  If a risk cannot be mitigated to a low risk priority through 
development activities, then alternate means of controlling/minimizing the risks can be 
explored.  The cost of these alternate means is much less early in the development 
process, rather than later. 
Key to the risk assessment effort is a clear pre-defined business process to scope 
the process.  In this case, the process would include the flow of data and activities for a 
chromatography data system within the laboratory in scope of the validation effort.  A 
final, complete, and detailed process can and probably will include many non-system 
considerations, such as procedures and people.  While a detailed business process will 
obviously be developed during the requirements phase, often the risk assessment phase is 
prior to this effort and might be limited to a high level overview.  The danger is that 
sufficient detail must be included to not expose the company to unexpected risks.  The 
basic overview process must not be too generic and should not be based on a 
preconceived model of how the genre of system being validated is used within a 
laboratory.  Whether a detailed process or an overview, the process used for risk 
assessment must be specific for the laboratory in question.  Anything else will expose the 
laboratory to risks associated with any unique requirements that the laboratory has in 
comparison to the generic example. 
For the risk assessment portion of this project, a high-level diagram of the 
business process was created.  Figure 2 below details the high-level process of a CDS in a 
typical pharmaceutical laboratory: 
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Figure 2, Chromatography Data System Process Flow 
 
D. Right-sizing based on risk 
While an increased focus on risks to product quality, safety, or efficacy is the 
critical benefit of risk assessment, another tangible benefit of this initial risk assessment 
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is right-sizing the validation effort, scaling the validation to fit with system risks and 
complexity.  Right sizing is not a buzz-word; it is a necessity for compliance at a depth 
that does not drive a firm out of using e-records systems, whether through maintenance 
costs or audit findings.  It can also be particularly applicable to COTS system 
implementations, since the software vendor might provide sufficient high-quality 
validation with their commercial product that a firm can mitigate risks without actually 
creating large, expensive, in-house validation packages. 
E. Research Question 
How can a COTS system validation package be right-sized based on a 
comprehensive risk assessment so that the deployment addresses risks to laboratory 
processes and data while remaining congruent with the goal of a pharmaceutical 
laboratory, namely to produce laboratory results not software? 
F. Intended Research Project 
The task of this thesis project will be to create the key elements of a right-sized 
validation package for a large chromatography system.  Specifically, validation 
deliverables for a generic CDS will be created when practicable, and then the key 
elements of a specific validation package for Empower®, a COTS CDS from Waters® 
Corporation, will be created. 
This effort will include comprehensive generic risk assessment and requirements 
documents for a typical chromatography data system deployed in a large pharmaceutical 
laboratory.  The generic risk assessment and requirements will drive the creation of 
validation deliverables in a risk-based and right-sized fashion.   
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Also as part of this project, after validation is authored, an Empower environment 
will be configured to demonstrate the practicality of the proposed validation package. 
The validation of Empower will attempt to demonstrate in a tangible and 
comprehensive way one possible way of validating a COTS solution versus a custom 
solution.  Deployment of a COTS solution with a right-sized validation might streamline 
design and testing while still mitigating risks identified in the chromatography data 
system risk assessment. 
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3.  METHODS 
A. Materials and instruments 
1.) Dependent Software 
Support software is required to open embedded report files, help files, and 
instrument control related files stored within the Empower application.  The 
following file extensions need to be supported for Empower deployment: htm and 
pdf.  Empower 2 at IU will require Windows 2003 Server and Microsoft Explorer 
as well as the software list in Table 1 for the storing of data and the opening of 
embedded files.  
Application Required Supporting Application 
Microsoft Internet Explorer version 6 or later version 
certified by Waters 
X 
Adobe Acrobat Reader  version 5.0 or higher X 
ORACLE (RDBMS) version 10.1.0.4.0 X 
Windows XP, Service Pack 1 or later version certified 
by Waters 
X 
Table 1, Applications Associated with Empower 
Additional software is required to complete this project, including elements of the 
Microsoft Office suite; Word, Excel, and Visio. 
2.) Empower Application License and Server 
Waters first released CDS software in 1993, called Millennium.  The 
current iteration, called Empower 2 (Empower Build 2154), is an upgrade of the 
prior version.  This CDS application and other Waters applications are deployed 
throughout the top 10 pharmaceutical companies, with over 200 installations [27]. 
 16
3.) IUPUI Local Area Network (LAN) 
The Risk Assessment process assumes the Empower application is 
installed on a server at IUPUI.  The system would utilize the IUPUI LAN to 
connect with Empower clients installed on local client computers.   
B. Validation Methods 
1) Risk Assessment: 
The risk classification method in the newest version of the Good 
Automated Manufacturing Practices (GAMP) guidance [28] is applied to assess 
and rate risks.  Using the GAMP 5 tables illustrated in Figure 3 below, risks are 
identified and an initial assessment is completed.   
Step 1: Calculation of Risk Class: 
Probability  Severity 
Low (1) Medium (2) High (3) 
High (3) Medium      High  High 
Medium (2) Low Medium High 
Low (1) Low Low Medium 
Step 2: Calculation of Risk Priority: 
Detectability  Risk Class from Step 1 
High (3) Medium (2) Low (1) 
High (3) Medium High High   
Medium (2) Low Medium High 
Low (1) Low Low Medium 
 
Probability = Likelihood of the fault occurring 
High-Frequently; Medium-Occasionally; Low- Seldom 
 
Severity = Impact on Patient Safety, Product Quality, Data Integrity (or other harm) 
High-Direct impact; Medium-Indirect impact; Low-Little or no impact  
 
Detectability = Likelihood that the fault will be noted before harm occurs 
High-Very Likely; Med-Likely; Low-Unlikely 
Figure 3, GAMP 5 Risk Assessment Tables 
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This assessment determines the risk priority of Low, Medium, or High for 
an uncontrolled risk given the GAMP defined risk factors of Probability, Severity, 
and Detectability. Uncontrolled risks within a pharmaceutical testing laboratory 
that are not prioritized Low priority, based on the GAMP table, might typically 
require some control.  Then, after controls are proposed, the new estimated Low, 
Medium, or High risk priority is determined.  If the controlled risk remains above 
Low, additional controls might be put in place or the laboratory might accept 
those risks and be forced to create other processes to mitigate them.  The GAMP 
method was chosen for this project because GAMP is an established and well-
respected document quoted by the FDA as source material in much of their 
guidance. 
The risk assessment process was mapped to the User Requirements and 
did not attempt to track risks back to functional requirements, given the COTS 
status of the intended deployed system.  This is appropriate within the newest 
GAMP 5 methodology, as described on page 120 of Appendix M3 [28].   
2) User Requirements: 
A workshop approach was used to determine generic CDS requirements, 
as detailed in Requirements by Collaboration: Workshops for Defining Needs 
[29].  This activity occurred within a single large pharmaceutical company, but 
the requirements have been documented for this project in a fashion that makes 
them truly generic to almost any large pharmaceutical company or even to many 
other types of laboratories using a CDS. 
 18
An UML (Unified Modeling Language) approach was deemed best to 
present these generic CDS requirements. UML is a modeling language used to 
explain requirements and guide design.  Use Cases within UML are part of this 
requirements model and specify a system’s requirements from a user-centric point 
of view [30].  This user-centric approach is best used with systems that rely on 
direct user interaction to initiate and/or complete system activities.  Given the 
extensive user interactions required with use of a CDS, this Use Case 
methodology is deemed appropriately applied.  The verbiage of Use Cases and 
their associated scenarios are also familiar to CDS users, permitting them to read 
and understand requirements.  Developers, or for a COTS, Configurers also 
understand how to deliver the system given their previous training in UML-based 
requirements and design. 
Use of Microsoft Visio® with built-in templates greatly simplifies creation 
of Data Flow and Use Case Diagrams. This software package guides creation of 
these tables and figures, through automatic application of UML theory.  Other 
packages also provides these features, but without as tight an integration to the 
Microsoft Office suite of products. 
3) Testing: 
Testing is a very expensive part of validation, so a key advantage of a 
COTS system is relying on the vendor’s testing where deemed appropriate.  In the 
case of Empower, a right-sized reduced testing effort would seem justified based 
on several factors.  These factors include: 
- Wide-spread usage of Empower throughout industry [27] 
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- GAMP guidelines [31] 
- A successful well-documented independent vendor audit [32] 
- Other international guidance [33] 
The ability to reduce testing is a large advantage to a COTS deployment.  
Clear guidance has been established that this sort of testing approach is 
appropriate.  An excellent example is ICH Q7A (GMP for active pharmaceutical 
ingredients), in §5.4 on Computerized Systems, which states in §5.42: 
“Commercially available software that has been qualified does not require the 
same level of testing” [33].  If a COTS system has extensive qualification 
(testing) from the vendor, verified and documented in a vendor audit, the system 
can be deployed with a reduced testing effort. 
Given this guidance, the quality systems of the vendor for the COTS 
application to be deployed are of particular interest when discussing right-sizing 
of in-house testing.  For the Empower system in this project, this vendor is Waters 
Corporation.  Waters is a larger vendor of laboratory analytical equipment and 
informatics software.  This vendor also has a documented vendor audit that 
speaks favorably of Waters and its SDLC and testing efforts [32]. The audit was 
provided by Watson pharmaceuticals and details the extensive Quality 
Management Systems that Waters has in place to ensure Empower is a quality 
product prior to delivery to customers.  In particular, Waters has implemented an 
extensive automated testing capability that ensures the basic core system is 
appropriately tested after any small changes, however small, are applied. While 
test scripts can be created, controlled, and executed in a myriad of automated and 
 20
non-automated tools, this sort of automated testing is often a necessary activity to 
prevent significant risk of a defect not being tested.  Waters extensive automated 
test suite ensures test personnel actions do not impact the results of test on the 
core Empower functionality. 
With the vendor audit available and using GAMP and other guidance, a 
right-sized testing approach is proposed in this project, eliminating most unit and 
integration level testing, pointing requirements that would normally require it to 
the vendor testing.  This approach can greatly reduce system implementation 
time, for the first and future vendor releases.  This approach is in stark contrast 
with the testing that would be required in a custom CDS solution.  A custom 
solution requires the firm creating it to perform detailed code reviews, unit level 
testing, boundary testing, and performance testing, all at a very detailed level. 
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4.  RESULTS 
A. Generic CDS versus Empower 
There were two distinct activities associated with this project: CDS validation 
followed by specific configuration for an Empower environment.  Traditionally, 
validation activities might typically begin with a system specific Validation Plan; 
however, a critical intent of this project was to create validation documents that were as 
transferable as possible to another CDS.  To achieve this goal, the CDS Risk Assessment 
and CDS Requirements Definition documents were written for a generic CDS, rather than 
focused on Empower.  These documents should be transferable to other CDS validation 
efforts, so long as the CDS is used in a similar laboratory setting.  This similarity in usage 
should not be assumed but evaluated on a case-by-case basis.  
The other validation deliverables created during this project were specific to the 
Waters-supplied Empower system.  This a necessary approach, given that validation 
documents after these early phases include detailed design, testing, and support 
documents that require vendor specificity to be meaningful. 
B. CDS Risk Assessment 
The first step of the thesis project was using a workshop approach with subject 
matter experts from a large pharmaceutical firm to determine generic CDS risks.  This 
effort followed GAMP guidelines [28] to assess a large summary of anticipated risks 
when deploying a CDS into a large pharmaceutical laboratory.  Business and Information 
Technology risks associated with a CDS, as well as risks related to product quality and 
record integrity, were addressed as part of this risk assessment.  Project management 
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risks, such as resourcing and costs, were not included, although it would be prudent for a 
firm to identify risks in these areas prior to implementation. 
The timing of the risk assessment process was much earlier in the validation 
process than suggested by some notable experts in CDS validation.  Bob McDowall, for 
example, suggests risk assessment be part of the requirements traceability and testing 
effort [16].  One consideration is that this later timing might be too late in the process to 
adequately identify risks in a timeframe that permits inclusion of those risks as input into 
vendor selection and requirements definition.  The earlier risk assessment timing in this 
project permitted prospective consideration of expected risks, leading to inclusion in the 
Validation Plan certain validation deliverables for risk mitigation.  These deliverables 
might have otherwise be missed if risk assessment had waited for the later timing 
suggested by McDowall. 
1) Peripheral Systems 
The scope of any risk assessment must define the boundaries for 
peripheral systems.  For this project, four peripheral systems were identified, 
including the common Laboratory Information Management System (LIMS).  
There are certainly other peripheral systems that were not included in the scope, 
most notably SDMS and ELN systems.  An assessment of the risks of these 
systems when used with a CDS could be undertaken as part of a separate research 
effort. The systems assessed in this project are summarized in Table 2 below: 
Peripheral System Assumption 
LIMS o Risks associated with CDS to LIMS transfers will be assessed 
o Risks associated with the use of LIMS are out-of-scope  
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Instruments o Risks associated with instrument firmware and instrument to 
CDS software communication will be assessed 
o Risks associated with qualification will not be assessed 
Printers o Risks associated with printer to CDS software communication 
will be assessed 
o Risks associated with printer hardware and installation will not 
be assessed 
Network/ 
Infrastructure 
o Risks associated with network communication will be assessed
o Risks associated with network installation and hardware will 
not be assessed 
Table 2, Peripheral Systems Associated with a CDS 
2) Definitions 
The types of records produced/managed by the CDS within a typical 
laboratory were defined.  Five record types were identified during this process 
and are defined in Table 3 below: 
Record Type Description 
 
Audit Trail 
A secure, computer-generated, time-stamped record used to 
independently record the user, date and time of operator entries and 
actions that create, modify, or delete electronic records. Record 
changes shall not obscure previously recorded information. 
Configuration System records that identify system parameters (report names, 
project size, and other specifications) 
Security System records that identify what access a user may have.  User 
types and privileges, user groups, etc.   
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Record Type Description 
 
Raw Data 
Any laboratory worksheets, records, memoranda, notes, or exact 
copies thereof that are the result of original observations and 
activities of a laboratory and are necessary for the reconstruction and 
evaluation of the result data. Raw data may include photographs, 
microfilm or microfiche copies, computer printouts, magnetic 
media, including dictated observations, and recorded data from 
analysts and automated instruments. 
 
Result 
The consequence of the application of a calculation or series of 
calculations to raw data that produces an interpretable and 
meaningful outcome for the attribute that is being measured.  Data, 
such as weights, that are generated external to the CDS and that are 
necessary to complete these calculations are documented, controlled 
and verified according to laboratory procedures. While these 
externally-generated data are stored in CDS, the CDS is not the 
source of the raw data.  Stored in a result record are the results along 
with the appropriate identifiers or links to the appropriate identifiers. 
Table 3, CDS Record Types 
3) Predicate Rules 
The risk assessment effort was based on FDA predicate rules and 
guidance, while applying GAMP methodology to determine the actual risk 
priorities.  There were five sections within 21CFR Part 211 predicate rules that 
were deemed to directly apply to use of a CDS within a typical pharmaceutical 
laboratory.  All the predicate rules found within 21CFR Part 11 were also deemed 
directly applicable to this risk assessment.  There are certainly other predicate 
rules that apply, especially to electronic records; however, this project focused on 
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a pharmaceutical analytical laboratory, thus Part 211.  To clarify which Part 211 
sections were deemed pertinent, those sections are summarized below in Table 4:  
Reference Content 
211.68 (a) • Automatic…equipment…including computers…may be used in the 
manufacture, processing, packing, and holding of a drug product. …, 
it shall be routinely calibrated, inspected, or checked according to a 
written program designed to assure proper performance. Written 
records of those calibration checks … shall be maintained. 
211.68 (b) • Appropriate controls shall be exercised over computer or related 
systems to assure changes in master production and control records 
or other records are instituted only by authorized personnel. Input to 
and output from the computer or related system of formulas or other 
records or data shall be checked for accuracy. The degree and 
frequency of input/output verification shall be based on the 
complexity and reliability of the computer or related system…a 
written record of the program shall be maintained along with 
appropriate validation data… 
211.180 (a) • Any production, control, or distribution record that is required to be 
maintained in compliance with this part and is specifically associated 
with a batch or a drug product shall be retained for at least 1 year 
after the expiration date of the batch…  
- Records required under 211.180 (records identified above) shall 
be readily available for authorized inspection during the retention 
period at the establishment where the activities described in such 
records occurred… 
- Records may be retained either as original or as true copies 
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Reference Content 
211.194 (a) • Laboratory records shall include complete data derived from all tests 
necessary to assure compliance with established specifications and 
standards, including examinations and assays… 
- Description of the sample with identification of source, quantity, 
lot number or other distinctive code, date sample was taken, date 
sample was received 
- Statement of each method used in the testing 
- Statement of the weight or measure used for each test, where 
appropriate 
- A complete record of all data secured in the course of each test 
(graphs, charts, spectra) properly identified to show the specific 
component, drug product, container, closure, in-process material, 
or drug product, and lot tested 
- A record of all calculations performed in connection with the test, 
including units of measure, conversion factors, and equivalency 
factors 
- A statement of the results of tests and how the results compare 
with established standards of SISPQ for the component, drug 
product container, closure, in-process material, or drug product 
tested 
- The initials and signature of the person who performs each test 
and the date(s) the tests were performed 
- The initials or signature of a second person showing that the 
original records have been reviewed for accuracy, completeness, 
and compliance with established standards 
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Reference Content 
211.194 (b) • Complete records shall be maintained of any modification of an 
established method employed in testing. Such records shall include 
the reason for the modification and data to verify that the 
modification produced results that are at least as accurate and reliable 
for the material being testing as the established method. 
Table 4, Predicate Rules for Pharmaceutical Manufacturing 
4) Identified Risks 
During a risk assessment workshop of subject matter experts from a large 
pharmaceutical manufacturer, sixty four (64) specific CDS risks were identified.  These 
risks were organized around four specific risk elements: People, System, Vendor and 
Record.  These risks elements were found to encompass all risks associated with a CDS 
and its usage in a laboratory setting. With the risks, mitigating controls were defined to 
reduce the risk priority status.  The most often recommended controls included Vendor 
Management, testing, user training and a procedure for Data Release and Review.  
Vendor management is a key control for 11 Vendor risks, 2 Record risks, and 2 System 
risks.  Training mitigated 17 People risks and 4 System risks.  Various types of testing 
mitigated 10 System risks and 6 Record risks.  A procedure for Data Release and Review 
mitigated 11 People risks and 4 Record risks.  It would appear these deliverables would 
typically be necessary when deploying a CDS into a large pharmaceutical laboratory.   
Even with recommended controls, some risks remained in a High or Medium risk 
priority status.  These would be the risks that the lab must accept as part of deploying a 
CDS with the limited set of proposed controls.   
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It was also noted that some of the risks associated with Vendor will always not be 
fully mitigated.  This is an attribute of deploying a COTS system that is created and 
maintained by a company different from the laboratory. A company purchasing a COTS 
system must be prepared to accept some risks that might typically be more controllable 
for in-house developed systems.  For example, the fiscal viability of the COTS system 
vendor is an issue that is typically out of the customer’s control, although data can be 
analyzed to bring a certain level of comfort to the COTS customer. 
Another significant area of risk was people risks.  With deployment of a COTS 
CDS, the user interface is limited to that supplied by an outside vendor.  If the interface is 
complex, user errors and confusion can erode the benefits of deploying a COTS system.   
The risk mitigation for these risks was typically user training.  A key element to consider 
when assessing vendors of the CDS would be to review the user training provided by the 
vendor to determine if it would suffice for the firm deploying the software. If not, the 
firm should integrate the costs of custom training for their staff into that vendor’s bid. 
There are also some significant Record risks that are inherent in any client-server 
system such as a COTS CDS.  Even with a well-tested COTS system, a vendor can only 
test a limited number of expected environments in which their product will be deployed.  
A firm deploying a complex client-server system will have to perform some in situ 
testing of the system to adequately mitigate these types of localized risks.   
Also unique by firm would be the processes that surround the COTS CDS.  
Deployment of a COTS CDS might necessitate changes in the laboratory processes to 
accommodate the inherent rigidity of a generic commercial CDS.  As determined during 
this assessment, one key area would be the processes surrounding the manipulation of 
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CDS data.  The recurring theme was risk mitigation via a data review and release 
procedure.  If the COTS CDS automates some of these data processes, that would have to 
be addressed in the procedure. If manual processes are required to supplement what is not 
automated within the CDS that would also need to be mitigated within the procedure. 
A separate CDS Risk Assessment document can be found as Appendix A.  A 
summary of the CDS Risk Assessment results can be found below: 
Risk 
Element 
Potential Risk 
 
Initial Risk
Priority 
Potential Mitigation 
 Measures 
Final Risk
 Priority 
People 
User selects incorrect 
processing method 
parameters (e.g. peak 
names, retention 
times) when creating 
or modifying a 
method 
High 
o Advanced Training for 
Method Developers 
o Method Creation and 
Review Procedure 
o Restricted Access for 
method creation and 
modification 
Low 
People 
User inputs incorrect 
sample parameters 
High 
o Basic Training for all users 
o Data Review and Release 
procedure 
Medium 
People 
User selects incorrect 
acquisition method 
parameters (e.g. 
instrument flow rate, 
data collection rate) 
High 
o Advanced Training for 
Method Developers 
o Method Creation and 
Review Procedure 
o Restricted Access for 
method creation and 
modification 
Low 
People 
User incorrectly 
identifies samples in 
sample set 
High 
o Basic Training for all users 
o Data Review and Release 
procedure 
Medium 
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Risk 
Element 
Potential Risk 
 
Initial Risk
Priority 
Potential Mitigation 
 Measures 
Final Risk
 Priority 
People 
Non-privileged user 
creates or modifies a 
method 
High 
o Restricted access for 
method creation and 
modification 
o Regular account roster 
review 
Low 
People 
User selects incorrect 
method to acquire 
data 
High 
o Basic Training for all users 
o System configuration 
facilitates correct method 
selection 
o Data Review and Release 
procedure 
Low 
People 
User selects incorrect 
method to process 
raw data files 
High 
o Basic Training for all users 
o System configuration 
facilitates correct method 
selection 
o Data Review and Release 
procedure 
Medium 
People 
User selects incorrect 
method to report data
Medium 
o Basic Training for all users 
o System configuration 
facilitates correct method 
selection 
o Data Review and Release 
procedure 
Low 
People 
User selects incorrect 
chromatography 
instrument to acquire 
data 
High 
o Basic Training for all users 
o System configuration 
facilitates correct 
instrument selection 
Low 
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Risk 
Element 
Potential Risk 
 
Initial Risk
Priority 
Potential Mitigation 
 Measures 
Final Risk
 Priority 
People 
User acquires data 
into incorrect sample 
set 
Medium 
o Basic Training for all users 
Low 
People 
User releases 
inaccurate result 
records into corporate 
LIMS 
Medium 
o Basic Training for all users 
o System Configuration 
Facilitates correct results 
selection 
Medium 
People 
User releases results 
when limits are 
failing 
High 
o Data Review and Release 
procedure Low 
People 
User performs tasks 
in CDS that are not 
validated nor 
supported by  team 
High 
o Security Design 
o Only specific options are 
allowed 
Low 
People 
User inappropriately 
overrides data 
disposition 
High 
o Basic Training for all users 
o Results Release Training 
o Data Review and Release 
procedure 
o Security Design 
Low 
People 
User inadvertently re-
integrates other user’s 
data 
Medium 
o Basic Training for all users 
o Data Review and Release 
procedure 
Low 
People 
User inadvertently 
reintegrates own data
Medium 
o Basic Training for all users 
o Data Review and Release 
procedure 
Low 
People 
User selects incorrect 
sampling rate (too 
high or too low) 
High 
o Basic Training for all users 
o Advanced Training Low 
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Risk 
Element 
Potential Risk 
 
Initial Risk
Priority 
Potential Mitigation 
 Measures 
Final Risk
 Priority 
People 
User re-processes 
with wrong method, 
calibration curve 
High 
o Basic Training for all users 
o Advanced Training 
o Data Review and Release 
procedure 
Medium 
People 
Support team is 
unable to provide 
sufficient support 
Medium 
o Operational Support 
training for support staff 
o Service Level Agreement 
High 
People 
User releases 
incorrect results to 
LIMS 
Low 
o Basic Training for all users 
Low 
System 
System is unable to 
maintain necessary 
performance 
standards 
Medium 
o Business Continuity 
Planning 
o Disaster Recovery Planning 
o Periodic Reviews 
o Appropriate training for 
support personnel 
o Adequate performance 
testing 
Low 
System 
Custom calculations 
are configured 
incorrectly 
High 
o Testing (configuration 
verification) 
o Training for development 
personnel 
Low 
System 
Firmware version of 
Instrument does not 
permit connection to 
the CDS 
High 
o Early notification of 
firmware changes from 
vendor 
o Vendor Management Plan 
High 
System 
Network becomes 
unavailable 
Medium 
o Disaster Recovery Plan 
Medium 
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Risk 
Element 
Potential Risk 
 
Initial Risk
Priority 
Potential Mitigation 
 Measures 
Final Risk
 Priority 
System 
Adequate system 
support does not exist
Low 
o System Acceptance 
commitment 
o High-level sponsorship 
Low 
System 
System security is not 
configured according 
to 
requirements/design 
High 
o Operational Support 
Training 
o Validated Security Design 
o Testing 
o Requirements Traceability 
Low 
System 
Instrument with un-
validated firmware 
acquires data into the 
CDS 
High 
o Communication strategy 
for firmware changes 
o Adequate Hardware 
Training 
o Data Review and Release 
procedure 
o Vendor Management Plan 
Low 
System 
Architecture does not 
provide enough 
redundancy in the 
event of outages 
Medium 
o Disaster Recovery Plan 
o Implement redundant 
Architecture Design 
Low 
System 
Data acquisition 
servers cannot 
communicate with 
databases 
Medium 
o Operational Qualification 
o Installation Qualification 
o Disaster Recovery Plan 
o Buffering of data 
High 
System 
Audit trails do not 
function properly 
Medium 
o System Testing 
o Client Acceptance Testing 
Low 
System 
Applications in the 
client affect the CDS 
functionality 
Medium 
o System Architecture 
Low 
 34
Risk 
Element 
Potential Risk 
 
Initial Risk
Priority 
Potential Mitigation 
 Measures 
Final Risk
 Priority 
System 
Data acquisition 
servers do not work 
as designed (do not 
buffer) 
High 
o System Testing 
o Operational Qualification 
o Installation Qualification 
Low 
System 
Data acquisition 
servers are not 
properly tested and 
validated for intended 
use 
High 
o System Testing 
o Installation Qualification 
o Operational Qualification Medium 
System 
Instruments are not 
connected correctly 
High 
o Installation Qualification 
Low 
System 
Data exceeds system 
storage capacity 
Medium 
o Performance Testing 
Medium 
System 
System does not 
permit reintegration 
and quantitation of 
data processed on 
prior CDS 
Medium 
o System Testing 
Low 
System 
Firmware update 
processes are not 
defined 
High 
o Release Management 
procedure Medium 
System 
Adequate change 
control processes are 
not defined 
High 
o Change Management Plan 
o Change Control procedure Low 
System 
System is not 
properly tested or 
validated for intended 
use 
Medium 
o Validation Plan 
o Test Plan 
Low 
 35
Risk 
Element 
Potential Risk 
 
Initial Risk
Priority 
Potential Mitigation 
 Measures 
Final Risk
 Priority 
System 
System clock is 
incorrect 
High 
o System Testing 
o Time Services 
Low 
System 
LIMS to CDS 
interface becomes 
unavailable 
Low 
o Business Continuity Plan 
Low 
System 
Data tapes from off-
site storage location 
cannot be retrieved in 
the event of a disaster
Medium 
o Disaster Recovery Plan 
o Business Continuity Plan 
High 
Vendor 
Vendor does 
not/cannot provide 
sufficient support 
Low 
o Vendor Assessment 
o Vendor Management Plan Medium 
Vendor 
Vendor discontinues 
support for version of 
software 
implemented 
Medium 
o Vendor Assessment 
o Vendor Management Plan 
Medium 
Vendor 
Vendor-provided 
software does not 
meet approved 
requirements 
Medium 
o Vendor Assessment 
o Vendor Management Plan 
Low 
Vendor 
Vendor is not 
financially or 
managerial stable 
Medium 
o Vendor Assessment 
o Vendor Management Plan Low 
Vendor 
Vendor does not 
deliver product by 
agreed delivery date 
Medium 
o Vendor Assessment 
o Vendor Management Plan Medium 
Vendor 
Vendor revises 
firmware frequently 
Medium 
o Vendor Assessment 
o Vendor Management Plan 
Medium 
 36
Risk 
Element 
Potential Risk 
 
Initial Risk
Priority 
Potential Mitigation 
 Measures 
Final Risk
 Priority 
Vendor 
Vendor does not 
provide timely 
firmware testing 
High 
o Vendor Assessment 
o Vendor Management Plan Low 
Vendor 
Vendor cannot meet 
licensing 
expectations 
Medium 
o Signed Contractual 
Agreement Low 
Vendor 
Vendors quality 
practices do not 
adhere to standards 
High 
o Vendor Assessment 
o Vendor Management Plan Low 
Vendor 
Vendors product has 
significant defects 
High 
o Vendor Assessment 
o Vendor Management Plan 
Medium 
Vendor 
Vendors product is 
discontinued 
Low 
o Vendor Assessment 
o Vendor Management Plan 
Low 
Vendor 
Vendors release 
strategy does not 
support internal 
release strategy 
High 
o Vendor Assessment 
o Vendor Management Plan 
Low 
Record 
Data cannot be 
migrated from legacy 
system 
High 
o Vendor Assessment 
o Vendor Management Plan 
o Data Migration 
Plan/Strategy 
Low 
Record 
Access to legacy data 
is limited 
High 
o Data Migration 
Plan/Strategy 
o Data archival system 
Low 
Record 
Printed record does 
not reflect electronic 
record 
Low 
o Vendor Assessment 
o Vendor Management Plan Low 
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Risk 
Element 
Potential Risk 
 
Initial Risk
Priority 
Potential Mitigation 
 Measures 
Final Risk
 Priority 
Record 
A record cannot be 
archived 
Low 
o System Testing 
Low 
Record 
Archived record does 
not match released 
data 
High 
o System Testing  
o Data Review and Release 
procedure 
Low 
Record 
A record could not be 
retrieved from 
archive 
Medium 
o System Testing 
Low 
Record 
A record is 
incorrectly retrieved 
from archive 
High 
o System Testing 
o Data Review and Release 
procedure 
Low 
Record 
A prep record from 
LIMS is incorrectly 
copied to the CDS 
High 
o System Testing  
o Data Review and Release 
procedure 
Low 
Record 
A result record from 
CDS is incorrectly 
copied to LIMS 
High 
o System Testing  
o Data Review and Release 
procedure 
Low 
Table 5, CDS Risks 
C. CDS Requirements 
Once the risk assessment efforts were completed, a set of generic CDS User 
Requirements was defined and documented using a Use Case approach within a 
Requirements Definition document.  A series of requirements workshops with key CDS 
stakeholders and users were conducted at a single large pharmaceutical manufacturer.  
The workshops followed the format and content prescribed within Requirements by 
Collaboration: Workshops for Defining Needs [29].      
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The first step of the requirements workshop process was determining the key 
stakeholders in that process.  They are described below: 
Stakeholder  Description People 
Advisor Reviews User Requirements for business 
impact and appropriateness 
Business Subject 
Matter Expert 
Direct User Analysts, IT support, Laboratory 
Management 
CDS Users 
Indirect User Additional business units that are impacted by 
the data and/or activities associated with CDS 
QA, QC, Regulatory, 
Manufacturing 
Owner Obtains business support, approves all 
requirements and system changes 
Business 
Management 
Supplier Large third-party CDS vendor CDS Vendor 
Table 6, Key Stakeholders for CDS Requirements 
Another early part of the requirements effort included creating a detailed set of 
Data Flows to ensure that no aspect of the system was ignored during the requirements 
process.  The Level 0, 1 and 2 diagrams are shown below in Figures 4 - 6: 
CHROMATOGRAPHY 
PROCESSCDS SERVER
INSTRUMENTUSER IN LABORATORY ROLE
OUTPUT DEVICE 
USER IN SUPPORT 
ROLE
LIMS DATABASE
 
Figure 4, Data Flow Level 0 
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Figure 5, Data Flow Level 1 
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Figure 6, Data Flow Level 2 
 
During the workshop process, it became clear that security was a key element of 
the requirements.  Assuming the Use Case and Scenario approach, a list of security 
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privileges associated with given actors was created to limit system activities to the correct 
actors. That information is summarized in Table 7 below: 
Actor Actor Privilege(s) 
Laboratory 
Instrument 
Acquire Data 
Master User Master Method Edit, Sequence Method Edit, Manage Sample Set, 
Manage Sample Set Queue, Instrument Configuration, Acquire 
Data, Process Data, Release Data, Report Data, Export Data, View 
Audit Trails 
Power User Manage Master Method, Master Method Edit, Sequence Method 
Edit, Manage Sample Set, Manage Sample Set Queue, Instrument 
Configuration, Acquire Data, Process Data, Release Data, Report 
Data, Export Data, View Audit Trails, Project Configuration 
Support Sequence Method Edit, Manage Sample Set, Manage Sample Set 
Queue, Instrument Configuration, Acquire Data, Process Data, 
Report Data, View Audit Trails, Project Configuration, System 
Configuration, Instrument Creation 
User Sequence Method Edit, Manage Sample Set, Manage Sample Set 
Queue, Instrument Configuration, Acquire Data, Process Data, 
Release Data, Report Data, Export Data, View Audit Trails 
Table 7, Security Privileges by Actor 
A total of eleven (11) Use Cases were defined for CDS use within a typical 
pharmaceutical manufacturing laboratory.  Within each Use Case were Scenarios that 
detailed the individual flows within that particular Use Case.  A total of 32 scenarios 
were defined.  Within each unique scenario were Functional Requirements specific to 
that particular scenario.  A total of 273 Functional Requirements were identified within 
the 32 scenarios.  Additional functional requirements (32) were also identified where the 
functional requirement did not fit only one scenario or any distinct, single scenario.  A 
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summary of the 11 Use Cases, 32 Scenarios, and 305 Functional Requirements are in 
Tables 8-10 below: 
1) CDS Use Cases and Descriptions 
Use 
Case ID 
Use Case 
Name 
 
Use Case Description 
UC01 Manage 
Method 
Describes the functionality for creating, editing, printing 
and copying methods.  Methods are used for data 
acquisition, data processing, exporting and result reporting. 
UC02 Manage 
Sample Set 
Describes the functionality for creating, editing, reviewing 
and searching sample sets. 
UC03 Manage 
Sample Set 
Queue 
Describes the functionality for managing the sample set 
queue.  This includes the starting, aborting, pausing, 
resuming and sequencing of the sample set queue.  The 
sample sets are queued for acquisition on an instrument. 
UC04 Acquire Data Describes the functionality for data acquisition from a 
laboratory instrument. 
UC05 Process Data Describes the functionality for processing of sample set 
data once data acquisition has completed successfully. 
UC06 Report Data Describes the functionality for reporting data, whether to a 
screen or to a printer.  
UC07 Release Data Describes the functionality for releasing data.  Data release 
is the activity by which data is given a disposition status 
appropriate to its content based on predefined business 
rules and procedures. This release process can involve 
sending data to another system (LIMS). 
UC08 Export Data Describes the functionality for outputting data via export 
functionality. 
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Use 
Case ID 
Use Case 
Name 
 
Use Case Description 
UC09 Manage 
Instrument 
Describes the functionality for configuring the laboratory 
instrument required for acquisition of a sample set. 
UC10 Manage 
Accounts 
Describes the functionality for user and system-level 
processes related to account management. 
UC11 Manage Data Describes the functionality for managing CDS data. 
Table 8, CDS Use Cases 
2) CDS Scenarios 
Scenario ID Use Case ID Scenario Text 
Sc01 UC09 The system controls a laboratory instrument 
Sc02 UC04 The system acquires data from a laboratory instrument 
Sc03 UC06 A user formats a report 
Sc04 UC06 A user displays data on the screen 
Sc05 UC01 A user creates a method 
Sc06 UC01 A user removes a method from use 
Sc07 UC01 A user copies a method 
Sc08 UC01 A user edits a method 
Sc09 UC01 A user edits a sequence method 
Sc10 UC08 A user exports a method 
Sc11 UC06 A user creates a report 
Sc12 UC01 A user copies a sequence method 
Sc13 UC01 A user locks a method 
Sc14 UC06 A user searches for a method 
Sc15 UC02 A user creates a sample sequence 
Sc16 UC02 A user modifies a sample sequence 
 43
Scenario ID Use Case ID Scenario Text 
Sc17 UC03 A user schedules a sequence on an instrument 
Sc18 UC05 A user processes a sample 
Sc19 UC03 A user aborts a sequence 
Sc20 UC06 A user displays and/or prints a report 
Sc21 UC03 A user modifies an instrument queue 
Sc22 UC06 A user searches for data 
Sc23 UC09 A user creates an instrument setup 
Sc24 UC09 A user modifies an instrument setup 
Sc25 UC07 A user dispositions a result 
Sc26 UC08 A user exports data 
Sc27 UC07 The system transfers data to a LIMS 
Sc28 UC09 A user monitors a baseline 
Sc29 UC03 A user pauses an acquiring sequence 
Sc30 UC10 A user logs into the system 
Sc31 UC10 A support user creates or modifies a user account 
Sc32 UC11 A user manages data 
Table 9, CDS Scenarios 
3) CDS Functional Requirements 
Scenario FR Number Requirement Text 
Sc01 FR01 
A user must have the capability to pass control parameters to an 
instrument  
Sc01 FR180 
The system must be able to control a laboratory instrument via 
a contact closure that is programmable for each injection. 
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Scenario FR Number Requirement Text 
Sc01 FR181 
The system must be able to control a laboratory instrument via 
a contact closure that is programmable for over the course of an 
entire sequence, not by injection 
Sc01 FR250 
The system must retain the following data for all samples: 
Instrument number; Sampling rate; Instrument Control 
Parameters; Voltage range 
Sc02 FR02 
The system must acquire data following user-configured 
parameters 
Sc02 FR59 
The system must be able to acquire weight data from a balance 
into the CDS 
Sc02 FR61 
The system must be able to acquire 3D data from a Photo 
Diode Array detector 
Sc02 FR183 Data must be buffered before written to the acquisition server. 
Sc02 FR184 
The system shall support an input range of  -0.25 v to 
+2.25volts 
Sc02 FR185 
The system shall support sampling rates between 0.25 and 100 
Hz inclusively 
Sc02 FR251 
The system must collect the following data for all samples: 
Sequence number; Assigned analyst 
Sc02 FR277 The system must allow acquisition during backup procedures 
Sc02 FR278 
In the case of a power failure, the system must automatically 
recover all data buffered at the instrument 
Sc02 FR286 
The system must be able to acquire 2D data from a Photo 
Diode Array detector 
 45
Scenario FR Number Requirement Text 
Sc02 FR322 
The System must require that input come from specifically 
authorized devices and perform device checks to verify the 
source.  If the source is invalid, the system must notify the user 
Sc03 FR03 A user must be able to format a plot in a report 
Sc04 FR230 
A user must be able to display a stack plot for multiple 
chromatograms from multiple sequences 
Sc04 FR231 
A user must be able to overlay multiple chromatograms from 
multiple sequences 
Sc04 FR232 
A user must be able to generate a sequential display for 
multiple chromatograms from multiple sequences 
Sc04 FR233 
A user must be able to overlay a solvent gradient on a 
chromatogram 
Sc04 FR234 
A user must be able to overlay a temperature gradient on a 
chromatogram 
Sc04 FR235 
A user must be able to display the following with the 
chromatogram on the screen: peak names, heights, areas, 
retention times, and results 
Sc04 FR236 
A user must be able to display the following with the 
chromatogram on a report: peak names, heights, areas, 
retention times, and results 
Sc04 FR237 
A user must be able to set individual preferences for what is 
displayed with the chromatogram on the screen 
Sc04 FR238 
A user must be able to display chromatograms in real-time as 
data are collected from an instrument 
Sc04 FR239 A user must be able to zoom within a chromatogram 
Sc04 FR247 A user must be able to place a text label on a chromatogram 
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Scenario FR Number Requirement Text 
Sc04 FR282 
The system presentation must have national language support 
and must be able to be implemented in the following language: 
English 
Sc04 FR285 
A user must be able to display the status of sequences and a 
sequence result report with injection and peak information after 
logging into the network via an external account provided by 
the company and then logging into the system 
Sc05 FR04 
Methods must include an assay specific default run template 
including: default placement of samples, standards, blanks, and 
control samples within a sequence; default standard 
concentrations 
Sc05 FR07 Method creation must require privilege 
Sc05 FR08 Methods must be definable at the laboratory level 
Sc05 FR151 
A user must be able to create a method without system 
suitability limits 
Sc05 FR152 
A user must be able to create a method without control sample 
limits 
Sc05 FR153 
A user must be able to create a method with control sample 
result limits 
Sc05 FR327 
A user must be able to create a method with check standard 
result limits 
Sc06 FR16 Method removal must require privilege 
Sc06 FR28 
Method audit trails must not be physically deleted from the 
system 
Sc07 FR17 Method copying must require privilege 
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Scenario FR Number Requirement Text 
Sc07 FR36 
A user must be able to copy a method from one server on the 
network to another 
Sc07 FR37 
The original system of a copied method must be identifiable 
after copying from one server to another 
Sc08 FR05 
Revisions to all methods must have a sequential revision 
number stored in the audit trail 
Sc08 FR06 All revisions of all methods must have a unique identifier 
Sc08 FR09 
Revisions to all methods must have a sequential revision 
number stored in the audit trail 
Sc08 FR18 Method editing must require privilege 
Sc09 FR11 
Changes to the sequence method must be included in the 
sequence's audit trail  
Sc09 FR20 Sequence method editing must require privilege 
Sc09 FR44 
An audit trail must be maintained for changes made to method 
parameters during sequence creation 
Sc09 FR95 
A user must be able to edit the non-acquisition portion of the 
method after sequence acquisition has started 
Sc09 FR97 
A user must be able to edit the sequence method before 
sequence acquisition has started 
Sc09 FR144 
A user must be able to modify the system suitability limits for a 
selected compound in a method 
Sc09 FR145 
A user must be able to modify the calibration curve limits for a 
selected compound in a method  
Sc09 FR147 
A user must be able to select at the sequence level whether 
limits are checked for samples or standards or both 
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Scenario FR Number Requirement Text 
Sc10 FR24 
The system must permit a method to be exported to a word 
processing program 
Sc10 FR25 Method exporting must require privilege 
Sc11 FR26 
A user must be able to display in a report a unique sequential 
revision number for a method  
Sc11 FR49 
A user must be able to display the identifications of the 
injections in a sequence in a report 
Sc11 FR127 
A user must be able to specify which peaks and which 
attributes will be reported 
Sc11 FR158 
A user must be able to display each replicate result along with 
the value of the average results 
Sc11 FR165 
A user must be able to include the following on a result report: 
software version number for data analysis and result calculation
Sc11 FR166 
A user must be able to include the following on a result report: 
acquisition machine 
Sc11 FR167 
A user must be able to include the following on a result report: 
processing machine 
Sc11 FR168 
A user must be able to include the following on a suitability 
result report: suitability calculation used 
Sc11 FR169 A user must be able to display specified limits on a report 
Sc12 FR31 
A user must be able to copy a sequence method to another 
sequence 
Sc13 FR32 A user must be able to lock a method  
Sc13 FR33 A user must be able to override the locking of a method 
Sc13 FR34 Method locking must require privilege 
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Scenario FR Number Requirement Text 
Sc14 FR35 
A user must be able to select methods by typing in the method 
code 
Sc14 FR55 
A user must be able to retrieve the total number of times a 
method was used by a given user  
Sc14 FR56 
A user must be able to retrieve the total number of times a 
method was used on a given instrument 
Sc15 FR38 
A privileged user must be able to retrieve a sequence file from 
an external LIMS and use it to create a CDS sequence file 
Sc15 FR39 
Changes to data within a sequence file must be synchronized 
between the LIMS and the CDS during transfer from one 
system to the other  
Sc15 FR40 
A user must be able to create a sample sequence without 
communicating with an external LIMS 
Sc15 FR41 
The system must provide the ability to sort preps received from 
an external LIMS by various fields (e.g. Lot Number) to aid in 
sample selection as the sequence file is being created. 
Sc15 FR47 
Each sequence must have its own unique identifier for each 
combination of server and data project 
Sc15 FR50 
The system must provide grid capabilities to facilitate sequence 
creation and editing (e.g., copy, cut, paste, auto-fill, exchange, 
insert, and delete) 
Sc15 FR51 
The system must provide a capability to auto-increment sample 
identifiers when creating a sequence 
Sc15 FR52 
The system must record the name of the user creating a 
sequence with that sequence 
Sc15 FR57 
The system must determine the factors and identifiers required 
for a sequence from the method 
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Scenario FR Number Requirement Text 
Sc15 FR58 
The system must allow a free text comment field stored with 
each sequence 
Sc15 FR60 
The system must permit a user to link transferred weight data 
from a balance system to the corresponding injection factors in 
a sequence 
Sc15 FR63 A sequence must be able to contain more than one method. 
Sc15 FR91 
A user must be able to create a sequence identifying at least one 
injection with each of the following injection types: blank, 
control, unknown, standard, check standard, suitability, test, 
and detectability 
Sc15 FR189 
The system must allow the notebook number and notebook 
page to be stored with each sequence 
Sc16 FR43 
Injections can be identified any time after the sequence is 
created but before results are calculated 
Sc16 FR92 
A privileged user must be able to add and delete an injection 
from a sequence before data acquisition starts 
Sc16 FR93 
A privileged user must be able to add and delete an injection 
from a sequence after data acquisition starts 
Sc16 FR96 
A privileged user must be able to substitute the non-acquisition 
portion of a method with another method after sequence 
acquisition has started 
Sc16 FR98 
A privileged user must be able to substitute the sequence 
method before sequence acquisition has started 
Sc16 FR99 
The system must require a privileged user to abort an active 
sequence before changing the acquisition portion of the method 
Sc16 FR190 
A privileged user must be able to modify the total number of 
injections for an acquiring sequence 
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Scenario FR Number Requirement Text 
Sc16 FR193 
A privileged user must be able to modify the run time of a non-
acquired injection in an acquiring sequence 
Sc17 FR42 
A user must be able to start a sequence by identifying only the 
data acquisition method, instrument number, and number of 
injections 
Sc17 FR53 
A user must be able to move a sequence to a different 
instrument with a compatible instrument type 
Sc17 FR64 
A user must be able to queue multiple sequences on an 
instrument 
Sc17 FR66 
A user must be able to queue a sequence with a delay of 48 
hours 
Sc18 FR14 
The system must allow a named peak in a method to be defined 
as the reference standard for any other peak in the 
chromatogram 
Sc18 FR15 
The system must allow the designation of more than one peak 
in the chromatogram as internal standard(s) 
Sc18 FR29 
The system must permit reprocessing of a sample using a prior 
revision of a method that has not been marked as logically 
deleted 
Sc18 FR62 A user must be able to process 3D Photo Diode Array data 
Sc18 FR101 
A user must be able to process a component in a sample 
injection from another component's standard curve 
Sc18 FR102 
A user must be able to process results in a sequence from a 
calibration curve acquired in another sequence 
Sc18 FR103 
A user must be able to process multiple components in a 
sample using multiple calibration standards from different 
sequences 
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Scenario FR Number Requirement Text 
Sc18 FR104 
A user must be able to logically delete a level from a standard 
curve and enter the appropriate audit comment 
Sc18 FR105 
The system must be able to create a normalized one-point 
standard curve 
Sc18 FR106 
A normalized one-point standard curve must be able to use the 
averages of the responses and concentrations as one point and 
then include the origin as the second point 
Sc18 FR108 
The system must be able to create a least squares calibration 
curve as corrected standard weight vs. response 
Sc18 FR109 
The system must be able to create a least squares calibration 
curve as 1/corrected standard weight vs. response 
Sc18 FR110 
The system must be able to create a least squares calibration 
curve as 1/corrected standard weight squared vs. response 
Sc18 FR111 
The system must be able to create a least squares calibration 
curve as log standard weight squared vs. log response 
Sc18 FR112 
The system must be able to create a non-linear, point-to-point 
calibration curve 
Sc18 FR113 
The system must be able to calculate the standard curve RSD of 
a multiple-level calibration curve 
Sc18 FR114 
The system must be able to create a calibration curve and 
calculate the normalized intercept to slope ratio, maximum % 
deviation, RSD of replicate injections, correlation coefficient, 
coefficient of determination, confidence interval parameters 
(slope, intercept, probability factors), actual intercept, and the 
actual slope 
Sc18 FR115 
A user must be able to process a single raw data file with 
several different methods 
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Scenario FR Number Requirement Text 
Sc18 FR116 
A user must be able to process a result to calculate the area 
percent of a peak as a percent of the total area of peaks 
integrated (within injection) 
Sc18 FR118 
The system must allow samples which have responses lower 
than the lowest point of the standard curve to be calculated by 
the normal regression line 
Sc18 FR119 
The system must allow samples which have responses lower 
than the lowest point of the standard curve to be calculated by a 
line drawn from the low standard through the origin 
Sc18 FR120 
The system must allow samples which have responses lower 
than the lowest point of the standard curve to be calculated by a 
line forcing the regression analysis through the origin 
Sc18 FR121 
The system must allow samples which have responses lower 
than the lowest point of the standard curve to be calculated by a 
second regression line of low concentration standards for the 
same component 
Sc18 FR122 
Sample responses that are greater than the highest response of 
the standard curve or less than the lowest response of the 
standard curve must be flagged as such 
Sc18 FR123 
The system must be able to create a calibration curve by 
grouping two non-consecutive peaks together 
Sc18 FR124 The system must be able to calculate dissolution results 
Sc18 FR125 
A calculated result must include a data integration revision 
number and time stamp 
Sc18 FR126 
The time stamp for a calculated result must be the actual time 
the calculation is performed 
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Scenario FR Number Requirement Text 
Sc18 FR129 
The system must be able to calculate a result for a peak using a 
response factor relative to another peak in the chromatographic 
run 
Sc18 FR132 
For a suitability sample, the system must calculate the 
following for a peak: retention time, peak width, theoretical 
plates, tailing, resolution, signal to noise, selectivity, and K-
prime 
Sc18 FR133 
For a suitability sample, the system must calculate the peak 
resolution for two non-adjacent peaks 
Sc18 FR135 
For a suitability sample, the system must provide the option of 
calculating system suitability parameters according to the USP 
calculations 
Sc18 FR136 
For a suitability sample, the system must provide the option of 
calculating system suitability parameters according to the EP 
calculations 
Sc18 FR137 
For a suitability sample, the system must provide the option of 
calculating system suitability parameters according to the JP 
calculations 
Sc18 FR138 
A user must be able to select the appropriate suitability 
calculation type to use for limit checking 
Sc18 FR146 
The system must flag peaks for all sample types if any of the 
following items are outside the limit: retention time, peak 
width, theoretical plates, tailing, resolution, signal to noise, 
selectivity, and K-Prime 
Sc18 FR148 
The system must flag peaks outside of limits configured in the 
method 
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Scenario FR Number Requirement Text 
Sc18 FR149 
The system must flag standards with a multiple-level 
calibration curve if any of the following items are outside the 
limit: the standard curve RSD of the line and the standard curve 
RSD of the normalized points 
Sc18 FR150 
The system must flag standards if any of the following items 
are outside the limit: the normalized intercept to slope ratio, 
maximum % deviation, RSD of replicate injections, correlation 
coefficient, coefficient of determination, confidence interval 
parameters (slope, intercept, probability factors), actual 
intercept, and the actual slope 
Sc18 FR157 The system must flag manually integrated peak areas 
Sc18 FR195 
The system must provide a graphical way to manually integrate 
peaks 
Sc18 FR196 
The system must be able to determine integration parameters to 
apply on a series on raw data from the integration parameters 
selected in a manual integration 
Sc18 FR197 
The system must give the user the option whether or not to save 
manual integrations the user has just created 
Sc18 FR198 
The system must provide a complete audit trail for any saved 
manual integrations 
Sc18 FR199 
A user must be able to review the integration history for an 
injection (using the audit trail) and to revert back to an previous 
set of integrations 
Sc18 FR202 
During manual and automatic integration, the system must use 
the raw data values to determine the y-coordinates of peak 
integration points 
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Scenario FR Number Requirement Text 
Sc18 FR203 
A user must be able to rename the peaks in a result without 
reintegrating 
Sc18 FR204 
The system must provide a background process for 
automatically integrating peaks 
Sc18 FR205 
The automatic integration process must be capable of 
integrating peaks at 3 times the noise level 
Sc18 FR206 
A user must be prompted for an audit trail reason when saving 
a automatic integration 
Sc18 FR207 Each integration must have a unique revision number 
Sc18 FR209 
The system must allow integrations to be performed 
automatically when the injection completes 
Sc18 FR210 
The system must be able to suggest analysis parameters (peak 
width, threshold, minimum area, minimum height) for a 
method based on a single injection 
Sc18 FR211 
The system must have the ability to identify peaks based on 
retention time (absolute or relative to a reference peak), relative 
peak position, or size within a window 
Sc18 FR212 
The system must have the ability to subtract a blank injection 
from a sample injection before automatically integrating peaks 
Sc18 FR213 The system must mark a blank subtracted result as such 
Sc18 FR214 
The following peak baseline types must be available: Valley to 
valley fit 
Sc18 FR215 
The following peak baseline types must be available: Vertical 
drop to a common baseline 
Sc18 FR216 
The following peak baseline types must be available: Tangent 
skim, backside 
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Sc18 FR217 
The following peak baseline types must be available: Tangent 
skim, front side 
Sc18 FR218 
The following peak baseline types must be available: 
Exponential skim 
Sc18 FR219 
The system must be able to integrate a peak based on a 
specified minimum peak area 
Sc18 FR220 
The system must be able to integrate a peak based on a 
specified minimum peak height 
Sc18 FR221 
The system must be able to integrate a peak based on a 
specified noise threshold 
Sc18 FR222 
When processing a suitability sample, the system must provide 
the following data: EP valley resolution 
Sc18 FR223 
When processing a peak, the system must provide the following 
data: peak height 
Sc18 FR224 
When processing a peak, the system must provide the following 
data: peak area 
Sc18 FR225 
When processing a peak, the system must provide the following 
data: peak start (x,y) and end points (x,y) for each peak 
Sc18 FR226 
When processing a peak, the system must provide the following 
data: baseline start (x,y) and end points (x,y) for each peak 
Sc18 FR227 
When processing a peak, the system must provide the following 
data: difference between the retention and start time at the 5% 
peak height, retention time at full height for a peak.   
Sc18 FR228 
When processing a peak, the system must provide the following 
data: peak width at baseline between resolution tangents for a 
peak 
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Sc18 FR240 
The system must be able to perform a chromatogram 
subtraction manipulation on two raw data files, saving the 
manipulated data while not changing the original data files 
Sc18 FR241 
The system must be able to perform a time shift manipulation 
on a raw data file, saving the manipulated data while not 
changing the original data file 
Sc18 FR242 
The system must be able to perform a scalar addition 
manipulation on a raw data file, saving the manipulated data 
while not changing the original data file 
Sc18 FR243 
The system must be able to perform a scalar subtraction 
manipulation on a raw data file, saving the manipulated data 
while not changing the original data file 
Sc18 FR244 
The system must be able to perform a scalar multiplication 
manipulation on a raw data file, saving the manipulated data 
while not changing the original data file 
Sc18 FR245 
The system must be able to perform a scalar division 
manipulation on a raw data file, saving the manipulated data 
while not changing the original data file 
Sc18 FR246 
The system must be able to perform a chromatogram addition 
manipulation on two raw data files, saving the manipulated data 
while not changing the original data files 
Sc18 FR252 
When processing a peak, the system must retain the following 
data: peak name, expected retention time (absolute), expected 
retention time (relative to another peak), and the Baseline type 
Sc18 FR253 
When processing a sample, the system must retain the 
following data: actual acquisition start date and start time 
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Sc18 FR254 
When processing a sample, the system must retain the 
following data: actual acquisition end date and end time 
Sc18 FR255 
When processing a sample, the system must retain the 
following data: actual injection run time 
Sc18 FR256 
When processing a sample, the system must be able to calculate 
the following data: noise amplitude (root mean square) 
Sc18 FR257 
When processing a sample, the system must be able to calculate 
the following data: Sample concentration, defined as 
SampleWeight/Dilution 
Sc18 FR258 
When processing a sample, the system must retain the 
following data: Software version of the integrator 
Sc18 FR259 
When processing a sample, the system must retain the 
following data: actual integration date 
Sc18 FR260 
When processing a sample, the system must retain the 
following data: actual integration time 
Sc18 FR261 
When processing a sample, the system must retain the 
following data: Name and system identifier of user who 
integrated the raw data 
Sc18 FR265 
The system must not allow processing of data that was 
generated from a different machine that had been running a 
newer version of the software 
Sc18 FR275 
The system must allow data processing during backup 
procedures 
Sc18 FR287 
A user must be able to process 2D data from a Photo Diode 
Array detector 
Sc18 FR289 
Every change to peak integration (automatic or manual) must 
be audit trailed 
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Sc18 FR323 
The system must perform the following calculations: Slope of 
the least-squares, linear regression line of the observed peak 
heights versus the expected peak heights, Standard Error of the 
least-squares, linear regression line of the observed peak 
heights versus the expected peak heights, Baseline Noise, and 
Baseline Drift 
Sc18 FR325 
The precision for suitability fields must be 6 digits after the 
decimal, including all fields that feed into results except area 
and height which are a precision of 0 
Sc18 FR326 
The precision for result fields must be 6 digits after the 
decimal, including all fields that feed into results except area 
and height which are a precision of 0 
Sc18 FR329 
The system must be able to calculate the RSD of the 
normalized points of a multiple-level calibration curve 
Sc19 FR67 A user must be able to abort an active sequence 
Sc19 FR68 A user must be able to abort a queued or delayed sequence 
Sc19 FR69 
A user must be able to restart an aborted sequence after the last 
acquired injection 
Sc19 FR100 
Aborting of a sample set must create an entry in the sequence 
audit trail 
Sc19 FR182 
When a sequence is aborted, the system must retain all raw data 
up to the point of aborting 
Sc19 FR187 
A user must be able to abort a sequence after the current 
injection 
Sc19 FR188 
A user must be able to abort a sequence immediately regardless 
of status 
Sc20 FR21 A user must be able to list a method on paper 
 61
Scenario FR Number Requirement Text 
Sc20 FR70 
A user must be able to report the number of sequences in the 
queue 
Sc20 FR71 
A user must be able to display the number of injections for each 
sequence in the queue 
Sc20 FR73 
A user must be able to display the method code for a sequence 
in a queue 
Sc20 FR74 
A user must be able to display the projected start and end times 
(per sequence) for sequences in the queue 
Sc20 FR86 
The system must be able to  track the component(s) used by an 
instrument 
Sc20 FR87 The system must be able to track method usage by instrument 
Sc20 FR88 The system must be able to track instrument usage by method 
Sc20 FR90 
The system must be able to display a summary of suitability 
data collected on an instrument for a selected period of time 
Sc20 FR155 
A user must be able to view a result as soon as it can be 
accurately calculated (i.e. before the sequence has completed, 
but after acquisition of any relevant standards) 
Sc20 FR156 
The system must permit reporting of flagged peaks which 
failed chromatographic parameters 
Sc20 FR159 
The system must be able to calculate the RSD of samples from 
the same lot number 
Sc20 FR160 
The system must be able to calculate the RSD of samples from 
the same sample number 
Sc20 FR161 
The system must be able to calculate the RSD of samples from 
the same storage conditions 
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Sc20 FR164 
The system must permit a user to view a report without printing 
it 
Sc20 FR179 
The system must be able to summarize system suitability 
statistics for selected methods in a report 
Sc20 FR248 
A user must be able to review all the audit trail information for 
a sequence in one location 
Sc20 FR262 
A user must be able to display the external standard run on a 
report for those sequences that use an external standard run 
Sc20 FR273 
The system must permit reporting of flagged peaks which were 
outside of acceptable ranges 
Sc20 FR276 
The system must allow data reporting during backup 
procedures 
Sc20 FR283 
The system reports must have national language support and 
must be able to be implemented in at least the following 
language: English 
Sc21 FR75 A user must be able to reorder queued sequences 
Sc21 FR85 
A user must be able to change the instrument a sequence is 
assigned to anytime prior to acquisition 
Sc22 FR76 
A user must be able to retrieve data by the analytical column 
name 
Sc22 FR82 
A user must be able to retrieve the instrument name for a 
sample sequence 
Sc22 FR83 
A user must be able to retrieve the number of injections 
actually made on an instrument 
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Scenario FR Number Requirement Text 
Sc22 FR89 
A user must be able to identify the instrument used to generate 
system suitability data for a selected sequence of data while 
sorting the data by method 
Sc22 FR94 
The system must inform a user that calibration standards are 
missing from a sequence if none exist in the sequence 
Sc22 FR264 
A user must be able to retrieve all the sequences that used a 
standard run as an external standard curve run 
Sc22 FR291 A user must be able to search for audit trails by sequence 
Sc22 FR292 
A user must be able to search for sequence method(s), peak 
integration(s), result calculation(s), and result release audit 
trail(s) by sequence 
Sc22 FR293 
A user must be able to search for method audit trail(s) by 
method name 
Sc23 FR77 
The analytical column used to acquire data on a 
chromatography instrument must be able to be tracked 
Sc23 FR78 
Instrument components must be permitted to be used in more 
than one instrument 
Sc24 FR79 
Modifying instrument components in an instrument setup must 
require privilege 
Sc24 FR80 
A user must be able to inactivate an instrument setup to make it 
unavailable for data acquisition 
Sc24 FR84 
A user must be able to change the component operating 
parameters in an instrument setup during sequence creation 
Sc25 FR130 A user must be able to disposition a suitability result 
Sc25 FR131 Dispositioning results must generate an audit trail entry 
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Scenario FR Number Requirement Text 
Sc25 FR139 
The system must permit a user to verify if a result has a status 
of rejected 
Sc25 FR140 A user must be able to enter a comment when rejecting results 
Sc25 FR141 A user must be able to release previously rejected results 
Sc25 FR170 
A user must be able to review and disposition results for an 
entire sequence 
Sc25 FR171 
A user must be able to review and disposition results for 
individual samples in a sequence 
Sc25 FR172 
A user must be able to review and disposition results for 
samples in a sequence while the sequence is still in progress 
Sc25 FR173 Dispositioning results must be limited to privileged individuals 
Sc25 FR174 
The system must provide for up to two levels of verification of 
the results prior to releasing the data 
Sc25 FR200 A user must be able to lock integrations after verification 
Sc25 FR201 A user must be able to unlock integrations 
Sc26 FR154 
A user must be able to export historical data for control 
samples to an external file 
Sc26 FR162 
A user must be able to export data in a word processor 
compatible format 
Sc26 FR163 
A user must be able to export data in a spreadsheet compatible 
format 
Sc26 FR178 
A user must be able to export data in a format compatible with 
external statistical packages 
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Scenario FR Number Requirement Text 
Sc26 FR271 
A user must be able to generate an export method that exports 
the following: sample identification information; item codes; 
lot numbers; individual results from final report; concentration; 
Area%; area; standard and sample weights; raw data points 
Sc26 FR281 
A user must be able to transfer screen contents from the CDS 
system to another application external to CDS 
Sc27 FR175 
The system must be able to transfer sample result data and 
associated sample identifiers to a LIMS upon a user's request 
Sc27 FR176 
The system must allow only released data to be transferred to 
LIMS 
Sc27 FR177 
The system must verify the integrity of each result prior to 
releasing it to the LIMS 
Sc28 FR186 
A user must be able to monitor a baseline without starting a 
sequence 
Sc29 FR191 
A user must be able to pause an acquiring sequence after the 
current injection is completed 
Sc29 FR192 
A user must be able to continue a paused sequence at a later 
time 
Sc30 FR302 
A user must be able to have different roles on separate servers 
as permitted by local management approval 
Sc30 FR303 Logging into the system will require unique identification 
Sc30 FR304 
The system must require that user identification codes be at 
least 7 characters 
Sc30 FR305 The system must require that passwords be at least 6 characters 
Sc30 FR306 
Users must be able to change their own passwords and be 
prompted to do so upon password expiration 
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Scenario FR Number Requirement Text 
Sc30 FR307 
Passwords must not be displayed or printed in a readable 
format 
Sc30 FR309 The system must record access violations for future review 
Sc30 FR311 
The system must suspend user access after three successive 
failed login attempts 
Sc31 FR298 
User access to the system must be defined at the laboratory 
level 
Sc31 FR300 
A user must be able to hold multiple roles in the system as 
permitted by local management approval 
Sc31 FR301 
A user must be able to have access to more than one laboratory 
on a server as permitted by local management approval 
Sc32 FR274 
The system must allow a user with privilege to Save/Rename 
spectral libraries and search those libraries 
Req Def FR12 
Whenever revisions to a record are made, the original entries 
must not be obscured 
Req Def FR13 
The system must have the ability to discern invalid records for 
raw data, result, security, audit trail, and configuration records 
Req Def FR48 
Electronic signatures and handwritten signatures executed to 
electronic records shall be linked to their respective electronic 
records to ensure that the signatures cannot be excised, copied, 
or otherwise transferred to falsify an electronic record by 
ordinary means 
Req Def FR72 
The system must include the following components as part of 
the signature on the electronic record:· Printed name of the 
signer, · Date and time of the execution of the signature and · 
Meaning associated with the signing 
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Scenario FR Number Requirement Text 
Req Def FR208 
When an electronic record that has been signed is displayed or 
printed, the signature elements must be viewable 
Req Def FR229 
Each electronic signature shall be unique to one individual and 
shall not be reused by, or reassigned to, anyone else - System 
must prevent duplication/reuse/reassignment of user ID 
Req Def FR249 
The system must be able to display, print and create electronic 
copies of all electronic records and their associated audit trails 
Req Def FR263 
At least one of the system user interface presentations must 
prevent multiple users from establishing concurrent sessions 
from a single terminal 
Req Def FR266 
The system must require that a user does not reuse a password 
that they have previously used 
Req Def FR267 
The system must close or lock all open windows when a user 
logs off the system 
Req Def FR268 
A user must perform first person verification before second 
person verification can be completed where two person 
verification is required by the laboratory 
Req Def FR269 
The system must provide the capability to create logical groups 
to logically group data to determine users accessibility to data 
Req Def FR270 
Printed name of the signer, date and time when the signature 
was executed, and meaning associated with the signing must be 
subject to the same controls as electronic records 
Req Def FR280 The system must allow for remote backups and support 
Req Def FR290 
The system shall be able to store default selections for the user 
to select when making a change 
Req Def FR294 The system must not permit the deletion of raw data files 
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Scenario FR Number Requirement Text 
Req Def FR295 The system must not permit the modification of raw data files 
Req Def FR296 The system must expire passwords automatically every 60 days 
Req Def FR308 Stored passwords must be encrypted and not readable 
Req Def FR312 
Reactivation of a suspended account must require system 
administrator intervention 
Req Def FR313 
Active system sessions must automatically lock after 30 
minutes of continuous inactivity 
Req Def FR315 Time stamps must be at least to the nearest second 
Req Def FR316 
Date/time stamps must be in a format that clearly reveals the 
month, day, year, and time zone 
Req Def FR317 
All date and time values must have leading zeroes where 
appropriate, e.g. 05:07:02 
Req Def FR318 The hour must be expressed in 24-hour format 
Req Def FR319 
Time stamps must use the time zone in which the acquisition 
server is located 
Req Def FR320 
The ability to set/reset system time must only be permitted by 
system administrators 
Req Def FR321 
The system must provide the capability to verify the time 
periodically with an external source to maintain 
synchronization 
Req Def FR333 
The system must provide a buffer used to retain raw data prior 
to writing to the acquisition server to prevent the loss of data if 
the acquisition server becomes unavailable 
Req Def FR337 
Any audit trail record must contain user id, date and time, full 
name, and the action taken of the user creating, modifying or 
deleting of raw data, result, security, and configuration records 
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Scenario FR Number Requirement Text 
Req Def FR338 The system shall not permit users to modify any audit trail 
Req Def FR339 
Creation, modification, or deletion of raw data, result, security, 
and configuration records will require an audit trail 
Table 10, CDS Functional Requirements 
The requirements are compiled in a CDS Requirements Definition in Appendix B.   
D. Validation Planning 
Once the Risk Assessment and Requirements processes were complete, the scope 
and content of the validation effort could be effectively planned.  Any validation requires 
significant planning due to both practicality and regulation.  The validation planning 
documents typically include a single Validation Plan approved prior to commencement of 
the validation effort.  The Validation Plan defines the validation strategy and describes 
the validation documentation that will be created. The Validation Plan serves as the set of 
criteria for accepting the system and approving the Validation Report.  It is also the 
opportunity to justify and explain any right-sizing efforts to be pursued.  The Validation 
Plan for this project defined a comprehensive list of documents.  Those marked below 
with a * were considered key deliverables and included as Appendices to this document: 
Validation Planning 
• Empower Validation Plan* 
• Empower Validation Roles and Responsibilities* 
Requirements 
• CDS Requirements Definition* 
• Empower Traceability Matrix 
System Design 
• Empower System Overview* 
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• Empower Security Design* 
• Empower Custom Field Design Specification documents* 
• Empower Template Project Design Specification document* 
Software Development and Source Code Review 
• No deliverables for software development will be created 
Testing 
• Empower Test Plan* 
• Empower Test Cases 
• Empower Test Scripts 
• Empower Test Summary Report 
• QAR document for vendor’s Installation, Installation Qualification, and 
Operational Qualification documents 
Training 
• Empower Training Plan* 
• QAR document for review of vendor’s training documents 
Vendor Management 
• Vendor Evaluation Report (ARC)* 
• Empower Vendor Management Plan – Waters* 
System Acceptance 
• Empower Validation Report 
• Release Description Document* 
Support Documents 
Security 
o Empower Security Plan 
Backup and Restoration 
o QAR document for review of vendor’s backup and restoration documents 
Disaster Recovery  
o Empower Disaster Recovery Plan  
Business Continuity  
o Empower Business Continuity Plan  
System Administration and Support 
o System Administration Document 
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Master Document List 
o Empower MDL 
Often, a Roles and Responsibilities section in the Validation Plan describes who 
will be involved and what the necessary qualifications are.  To simplify for the likely 
scenario that people and roles might change over the course of an extended validation 
effort, as well in support after the system is accepted, the Validation Roles and 
Responsibilities information can be placed in a separate document.  Validation Plan and 
Validation Roles and Responsibilities documents can be found in Appendix C. 
E. System Design 
Empower Design was a prime candidate for right-sizing, given the COTS origin 
of the systems.  This COTS status limits what the consumer can change; therefore, 
greatly reducing the design documentation effort.  This minimized design approach is in 
contrast to the often arduous design activities and deliverables required for a system 
deployment with extensive custom code.  Custom code deployments require code review, 
deep unit level testing, and tracing of each and every requirement through detailed 
Design to Testing.  For Empower, there is no custom code defined; the system is 
configured only completed within the confines of the vendor software. 
System design for a COTS system from such a strong vendor was right-sized into 
a high-level System Overview document, a Security Design document, to address 
customer-specific security configurations, and some specific design deliverables for 
configured portions of the COTS application.  Most of the 305 functional requirements 
were traced to the Vendor and required no additional design.  This approach is supported 
in the latest GAMP documentation [31], given Empower software and Waters supplier 
maturity. 
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1) System Overview 
The System Overview document defines the system components and provides 
general diagrams of the system.  Graphical representations of the design particulars can 
be seen in Figure 7 (System Components) and Figure 8 (System Overview) below: 
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2) Security Design 
The Security Design document details all configured security settings in the 
application.  Design settings include the configurations for: 
• Empower User Types 
• Empower User Groups 
• Empower System Policies 
• Server security 
• Instrument security 
a) Empower User Types 
To meet system requirements, only four User Types were deemed required: 
PowerUser, MasterUser, BasicUser, and Support.  ‘Administrator’ and ‘Guest’ are also 
default User Types in Empower and cannot be removed.  These Empower User Types are 
the key means of configuring user level privilege granularity.  Table 11 below describes 
these User Types in terms of what activities each User Type is expected to perform 
within Empower: 
User Type Description 
 
PowerUser 
Laboratory users that perform some support activities, method 
development/management activities, and typical laboratory activities
 
MasterUser 
Laboratory users that perform method development/management 
activities and typical laboratory activities 
BasicUser Laboratory users that perform typical laboratory activities 
Guest People with very limited (read-only) access to the CDS 
Support Users that support the CDS, but do not perform laboratory analyses 
Administrator Default User Type with all privileges 
Table 11, Empower User Type Descriptions 
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As User Types are created in Empower, the system requires the selection of the 
individual privileges to be assigned to each User Type.  Security Design documents each 
of these privileges for the User Types listed in Table 11 above.  Then, the Empower 
system can be configured to match Security Design.  Table 12 below details the 
privileges assigned to these Empower User Types: 
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Administrator  x       
Archive and Remove Sample/Project Archives x       
View Audit Trails x x  x x x  
Archive System Audit Trails x x      
Clear/Restore Offline System Audit Trails x       
Clear/Restore Offline Project/Sample Archives x       
Restore AutoArchived Projects x       
Paste Shallow Copies x       
Lock Channels x   x x   
Unlock Channels x x  x x   
Alter Custom Fields x       
Create Custom Field x       
Delete Custom Field x       
Lock Custom Field x       
Unlock Custom Field x       
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Alter Default Strings x   x    
Create Default Strings x   x    
Delete Default Strings x   x    
Alter Plate Type x       
Create Plate Type x       
Delete Plate Type x       
Alter System Policies x       
Alter Any Project x x      
Backup Projects x x      
Create Projects x x  x    
Create Projects at the Root x x  x    
Delete Projects x       
Restore Projects x x      
Change Project Parent x x  x    
Lock Projects x x  x    
Unlock Projects x x  x    
Change Project Owner x x  x    
Change Project Quota x x      
Create Project Path x x      
Change Project Path x x      
 76
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Specify Project Path x x      
View Multiple Projects x x  x x x  
Alter Users x x      
Create Users x x      
Delete Users x x      
Alter User Type x       
Create User Type x       
Delete User Type x       
Alter User Groups x x      
Create User Groups x       
Delete User Groups x       
Allow Shallow Copies of FAT Projects x       
View Quantitation Peak Fields in Review x x  x x x x 
Allow Calibration & Quantitation in Review x   x x x  
Alter Customized Time Zone List x       
Run Empower AQT x x      
Validation Administrator x   x    
Alter Project Type x   x    
Delete Data x       
Export Data x x  x x x  
 77
 
 
 
PRIVILEGES 
A
dm
in
ist
ra
to
r 
Su
pp
or
t 
Po
w
er
U
se
r 
M
as
te
rU
se
r 
Ba
sic
U
se
r 
G
ue
st
 
Import Data x       
Delete Libraries x       
Save Libraries x   x x   
Rename Libraries x   x x   
Delete Export Methods x   x    
Save Export Methods x   x x   
Delete Instrument Methods x   x    
Save Instrument Methods x x  x x x  
Delete Locked Methods x   x    
Lock Methods x   x x   
Delete Processing Methods x   x    
Save Processing Methods x   x x   
Modify Integration Parameters x x    x  
Modify Component Times x     x  
Modify Component Constants/Default Amounts x       
Delete Reporting Methods x   x    
Save Reporting Methods x x  x x   
Modify Report Scaling Only x     x  
Modify Default Report Methods x       
Modify Default Report Groups x       
 78
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Clear Read Only Methods x x  x x   
Save Methods as Current x   x x   
Delete Sample Set Methods x   x    
Save Sample Set Methods x x  x x x  
Delete Sample Set Mth Templates x   x    
Save Sample Set Mth Templates x   x x   
Delete Method Sets* x   x    
Save Method Sets x   x x   
Delete Validation Protocol Methods x       
Save Validation Protocol Methods x       
Delete Tune Methods x       
Save Tune Methods x       
Delete MS Calibration Methods x       
Save MS Calibration Methods x       
Delete 3D After Processing x       
Copy To Projects x x  x x   
Delete Calibration Curves x       
Save Calibration Curves x   x x x  
Delete Results x       
Save Results x   x x x  
 79
 
 
 
PRIVILEGES 
A
dm
in
ist
ra
to
r 
Su
pp
or
t 
Po
w
er
U
se
r 
M
as
te
rU
se
r 
Ba
sic
U
se
r 
G
ue
st
 
Save Results and Calibrations in Review x   x x x  
Delete Validation Studies x       
Save Validation Studies x       
Clear Read Only Validation Studies x       
Sign Off Results 1 x   x x   
Sign Off Results 2 x   x x   
Approve Validation Protocol Methods x       
Approve Validation Study Data x       
Override Validation Data Checks x       
Specify Report Methods for Sign Off x   x    
Alter Sample x x  x x x  
Save View Filters x x  x x x  
Make View Filters Public x x  x    
Acquire Samples x x  x x x  
Edit Sample Sets x x  x x x  
Reinject Samples x       
Allow Interactive Sys Changes x x      
Alter Running Sample Sets x x  x x x  
Access Real Time Plot from Open Access x       
Alter Any Queue x x  x x x  
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Alter My Queue x       
Warn on Service Limit x       
Use Wizard Templates x x  x x x  
Allow Remote LAC/E Reboot x x      
Access Real Time Review From Run Samples x x  x x x  
Verify Incomplete Data in Raw Data Files x   x    
Table 12, Empower User Type Privileges 
b) User Groups 
While User Types control privileges, Empower User Groups control access to 
data, instruments, and acquisition servers.  User Groups were defined in three types: a 
‘Support’ User Group, a ‘Lab_Power’, and a ‘Lab_User’ User Group.  The Support User 
Group was given access to all projects, acquisition servers, and instruments.  In contrast, 
the two ‘Lab_’ User Groups are used to create distinct data areas, called Labs, on the 
Empower system.  The Lab is a value that changes based on what data and instruments 
the user needs access to.  This approach permits requirements for segregating data by 
laboratory to be fulfilled.  Each ‘Lab_’ User Group is only given access to distinct 
instruments and data associated with the proper laboratory.  Whenever a data project or 
instrument is created, the support personnel assign the correct ‘Lab_’ User Group(s).  
There can be more than one ‘Lab_’ User Group assigned to a data project or instrument.  
The Lab_Power group is for Power Users to reboot acquisition servers (LAC/Es). 
 81
c) System Policies 
A key part of configuring Empower for use within a specific laboratory is 
implementing a lab-specific set of System Policies.  These policies are Waters-provided 
settings that permit a customer to configure their Empower environment to meet local 
requirements.  This is a key functionality within Empower, basically permitting a 
‘custom’ system without custom coding.  Based on the user requirements in this project, 
configuration is required.  The following System Policy settings are appropriate: 
User Account Policies Tabbed Page 
Check all boxes in the Accounts and Passwords section, with the following details: 
• Passwords Expire every 60 days 
• Limit # of Entry Attempts to 3 tries 
• Enforce Minimum Password Length of 6 characters 
Check all boxes in the Login Window Policies section, with the following details: 
• Global Default User Interface is QuickStart 
New Project Policies Tabbed Page 
Check the following options in the Default Full Audit Trail Settings section: 
• Full Audit Trail Support 
Select the following options in the Default Full Audit Trail Settings Section: 
Project Object Comment Confirm Identity
Method Unrestricted  
Result Unrestricted  
Sample Unrestricted  
Deletion Unrestricted  
 82
Check the following options in Full Audit Trail Settings Section: 
• Don’t allow user to change default Full Audit Trail Support Setting 
• Don’t allow user to change default ‘Require User Comments On’ Setting 
• Don’t allow user to copy from non-FAT projects into FAT projects 
System Audit Trail Policies Tabbed Page 
Select the following options for the table in the System Audit Trail Policies Section: 
System Object Comment Confirm Identity 
Project Unrestricted  
Empower Nodes Unrestricted  
System Unrestricted  
Library Unrestricted  
User Unrestricted  
User Group Unrestricted  
User Type Unrestricted  
Plate Type Unrestricted  
System Audit Trail Unrestricted  
Offline System Audit Trail Silent  
Project/Sample Archives Silent  
Offline Project/Sample Archives Silent  
Default Strings Silent  
Database Properties Silent  
AutoArchive Properties Silent  
System Policy Unrestricted  
SDMS Archive Properties Silent  
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Data Processing Policies Tabbed Page 
Check all boxes in Data Processing Policies section, with the following details: 
• Do NOT check Use v2.XX Style Retention Time Calculations 
Check all boxes in Data Processing Technique section, with the following details: 
• Default Integration Algorithm is Traditional 
Other Policies Tabbed Page 
Check all boxes in Result Sign Off Policies section, with the following details: 
• Sign Off Inactivity Delay of 30 minutes 
• Multiple signoff behavior:  Allow the Same Reasons 
• Do NOT check any boxes in the Valid Sign Off 1 Reason(s) section 
Check all boxes in Other Policies section, with the following details: 
• Applications Timeout after 30 minutes 
• Do NOT check Disallow Use of Annotation Tools 
Select the following details in the Date Display Policies: 
• Show Region Abbreviation 
• Use “long” date formats 
E-Mail Policies Tabbed Page  
Do not make any changes to this section. 
d) Server Security 
The database server for Empower was configured to have standard Windows 
security groups via the IUPUI WAN.  Users have no access to the raw data files, only 
being permitted to access them via the UI. 
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Each Empower Acquisition server (LAC/E) is configured to have Lab_Power, 
Support, and Administrator User Types having access, where Lab is the appropriate 
laboratory for that LAC/E. 
e) Instrument Security 
Each chromatographic system (instrument) is configured to have Lab_Power, 
Lab_User, Support, and Administrator User Types having access, where Lab is the 
appropriate laboratory for that chromatographic system.  This limits access of instruments 
to only those laboratory personnel that are associated with a particular laboratory, 
meeting requirements for individual laboratories within the Empower system. 
3) Custom Fields 
To meet the user requirements, one area that involved more design was the 
creation of several “custom fields” in the Empower software.  These fields are truly 
configured within the software and were not defined as custom code. The risk associated 
with these custom fields, however, required creation of unique Design Specification 
documents. Each custom field was given a unique Design Specification to ensure 
traceability.  The Design Specification described the custom fields in terms of the COTS 
package configuration required to create the custom field.  For example, a calculation that 
had a numerical result would have the “precision” defined, since that is a configured 
setting when creating a numerical custom field within Empower.  The number of custom 
fields a laboratory chooses to use within Empower will directly correlate to the design 
and testing effort associated with an Empower deployment.   Often, however, this sort of 
configuration is required to permit a laboratory to tailor a COTS package to fit their 
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present business model and process flows.  That was the case within this project, with 7 
custom fields being defined.  These custom fields are listed in Table 13 below: 
Field Name Description Requirement(s) 
ChromColumn Text field permitting a user to enter the 
analytical column associated with a sample 
FR76, FR77 
ChromComments Text field permitting a user to enter a 
comment associated with a sample 
FR58 
ChromConcentration Calculation field for ChromConcentration: 
= Sample Weight / Dilution 
FR257 
InjType List of values permitting a user to enter the 
injection type associated with a sample 
FR91 
Lot Text field permitting a user to enter the 
Lot number associated with a sample 
FR159, FR271 
Notebook Text field permitting a user to enter the 
notebook identifier associated with a 
sample 
FR189 
NotebookPage Text field permitting entry of the notebook 
page identifier associated with a sample 
FR189 
Table 13, Empower Custom Fields 
‘Dilution, ‘Level Values’, ‘SampleName’ and ‘SampleWeight’ are also default 
Custom Fields in Empower and cannot be removed.   
4) Template Project 
Empower software is logically controlled via data projects, which are stored as 
distinct tablespaces in the Oracle environment.  To control the deployment of the 7 
custom fields described above, a Template Project was created.  The configuration 
required was described in a corresponding Template Project Design Specification. 
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System Overview, Security Design, Custom Field Design Specifications and the 
Template Project Design Specification, can be found in Appendix D. 
F. System Testing 
Drawing upon strategies outlined within the GAMP Good Practice Guide: Testing 
of GxP Systems [31], testing for the Empower implementation was an example of 
validation right-sizing.  The GAMP Good Practice Guide specifically directs: 
“On purchasing a configurable package the User does not need to 
repeat testing already carried out by the Supplier, assuming the Supplier 
has a suitable quality management system in place and that the package is 
‘standard’ (rather than being developed or modified specifically for the 
Users’ application).  
The application life cycle test activities can be limited to those which 
verify that the configuration has been correctly implemented such that the 
overall system performs as defined in the user requirements.” 
This GAMP guide focuses attention on the supplier’s Quality Management 
System (QMS) to determine scope of testing for a COTS system.  The supplier (vendor) 
for Empower, Waters Corporation, has a robust positive audit history, including a very 
positive Audit Repository Center (ARC) audit from the respected International 
Association for Pharmaceutical Science and Technology [32].  The finding states that 
“auditors found that Waters has a very well organized formal system to document the 
software development life cycle.”  Also important to note is that the 94 page audit 
checklist contained within this audit.  The checklist included a detailed review of Waters 
focused on the detailed QMS followed for software development.  Auditors felt that the 
“Waters Quality system is defined” and “Regular scheduled internal audits are performed 
throughout the year”.  The auditors determined that this “Auditing ensures that 
procedures reflect working practice.”  Of particular interest, there are 16 pages of the 
checklist dedicated solely to Testing, all with positive outcomes.  Given this audit, the 
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testing for Empower will not include replicating the testing already completed by Waters 
Corporation.  Testing will rather rely on the supplier testing, and only supplement what 
Waters already provides as part of purchasing the COTS software.  This approach is also 
espoused by Bob McDowall as he says “only test your configuration of the system” and 
“Even for high-risk systems, I would suggest that you only test representative 
functions…”  [16].   
This GAMP guidance and audit history resulted in formulating a test strategy that 
primarily focused on Vendor Management, rather than the tedious and expensive unit 
level testing activities that are so critical with custom applications.  These unit level tests 
are superfluous and not warranted when purchasing well-tested COTS code.  System 
level and Acceptance testing was typically considered sufficient for overall system 
activity confirmation, with the few unit level testing and the associated unit level test 
scripts reserved for the custom fields created in Empower and security configurations.   
A Test Strategy document that explains the overall testing approach and rationale 
is found in Appendix E, with most content repeated in this report.  A breakdown of 
testing, based on audit findings and GAMP guidance, is detailed in Table 14 below: 
Test Level  Description 
Unit • Application Configurations 
IU specific configurations of the Empower system will be visually 
verified versus the corresponding system design document(s). This 
class includes the template project and application security 
configurations. The application configurations will be tested on a 
server (not project) basis.   
• All Unit Test scripts must be successfully and completely executed 
and reviewed prior to the execution of higher-level tests. 
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Test Level  Description 
Unit • Custom Fields 
IU will perform unit testing on any custom fields introduced or 
modified in a release. 
The type of custom field will determine the type of testing, with two 
fields types identified: Data Entry and Calculation. 
o Data entry fields are defined as fields that have no arithmetic 
formula identified in the Design Specification, such as 
keyboard entries or data copied.  
Data Entry fields will be visually verified against the pertinent 
system design document.   
o Calculation fields are defined as fields that have an arithmetic 
formula identified in the Design Specification.  
Calculation fields will be fully functionally tested versus the 
logical conditions specified.  
• All Unit Test scripts must be successfully and completely executed 
and reviewed prior to the execution of higher-level tests. 
Integration Integration level testing should primarily be conducted during system 
testing when Empower owns an automated data transfer interface to 
another system.  When applicable, the ownership of the interface should 
be documented in the test plan of a given release of Empower. 
If applicable, additional integration tests may optionally be created and 
conducted to verify operational details of interactions and data 
transaction status between Empower – Interface Engine – The System 
Transferring Data to/from Empower without executing the entire end-
to-end system tests.   
If present, the Integration Tests must be successfully and completely 
executed and reviewed prior to the execution of higher-level System 
tests.   
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Test Level  Description 
System  System level testing will consist of a test designed to verify that all 
components utilized/impacted by the Empower application are working 
together correctly in the IU environment.  This test will be 
comprehensive and end-to-end. 
The System Test must be successfully and completely executed and 
reviewed prior to the execution of higher-level Acceptance tests. 
Acceptance Acceptance testing will be conducted for each major release.   
The Acceptance test consists of:  
• Demonstration of new or changed functionality   
• Presentation of system requirements not fulfilled by the release 
Key Business Partners will grant approval that the release is acceptable 
for implementation.   
The Acceptance Testing is a demonstration of the system functionality. 
The timing of this demonstration is independent of the System level 
testing status. Any issues identified during the execution of the 
Acceptance Test will be evaluated for impact on the System Level tests 
and impacted tests will re-executed as necessary.  Any re-execution of 
System tests will necessitate new Acceptance testing. 
Regression IU relies on the software vendors to perform regression testing.  
For all IU Empower releases, an impact assessment will be conducted to 
determine which Empower Unit, Integration, and System level tests will 
be executed as the Regression suite. 
For the changes to the IU design elements, in particular the calculation 
custom fields, the calculation dependencies will be analyzed to 
determine which custom fields depend on the results produced by a 
modified custom field. All custom fields dependent on a modified 
custom field will be subject to a regression test that will consist of re-
executing the existing unit test script for the dependent custom field.  
Table 14, Empower Testing 
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1) Unit Testing 
The manner in which calculation custom fields will be tested requires additional 
detail.  Custom fields for Empower are created via a custom field wizard.  The fields 
within this wizard accept input form the configurer and then use vendor code to assemble 
the correct custom field.  With this built-in functionality, various aspects of these input 
fields are tested by the supplier.   If a custom field has been configured to have a lower 
limit in the custom field wizard, for example, the ability of the system to limit entry of 
values below that limit will not be implicitly tested.  The rationale is that the accuracy of 
the custom field wizard to translate a lower limit inputted during system configuration 
has been tested by the supplier during extensive software testing.  Also, the width of a 
custom field in the database, although configured by the user, will not be directly verified 
in the database.   Once again, accuracy of the custom field wizard to translate a width 
limit inputted during system configuration has been tested by the supplier. 
Due to the potential for calculations to be mis-entered, Empower custom field 
testing will compare any calculated value obtained in a custom field versus Excel.  The 
comparisons will be driven from the field values entered on the corresponding Empower 
Custom Field Design Specification, as created to meet Functional Specifications.  
Comparison of differing arithmetic engines is always a challenge, given the way 
computations are carried out differently when crossing calculation platforms.  In this 
case, the arithmetic precision of Excel and Empower calculation algorithm engines may 
differ; therefore, small differences between the expected result and the actual result are 
permitted as follows: 
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The precision for which the custom fields will be tested is taken from the precision 
attribute in the corresponding Empower Custom Field Design Specification. 
1. Any values extracted from Empower for input to the calculation will be entered 
on the workbook using the precision defined in the Empower Custom Field 
Design Specification for the source data field. (e.g. If SampleWeight is an input, 
then whatever precision was specified for SampleWeight will be applied when 
entering the field into the Excel sheet calculation.) 
2. The calculation result precision will be entered in each workbook as defined in 
the Empower Custom Field Design Specification for the target field. 
3. The test will be considered successful if the difference between the Empower 
result and the test workbook result taken at the result precision recorded on the 
workbook is less than or equal to 0.001% according to this formula:   
Absolute[(Empower_result - Workbook_result ) / Empower_result] <= 0.00001 
While 0.001% is arbitrary, there does need to be some concession for the 
differences between any two calculation engines, in this case Excel and Empower.  This 
value provides a reasonable difference that can occur without leading to significant risk 
that the calculation within Empower is incorrectly calculated. 
Template project configuration and Security configurations will also be unit 
tested, with visual verification that settings have been appropriately applied versus the 
design documentation.  The functionality of the system will not be verified, just that the 
settings have been properly applied.  For example, the template project will be verified to 
ensure the appropriate number of custom fields is contained within the project.  A 
security example would be the user requirement that states passwords shall have a 
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minimum length of 6 characters.  This is a configured setting within the Empower 
software.  The Unit test will visually verify that the software setting has been properly 
applied to require a password of at least 6 characters in length. The test will not include 
actual entering of a password to verify that less than 6 characters are not permitted. The 
supplier has already tested that functionality.  
In addition to the unit level testing activities listed above, installation and 
qualification verifications can also be purchased from the supplier to document platform 
and installation testing.  The intent of this project would be to purchase installation, 
installation qualification, operational qualification, and performance qualification from 
the vendor.  These routine protocols are one area in which right-sizing can be 
emphasized, negating the need for testing in these areas.  Only a Quality Audit Review 
(QAR) of the vendor documentation will be required to document the review of the 
vendor materials.   
While this approach does expose the firm to additional costs, the purchase of 
these qualifications from the vendor reduces testing costs and eliminates the cost of 
maintenance and execution of separate firm-specific installation and qualification 
protocols.  This savings offset the initial and on-going costs of purchasing from the 
vendor. 
2) Integration Testing 
As noted above, it is assumed that no interfaces presently exist with Empower.  If 
interfaces were created, these should be tested per the design of the interface.  For 
example, a future LIMS interface would require an integration testing effort to confirm 
that the interface does not impact other portion of Empower and functions as expected. 
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3) System Testing 
This is an area of testing that cannot be eliminated by using supplier testing, since 
each implementation can have its own unique characteristics.  A simple set of end-to-end 
tests will verify that the system functions in total and in location.  
4) Regression Testing 
This is typically an expensive type of testing, since it is on-going during the entire 
lifetime of a software deployment.  Fortunately, this is one area that a good supplier can 
add the most value.  Waters conducts extensive regression testing using an automated test 
suite that performs days of testing in hours.  Regression testing will rely on Waters, other 
than testing custom fields if changes are made that impact a field.  If additional efforts are 
required, a separate assessment will document those efforts. 
5) Acceptance Testing 
With a COTS system, this type of testing becomes particularly important.  Rarely 
does a non-custom software package not have unmet requirements, might may only be 
identified by thorough acceptance testing.  While many of these are non-critical and do 
not impact laboratory operations, some of these requirements might leave such large gaps 
in the current business process so that the software is not deployable without significant 
action by the laboratory.  If large gaps to exist, this does not doom the software to failure, 
but it does require robust acceptance testing, including full disclosure and discussion of 
gaps in software functionality versus business process.  With appropriate attention, the 
system can still be successfully deployed without unexpected and costly laboratory 
impact. 
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6) Gap Analysis 
As part of the Validation Report, a gap analysis will be completed to document 
areas of the system that remain risks after System and Acceptance testing is complete.  
This discussion will also include what mitigation steps will be required to address those 
gaps. 
G. Training 
For training, the decision to deploy a COTS solution can reduce the validation 
effort if the laboratory can rely on vendor training, rather than creating a custom set of 
training materials.  This approach is only valid if the laboratory is willing to undergo the 
expense of using vendor training and potentially modifying processes to correspond with 
generic vendor training.  Waters does offer on-site courses for customers when the 
number of students is large enough.  The expense of these courses, and the on-going 
expense of training new users, must be weighed versus the maintenance nuisance of 
custom training.  Often, the maintenance costs of custom training might equal or exceed 
the costs of just relying on vendor training.  If the laboratory already routinely creates 
training materials and has the processes and procedures in place to handle custom 
training materials, then the Empower training could be a custom course, potentially 
providing a lower cost option when new users are added to the laboratory. 
Whatever the choice made, the training for a system deployment must be 
complete and accurate, covering all aspects of system use that are commonly used within 
the laboratory.  Training is an area that gets significant regulatory scrutiny, since a system 
is only as complete as the training of its users. 
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For the purposes of this project, it was assumed that the laboratory would use the 
vendor training; once again an example of right-sizing based on assessed risks.  While a 
Training Plan was necessarily created (Appendix F), the plan does rely on vendor 
training, with documentation of vendor training review via a Quality Audit Review 
(QAR) of the training documentation. 
H. Vendor Management 
A vendor of a high-risk system such as a CDS should require an actual vendor 
audit [16].  The vendor for Empower, Waters Corporation, was deemed to be reliable and 
have an adequate QMS and defined SDLC, based on a publicly available third party 
audit.  While results from this point-in-time audit were used to right-size validation 
efforts, the maintenance of Waters in a reliable and consistent state of compliance must 
be assured. 
Thus, the vendor management portion of the validation was scrutinized and made 
more robust, given the emphasis placed on vendor management as a key control to 
mitigate vendor-related risks.  Without vendor control and management, a COTS system 
can quickly become a risk-laden, even dangerous, system.  An uncontrolled vendor can 
deploy a system that appears to be solid and well-tested, but lacks any foundation of 
quality that ensures even the most basic laboratory activities are valid and supportable. 
Some expected risks of an Empower deployment and the plans to mitigate them 
are listed in Table 15 below: 
Risk Mitigation 
Waters testing of selected 
requirements that IU deems critical 
may not meet IU’s expectations.  
Rely preferentially on vendor testing wherever 
possible.  Mitigate with local testing if 
necessary.   
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Risk Mitigation 
IU is unaware of a critical defect Waters communicates defects on their web-site 
in a timely manner.  IU will monitor the Waters 
web-site as part of system management 
activities, performing assessments of defect 
impacts deemed necessary. 
Waters may not communicate 
changes in their quality system.  
Frequent review of Waters certifications via 
review of public records and Waters 
publications.  If significant changes occur, 
perform additional evaluation. 
Waters may not address defects or 
enhancements deemed critical by IU 
in a time frame acceptable to IU. 
Communicate any critical issues to Waters 
support immediately.  Communicate timelines 
to users to permit them to adjust processes as 
needed. 
Waters may delay delivery of new 
versions, releases, and service packs.
Communicate any critical timelines to Waters 
support immediately.  Communicate timelines 
to users to permit them to adjust processes as 
needed. 
Waters does not communicate 
defects that are found during internal 
testing. 
Assumption is that internal defects are small if 
they have not been noted during IU usage.  If a 
defect is noted at IU, prompt reporting to 
Waters will be completed.  
 Table 15, Vendor Risks 
An obvious emphasis in the list above is timely and frequent communication with 
the vendor to ensure the vendor understands the needs of the laboratory.  Equally 
important, communication with the laboratory is another key part of deploying a COTS 
system.  The laboratory and the vendor must communicate to avoid exposure of either 
party to significant risks. 
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The vendor’s various offerings when it comes to communications are also 
important to consider and leverage.  A vendor that has a customer-friendly approach to 
communicating, such as pro-active public notification of defects and/or enhancements, 
can be a valued partner. A vendor that is a closed door approach, however, can become a 
significant source of risk for any firm that chooses to blindly use their products.  All 
potential customers would be well advised to consider this aspect of the COTS system as 
much, or even more so, than the software’s functionality.  Waters offers timely defect and 
enhancement notifications via their web page.  Customers with support accounts can elect 
to automatically receive proactive notification of content changes on the Waters site. 
Another consideration when managing and considering a COTS system is any 
outside certification(s) held by the supplier, such ISO9001 and ISO 90003 and others.  
While these certifications are voluntary, they do show an effort by the supplier to be 
scrutinized by outside agencies.  This sort of openness is important for customers.  
Waters holds outside certifications, including ISO certifications.  These are regularly 
maintained and indicate a vendor that recognizes the importance of outside opinions and 
the value of outside oversight and verification. 
Given the supplier’s current good standing, vendor management of Waters was 
right-sized to permit the laboratory to focus on more important tasks, such as the analysis 
of drug product.  A Vendor Management Plan document was created and detailed the 
primary communication with and management of the vendor.  These are detailed below: 
1) User Symposium 
Representatives from Indiana University may attend the annual Waters Inform 
meeting. This global meeting provides an opportunity for IU to interact with other 
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customers of Waters, including large pharmaceutical corporations. This venue permits IU 
to further assess the performance of Waters with customers that have interests similar to 
that of IU.   Key subject matter experts from Waters Corporation also participate in the 
symposium, affording an open opportunity to discuss any issues that are important to IU. 
2) Follow-up Vendor Evaluations 
The Empower System Owner will determine if additional vendor evaluations 
using audit processes detailed in literature [16] are necessary.  The Empower System 
Owner will also determine the scope of those evaluations, based on the following 
situations: 
• Significant changes to Waters quality practices occur, including implementation 
of a new quality system or substantial changes to an existing quality system 
• Major application release or upgrade 
• Major bug discoveries and fixes 
3) Software Release Notes and Defect Notification 
The vendor provides software release notes for each release of the software.   
These release notes provide details around features included and defects corrected in the 
release.  Vendor defect and issue information can be obtained through Waters’ website.  
These will both be reviewed quarterly or as deemed necessary by the System Owner. 
The Vendor Management Plan is included as Appendix G. 
I. System Acceptance 
Once validation efforts are complete, including Acceptance Testing, the Empower 
system undergoes a System Acceptance.  A Validation Report addresses every 
deliverable that was in the Validation Plan, with any issues that are outstanding being 
 99
listed.  The appropriate management reviews this report and determines if the system is 
acceptable and deployable.  In addition to this extensive validation report, a separate 
Release Description Document (RDD) might be created.  This summary document just 
lists the impacts to a laboratory deploying that particular Empower version.  The RDD 
offers a compact document that avoids a laboratory deciphering the many pages of a 
typical Validation Report.  An example RDD is included as Appendix H. 
J. Support Documents 
Validation documents can tend to be created for the initial system deployment 
effort, but seldom needed during regular system usage.  This is not the situation with a set 
of documents that are beyond the standard software development lifecycle deliverables of 
Validation Plan, Requirements, Design, Testing, and Validation Report.  These other 
validation documents are the documents that direct the daily activities of normal system 
usage and are described in Table 16 below: 
Deliverable Description 
Security Plan Discusses the physical and logical security to protect the 
Empower application, the integrity of the data within the 
system, and the associated validation documentation. 
Business Continuity Plan Describes the business operations required to perform 
operations in the event that Empower is not available.   
Disaster Recovery Plan Describes how to restore system operations in the event 
of a disaster scenario.  This plan must include sufficient 
information to be implemented under disaster conditions, 
such as loss of network and other normal facilities.  The 
plan often includes list of contacts, printed out 
procedures, and other key information. 
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Deliverable Description 
Backup and Restoration A defined process for backing up and restoring critical 
system data and/or functions in a timely manner.  This 
process must be complete within a timeframe that is 
acceptable to the laboratory using Empower. 
For this project, this deliverable would be a QAR 
document for review of vendor’s backup and restoration 
documents. 
System Administration and 
Support Document 
Contains procedures for the use and maintenance of the 
system.  Could also be split into separate standard 
operating procedures (SOPs), based on a given activity. 
For this project, this document would contain 
procedures for creating and maintaining: 
• User Accounts 
• Laboratories 
• Instruments 
• Data Review and Review 
Master Document List The objectives of this document are to: 
• Ensure validation documents can be readily retrieved; 
• List applicable standards, policies, and procedures for 
the system validation, development, and maintenance; 
• Provide the official location of validation 
documentation 
Table 16, Support Documents 
K. Empower Configuration 
Configuration of the software during after the risk assessment and user 
requirements phases ensures all requirements and risks have been identified, or at least an 
attempt has been made to complete this effort. 
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For this project the Empower system was configured according to validation 
deliverables, including: 
• User Types with privileges 
• A “Demo” laboratory with associated Lab_User Groups 
• Empower System Policies 
• A Demo instrument 
• Template Project 
1) User Types 
User Types (4) were configured using the COTS functionality in Configuration 
Manager: PowerUser, MasterUser, BasicUser, and Support.  There are also 2 default User 
Types: Administrator and Guest. A screenshot of the list of User Types can be seen 
below in Figure 9:  
 
Figure 9, User Type List 
Upon creation of a new User Type, the User Type privilege checklist 
automatically appears, requiring the configuration of the individual privileges for that 
User Type.  These are defined in Security Design and described in Table 12 of this 
document.  A screenshot of the User Type privilege configuration can be seen below in 
Figure 10: 
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Figure 10, User Type Privilege Configuration 
 
2) User Groups 
For the purpose of this project, a laboratory named “Demo” was configured 
within Empower as per Security Design.  There were 3 User Groups configured using the 
COTS functionality within Configuration Manager: Demo_Power, Demo_User, and 
Support.  There is also a default User Group of Administrators. A screenshot of the User 
Group list can be seen below in Figure 11:  
 
Figure 11, User Group List 
3) System Policies 
System Policies were configured within Empower following Security Design and 
using the COTS functionality within Configuration Manager.  A screenshot of the menu 
item can be seen below in Figure 12:  
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Figure 12, System Policies Menu 
System Policies were configured within Empower following Security Design and 
as described in this document.  Configuration was completed using the COTS 
functionality within Configuration Manager with no custom code or non-COTS 
configuration required. Some screenshots of the configuration can be seen below in 
Figures 13-15: 
 
Figure 13, User Account Policies 
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Figure 14, New Project Policies 
 
 
Figure 15, Data Processing Policies 
4) Demo instrument 
A demo instrument was configured within Empower following Security Design 
and using the COTS functionality within the New Chromatographic System Wizard 
within Empower.  The instrument was defined by selecting the equipment connected to 
an acquisition server (LAC/E), and then selecting the appropriate User Groups to be 
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applied: Demo_Power, Demo_User, and Support.  Some screenshots of the configuration 
can be seen below in Figures 16 and 17:  
 
Figure 16, New System Wizard 
 
 
Figure 17, Instrument Access Control  
5) Template Project 
For the purpose of this project, a template project was configured within 
Empower as per the Template Project Design Specification.  Within the project were 
configured 7 custom fields as per the individual Custom Field Design Specifications.  
When the Template project was created, the Support User Group was given access.  
Then, members of the Support User Group create an individual Lab_Template projects 
for each specific laboratory.  For this project, a Demo_Template project was also created 
to correspond with the ‘Demo_’ User Groups and the ‘Demo’ instrument. Screenshots of 
the Template project and Custom Field configuration can be seen below in Figures 18-22:  
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Figure 18, Template Project Access Control 
 
 
 
Figure 19, Template Project General Properties 
 
 
Figure 20, Custom Field Wizard 
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Figure 21, Template Project Custom Fields List 
 
 
Figure 22, Demo_Template Project 
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5.   CONCLUSION 
This project resulted in creation of a generic CDS risk assessment and 
requirements documents that permit reasonable right-sizing of validation activities even 
in a significantly regulated environment, such as a large pharmaceutical laboratory.  The 
other key validation deliverables from this project can then be used to configure an 
Empower environment in a pharmaceutical laboratory.   
The activities from this project produced validation documentation in a manner 
that reflected the risks of a critical raw data collecting system, while accounting for the 
COTS origin of the system.  The project deliverables included a complete CDS risk 
assessment effort, a comprehensive set of CDS user requirements, Empower-specific 
design and testing documents, as well as critical validation documentation for training, 
vendor management and release management.  Further, the validation was applied to 
configure an Empower environment, demonstrating the practicality and deployability of 
the proposed configuration. 
The validation approach from this project’s effort could easily be extrapolated to 
other types of COTS laboratory systems, such as Electronic Laboratory Notebooks (ELN) 
or even LIMS (Laboratory Information Management Systems).  The only requirement 
would be that the system in question is a COTS system with no custom code required to 
implement.  If this fundamental assumption is not met, much of the risk-based right-
sizing applied herein would be forfeit and no longer applicable. 
A.  Overview of Findings from Risk Assessment 
In a workshop format and following GAMP [28] guidelines, sixty four (64) 
specific risks generic to use of a CDS in a pharmaceutical testing laboratory were 
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identified.  These risks were organized around four specific risk elements: People, 
System, Vendor and Record.  The often recommended controls included vendor 
management, system testing, user training, disaster recovery plans, and a procedure for 
data release and review.  It would appear these particular deliverables would be necessary 
when deploying a CDS into a large pharmaceutical laboratory.  Even with the 
recommended risk mitigation controls, some risks remained in a High or Medium status.  
These would be the risks that the laboratory would have to accept as part of deploying a 
CDS with the limited set of controls set forth.  It was also noted that some of the risks 
associated with Vendor will always not be fully mitigated.  This is an attribute of 
deploying a COTS system that is created and maintained by a company different from the 
laboratory.  A laboratory would have to monitor these risks and their impacts to ensure 
that the risks are under control and are not impacting product quality, safety, or efficacy. 
B. Overview of Findings from Defining Requirements 
A generic CDS Requirements Definition was created without foreknowledge of 
the COTS system to be deployed.  This approach permitted the CDS vendor selection to 
be appropriately conducted solely on the documented CDS risks and requirements, 
independent of any vendor-specific expected functionality. The CDS Requirements 
Definition document provided a single place to explain all the requirements, listing 
system requirements and separately defining those requirements that fit into the business-
focused Use Cases.  Since each vendor is marketing a generic CDS, it is important to 
develop requirements to a level that guides configuration of the COTS system. 
While a project goal was to author a generic requirements specification, any reuse 
of these requirements by another firm would necessitate a comprehensive review with 
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appropriate local personnel to ensure the details of the requirements are truly applicable 
within that specific firm. 
C. Overview of Findings from Defining Key Empower Validation Deliverables 
1.) Planning – Empower Validation Planning included a Validation Plan document 
to plan for the validation effort.  Since the Validation Plan itself is historical once 
a release is complete, but roles and responsibilities might change with future 
releases, the roles and responsibilities section was extracted into a separate to 
facilitate those anticipated future changes.  The planning included an important 
assumption that the COTS vendor would be reliable, thus permitting a reduction 
in the amount of validation required.  For example, no deliverables around code 
review were specified, since it is assumed the vendor code review would suffice.  
Also, training documents from the vendor were assumed to suffice, as well as 
vendor installation protocols.  These assumptions permitted a plan for right-sizing 
the validation and narrowing the total validation effort. 
2.) Design – Empower Design included a System Overview document to explain the 
system in the event of an audit.  In addition, a Security Design document was 
created, since the risk assessment indicated that there would be a required 
hierarchy of user privilege to safeguard data based on user experience and 
training level.  Custom Field Configuration and Template Project Specification 
documents were also created to document the custom fields and template data 
project that are deployed with the Empower system.  Detailed design was avoided 
by relying on the vendor to document most aspects of design.  Design and Testing 
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were the two areas that most leveraged the COTS origin of Empower to reduce 
the validation effort. 
3.) Testing – The Empower Test Strategy document was created and details the exact 
approach being taken to ensure the COTS system testing is sufficient to mitigate 
risk, while still providing a right-sized approach.  It indicates a reduced approach 
to testing based on vendor management and past supplier reliability.  If this 
supplier reliability were to change, the Test Strategy would, of course, be 
reviewed and adjusted as necessary. 
4.) Training – The Empower Training Plan document was created and details the 
exact approach being taken to ensure users are appropriately trained without the 
pharmaceutical company incurring the cost of maintaining custom training. 
5.) Vendor Management – The Empower Vendor Management document details a 
significant investment in managing the vendor.  Based on this document, it would 
appear that risks are only controlled for COTS system when the client and host 
companies have sufficient communication channels in place.  Any less than a 
two-way communication stream may result in greatly increased risk and 
potentially one company becoming an anachronism. 
D. Overview of Findings from Configuration of Empower 
Empower is configurable to meet this particular set of user requirements for a 
CDS used in a pharmaceutical laboratory.  If these requirements reflect a generic set of 
CDS requirements, then this configuration would be usable in other laboratories.  Any 
changes in the requirements for a specific deployment would most likely lead to 
configuration changes. 
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One other finding was that Empower has some undocumented limitations in 
custom field naming.  The original intent was to use Column, Comments, and 
Concentration as custom field names.  After entering these into Empower, however, 
Column gave an ORACLE error and Concentration and Comments were reserved by 
Empower and unavailable.  These field names were subsequently changed to 
ChromColumn, ChromComments, and ChromConcentration.  Before approving a 
Custom Field Design Specification, it would be wise to verify that proposed field name is 
available in Empower.  These sorts of limitations are unique to COTS systems. 
6.   DISCUSSION 
Validation of a complex COTS system such as Empower would appear to be 
simple until one considers how much time is spent on each deliverable.  One benefit of 
this project was placing risk-based examples of validation deliverables into the public 
sector for comparison and consumption. 
A. Comparison to Other Validation Approaches 
While this project focused on a risk-based approach to validation for a COTS 
system, there are other approaches.  The approach to validation described within this 
project assumed many details, including: 
• The COTS origin for the CDS being deployed 
• The predicate rules to comply with - Part 11, Part 210/211 
• The environment to be deployed in - pharmaceutical testing laboratory 
• A good vendor audit 
• A confidence in the risk assessment and requirements based on a 
comprehensive workshop approach 
 113
The absence of any or all of these factors might result in a retreat to other more 
detailed traditional validation approaches.  It is useful to consider those approaches and 
compare them with the approach used for this project.  A useful graphic to describe the 
levels of validation that can exist for software development is found within Bob 
McDowall’s book on CDS Validation [16].  That figure and a discussion of its contents 
follow: 
User 
Requirements 
Specification
Functional 
Specification
Design 
Specification
System Build 
(Writing Code)
Qualification
(IQ, OQ, and PQ)
System 
(Integration) 
Testing
Unit and Module 
Testing
Maintain System Operate System Retire System
Fit?
Fit?
Fit?
 
Figure 23, Deep V model for system operation and retirement 
McDowall focuses on the level of the V that validation must reach depending on 
the reliability of the source of the CDS and the risks associated with the system.  The 
approach of this project’s validation effort remained primarily at the User Requirements 
and Qualification level of the V, but it did have to trace down the V for the Custom Field 
Design Specifications with associated Unit level testing.  This approach is consistent with 
McDowall’s recommended approach for a COTS laboratory system deployment, saying 
 114
“The rationale for this is that most laboratory systems are commercially available and are 
implemented not developed” [16].  McDowall explains that some levels of the V for a 
COTS system are not completed by the customer, saying “only through the vendor audit 
are details on the design and development of the system available”. 
So, if unexpected risk factors warrant a change in validation strategy, a firm can 
always trace another level down in the V, much like this project did around custom fields 
within the system.  This Deep V approach becomes scalable and can guide validation that 
is either risk-based and shallow in the V, or voluminous and deep into the V. 
B. Limitations on Research 
Limitations of the Risk Assessment Tool 
The GAMP guidelines, while attempting to be generalized, are somewhat tailored 
toward current manufacturing system validation and deployment.  As such, these 
guidelines might not be directly transferable to other types of system deployments.  The 
latest iteration, GAMP 5, does make an effort to narrow gaps and become more universal.  
This project used GAMP 5 to attempt to provide a more generally applicable CDS 
validation. 
Limitations of the Requirements approach 
The requirements document created is specific to one large pharmaceutical 
company’s laboratories.  It is duly noted here that user requirements will vary from 
deployment to deployment.  The requirements documents should be scrutinized and 
modified as needed to reflect the requirements of the actual site deploying the product. 
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C. Recommendations for Future Research 
If this project were to expand beyond a Masters level of work, the current pages 
of validation could be increased to thousands to build a body of validation including an 
entire laboratory facility.  Also, another student could undertake to deploy interface 
systems that connect to the deployed configuration of Empower. 
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Risk Management 
Risk Management Purpose 
The purpose of risk management is making informed decisions by the appropriate people 
in order to focus on the most critical aspects of a process and then focus the computer 
system validation effort on those critical functions.  Risk management is an iterative 
process and this document will be updated as necessary throughout the system life cycle. 
The results from this risk assessment will be used as input to determine the extent of 
validation for the Chromatography Data System (CDS) and to focus the validation effort 
on areas that will have the most impact on ensuring product quality and record integrity. 
Scope 
Business and Information Technology risks associated with a CDS, as well as risks 
related to product quality and record integrity are addressed as part of this assessment.   
Project management related risks, such as resourcing and costs, are not included. 
Assumptions Around Peripheral Systems 
Peripheral System Assumption 
Laboratory 
Information 
Management System 
(LIMS) 
o Risks associated with the CDS to LIMS transfer utility will 
be assessed 
o Risks associated with the use of LIMS are out-of-scope for 
this assessment 
Instruments o Risks associated with instrument firmware and instrument 
to CDS software communication will be assessed 
o Risks associated with qualification will not be assessed 
Printers o Risks associated with printer to CDS software 
communication will be assessed 
o Risks associated with printer hardware and installation will 
not be assessed 
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Peripheral System Assumption 
Network/Infrastructure o Risks associated with network communication will be 
assessed 
o Risks associated with network installation and hardware 
will not be assessed 
Record Definitions 
Record Type Description 
 
Raw Data 
Any laboratory worksheets, records, memoranda, notes, or exact 
copies thereof that are the result of original observations and 
activities of a laboratory and are necessary for the reconstruction and 
evaluation of the result data. Raw data may include photographs, 
microfilm or microfiche copies, computer printouts, magnetic 
media, including dictated observations, and recorded data from 
analysts and automated instruments. 
 
Audit Trail 
A secure, computer-generated, time-stamped record used to 
independently record the user, date and time of operator entries and 
actions that create, modify, or delete electronic records. Record 
changes shall not obscure previously recorded information. 
 
Result 
The consequence of the application of a calculation or series of 
calculations to raw data that produces an interpretable and 
meaningful outcome for the attribute that is being measured.  Data, 
such as weights, that are generated external to the CDS and that are 
necessary to complete these calculations are documented, controlled 
and verified according to laboratory procedures. While these 
externally-generated data are stored in CDS, the CDS is not the 
source of the raw data.  Stored in a result record are the results along 
with the appropriate identifiers or links to the appropriate identifiers. 
Security System records that identify what access a user may have.  User 
types and privileges, user groups, etc.   
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Record Type Description 
Configuration System records that identify system parameters (report names, 
project size, and other specifications) 
Risk Management Process Overview 
 Risk Assessment 
 Risk Analysis 
• Overall Impact Assessment 
o Process overview 
o Predicate rule requirements 
o Record Identification 
o Risk Elements 
o Overall Impact Assessment 
• Identification and analysis of individual risks 
 Risk Control 
• Identifying controls to decrease the risks to acceptable levels 
• Determining if residual risk is acceptable 
 Risk Monitoring 
• Monitoring the effectiveness of the risk control measures and continue to 
identify and evaluate any new risks 
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Risk Analysis 
Process Overview 
Chromatography Data Management Systems are designed to collect, analyze, store, and 
report data from chromatography instrumentation. 
Chromatography Data System Process Flow 
 
Integrate and
Name
Peaks
Create/
Maintain
Method
Report
Results
Verify
Results
Disposition
Results
Calculate
Results
Acquire
Data
Create/
Maintain
Sample Set
Schedule
Sample Set
Privileged User defines assay
specific method
User selects method, identifies
injections, and enters necessary
supporting data (i.e. sample weight)
User selects instrument and
schedules data acquisition
Systems sends control data to
instrument and collects raw data
from instrument
System automatically
integrates peaks or user
manually integrates peaks.
System names peaks
User prints results on paper
(optional)
System calculates results
User verifies results
User accepts/rejects results.
Accepted results from LIMS samples
are transferred back to LIMS.
Transfer LIMS
Worklist
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Predicate Rule Requirements  
• 211.194 (a) Laboratory records shall include complete data derived from all tests 
necessary to assure compliance with established specifications and standards, 
including examinations and assays… 
- The initials and signature of the person who performs each test and the date(s) the 
tests were performed 
- The initials or signature of a second person showing that the original records have 
been reviewed for accuracy, completeness, and compliance  
• 211.194 (b) Complete records shall be maintained of any modification of an 
established method employed in testing. Such records shall include the reason for the 
modification and data to verify that the modification produced results that are at least 
as accurate and reliable for the material being testing as the established method. 
• 211.68 (a) Automatic…equipment…including computers…may be used in the 
manufacture, processing, packing, and holding of a drug product. If such equipment is 
so used, it shall be routinely calibrated, inspected, or checked according to a written 
program designed to assure proper performance. Written records of those calibration 
checks and inspections shall be maintained. 
• 211.68 (b) Appropriate controls shall be exercised over computer or related systems to 
assure that changes in master production and control records or other records are 
instituted only by authorized personnel. Input to and output from the computer or 
related system of formulas or other records or data shall be checked for accuracy. The 
degree and frequency of input/output verification shall be based on the complexity and 
reliability of the computer or related system…a written record of the program shall be 
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maintained along with appropriate validation data… 
• 211.180 (a) Any production, control, or distribution record that is required to be 
maintained in compliance … and is specifically associated with a batch or a drug 
product shall be retained for at least 1 year after the expiration date of the batch…  
- Records required under 211.180 (records identified above) shall be readily 
available for authorized inspection during the retention period at the establishment 
where the activities described in such records occurred… 
- Records may be retained either as original or as true copies 
GMP Policy and Procedure Requirements  
 Part 20, Testing Laboratories 
 Electronic Records/Electronic Signatures, 21Code of Federal Regulations Part 11 
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Chromatography Data System Overview 
Risk Assessment
  CDS
LIMS
D
at
a
Printer
Da
ta
Application 
Server
Database 
ServerData
Commands/Requests
Instrument
Control Data
Raw Data
User
D
at
a
Re
qu
es
ts
 
Core system (chromatography application) 
The function of the core system is to acquire raw data from chromatography 
instrumentations, to store the data to a database, to process raw data to generate results, 
and to report those results to a printer or LIMS.  These actions should all be accompanied 
with appropriate audit trail records and in a secure environment. 
CDS to LIMS transfer utility 
The function of a LIMS interface is to transfer information between a LIMS and CDS.   
Instrument Firmware to CDS Software communication 
The function of instrument firmware is to provide a managed code environment that 
instrument manufacturers utilize to control instrumentation.  Another benefit is the 
configuration management that this formal code provides to ensure instrumentation is 
able to communicate with chromatography data systems. 
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Risk Elements 
People Elements 
The following table represents the generic roles and responsibilities associated with a 
Chromatography Data System (CDS) at a larger pharmaceutical firm.  It describes the 
role types, approximate number, and associated responsibilities for the users that will 
have access to CDS.   
Direct (D)-Intrinsic involvement in the generation and/or review of the records 
Indirect (I)-Extrinsic involvement in the generation and/or review of the records 
Type of User # of 
Users 
Raw 
Data 
Result Audit 
Trail 
Security Configuration
Laboratory 
Personnel (inc. 
Technical Services) 
~2000 D D D I I 
Laboratory 
Management 
~100 I I I D I 
System Support ~70 I I I D D 
Quality 
Representatives 
~70 I I I I I 
Regulatory ~200 I I I I I 
System Elements 
Chromatography Data Systems used in a regulated environment are typically client/server 
systems which permit acquisition and processing of chromatography raw data obtained 
from labs with appropriate storage into a secure database structure.  
The complexity of a CDS is high based on the physical connectivity and advanced data 
manipulation activities.  System hardware complexity is typical for a system with this 
level of business impact and regulatory scrutiny (e.g., change control systems, LIMS).   
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A significant portion (75%) of all data generated within a typical quality control lab is 
based on chromatography; therefore the extent of use of a CDS is nearly universal within 
the lab environment.   
Known issues of CDS use are: 
o Remote storage of chromatography data can be problematic due to connectivity  
o Inability of CDS to complete complex calculations to properly process raw data  
o Inability to interface all chromatography instruments within a lab 
o Difficult to validate and qualify due to large footprint into lab documentation  
o Complexity of managing a distributed system 
Vendor Elements 
Due to core mission of educating and not developing custom software, Indiana University 
has chosen to strongly favor a COTS implementation of a CDS.  In order to successfully 
implement a COTS solution and mitigate the risks associated with using COTS, a heavy 
emphasis on vendor relationship and management must be pursued.   
Record Elements 
Record Identification Record Format Relied 
Upon (Paper/Electronic) 
Raw data records—relied on to make regulatory decisions 
(these records are inputs to result records) 
Electronic 
Result records, as indicated in 211.194(a)—relied on to 
make regulatory decisions 
Paper/Electronic 
Audit trail records—relied on to make regulatory 
decisions (these are records that support result records) 
Electronic 
Security records—relied on to make regulatory decisions 
(records that support result records) 
Electronic 
Configuration records—relied on to make regulatory 
decisions (inputs to result and security records) 
Electronic 
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Impact of Errors (due to software or humans) on Records 
High-Direct impact to SISPQ  
Medium-Indirect impact to SISPQ 
Low-Little or no impact to SISPQ 
 
Record Type Impact Rationale 
Raw Data High 
Due to lack of detectability.  Total reliance on this record 
to generate results.  An error in a raw data is not detectable.
Result High Used for quality decisions in lot release, clinical trials, etc. 
Audit Trail High 
Regulatory requirements state that audit trail records must 
be maintained as part of the electronic records 
Security High 
Security Records are precursors to the raw data and result 
record.  Must be accurate. 
Configuration  Medium Incorrect records are less likely to impact product. 
 
Methods of Detection 
o System notification of record errors (OS/application/database), error notifications 
sent to support personnel 
o Manual verification of records via procedures 
o Routine monitoring for record errors 
Overall Impact Assessment 
Impact on Product Quality Impact on Record Integrity 
High High 
Overall Potential Impact: High 
Rationale 
Direct impact on product (e.g., lot release, stability, production optimization and 
investigations, clinical trial data); in scope. 
Risk Identification and Analysis 
Risk identification and analysis was completed per GAMP 5, Appendix M3, pp 114-115.   
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Probability = Likelihood of the fault occurring 
High - Frequently Medium - Occasionally Low - Seldom 
  
Severity = Impact on Patient Safety, Quality, and Data Integrity (or other harm) 
High - Direct impact  Medium - Indirect impact  Low - Little or no impact  
  
Detectability = Likelihood that the fault will be noted before harm occurs 
High - Very Likely Medium - Likely Low - Unlikely 
Step 1: Calculation of Risk Class: 
Probability  
Severity Low (1) Medium (2) High (3) 
High (3) Medium      High  High 
Medium (2) Low Medium High 
Low (1) Low Low Medium 
Step 2: Calculation of Risk Priority: 
 Detectability   
Risk Class from Step 1 High (3) Medium (2) Low (1) 
High (3) Medium High High   
Medium (2) Low Medium High 
Low (1) Low Low Medium 
 
Proposed Acceptance Criteria  
All risk areas with a risk priority of “medium” or “high” will be evaluated.  Mitigation 
efforts will be commensurate with risk priority.  No mitigation signifies acceptance of the 
risk as it stands.  
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Introduction 
Purpose 
The purpose of this document is to define the scope of user requirements for the 
deployment of a CDS.  This information summarizes the results of the requirements 
definition stage of the project and will be used to define the functional and non-functional 
requirements for the software configuration. 
Scope 
In-Scope 
This document will define the requirements for a CDS as deployed at Indiana University 
Purdue University Indianapolis (IUPUI).  Use of the CDS will be limited to the 
acquisition, processing, releasing, and reporting of laboratory chromatographic raw data 
and all pertinent user-entered meta-data.  The CDS includes interfaces to laboratory 
instruments. 
Out-of-Scope 
• Laboratory requirements for instrumentation, including installation, operation, 
and qualification 
• User Training Requirements 
• Local Business Procedure Requirements 
• Assay Requirements 
• Archiving and Archiving Interface Requirements 
People and Organizations 
The table describes and identifies the stakeholders required for a successful 
implementation of the CDS at IUPUI.  
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Table 1 People and Organizations 
Stakeholder 
Class 
Brief Description People 
Advisor Reviews User Requirements for business 
impact and appropriateness 
Business Subject 
Matter Expert 
Supplier Large third-party CDS vendor CDS Vendor 
Owner Obtains business support, approves all 
requirements and system changes 
Business 
Management 
Direct User Analysts, IT support, Laboratory 
Management 
CDS Users 
Indirect User Additional business units that are impacted by 
the data/activities associated with the CDS 
Quality Assurance, 
Quality Control, 
Regulatory, 
Manufacturing 
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System Process Flow Diagram 
The CDS is designed to collect, analyze, and report data from chromatography 
instrumentation. 
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Figure 1 System Process Flow 
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Data Flow Level 0 Diagram 
The Level 0 Data Flow Diagram for the CDS is below.  The Level 1 and Level 2 
diagrams after this overview detail specific data flows with the Level 0 diagram. 
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Figure 2 Data Flow Level 0 
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Data Flow Level 1 Diagram 
The Level 1 Data Flow Diagram for the CDS is below.  The Level 2 diagram after this 
diagram details specific data flows within the Level 1 diagram. 
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Figure 3 Data Flow Level 1 
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Data Flow Level 2 Diagram 
The Level 2 Data Flow Diagram for the CDS is below.  This diagram provides step-level 
and actor detail for the data flow through the CDS with specific interfaces. 
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Figure 4 Data Flow Level 2 
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Security Table 
This table summarizes the user security privileges by Actor. These privileges will be 
incorporated into the final security configuration of the CDS.  
Table 2 User Security Privileges by Actor 
Actor Actor Privilege(s) 
Power User Manage Master Method, Master Method Edit, Sequence Method Edit, 
Manage Sample Set, Manage Sample Set Queue, Instrument 
Configuration, Acquire Data, Process Data, Release Data, Report 
Data, Export Data, View Audit Trails, Project Configuration 
Master User Master Method Edit, Sequence Method Edit, Manage Sample Set, 
Manage Sample Set Queue, Instrument Configuration, Acquire Data, 
Process Data, Release Data, Report Data, Export Data, View Audit 
Trails 
User Sequence Method Edit, Manage Sample Set, Manage Sample Set 
Queue, Instrument Configuration, Acquire Data, Process Data, 
Release Data, Report Data, Export Data, View Audit Trails 
Support Sequence Method Edit, Manage Sample Set, Manage Sample Set 
Queue, Instrument Configuration, Acquire Data, Process Data, Report 
Data, View Audit Trails, Project Configuration, System 
Configuration, Instrument Creation 
Laboratory 
Instrument 
Acquire Data 
Glossary 
This table defines terms used in this Requirements Definition.  
Table 3 Glossary of Terms 
Term Definition 
Actor User or another system that interfaces with the CDS. 
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Term Definition 
Acquisition 
Method 
A method containing the specific parameters required to collect a 
complete raw data file from a laboratory instrument. 
Audit Trail A secure, computer-generated, time-stamped record used to 
independently record the user, date and time of operator entries 
and actions that create, modify, or delete electronic records. 
Record changes shall not obscure previously recorded 
information. 
Functional 
Requirement 
Policies or constraints that shape, define, and limit the Use Case. 
Functional Requirements are integral to the scenarios that 
describe the Use Cases.  As such, they are included with the Use 
Case Definitions with the appropriate scenario. 
CDS Chromatography Data System 
CCB Change Control Board 
LIMS Laboratory Information Management System 
Method A specific document or data file used to detail parameters 
required to accurately and completely collect an analyte and 
measure all appropriate characteristics or properties. 
Master Method A method associated with a business area or laboratory and 
independent of a single set of samples. 
Non-Functional 
Requirements 
Requirements that do not rely on a system initiated action or are 
defined external to the system by policy or procedure. (e.g. 
performance, ER/ES). 
QA/QC Quality Assurance/Quality Control 
Privilege/Privileged A phrase used to indicate a security or training constraint placed 
on an action or individual.  Clarification of the constraint must 
be completed in the design phase of system development. 
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Term Definition 
Raw Data Any laboratory data that are the result of original observations 
and activities of a laboratory and are necessary for the 
reconstruction and evaluation of the result data. Raw data may 
include recorded data from analysts and automated instruments. 
Result The consequence of the application of a calculation or series of 
calculations to raw data that produces an interpretable and 
meaningful outcome for the attribute that is being measured. 
Data that are generated external to the system, such as weights, 
and that are necessary to complete these calculations are 
documented, controlled and verified according to local 
procedures. While these externally generated data may be stored 
in the system, the system is not the source of the raw data. Stored 
in a result record are the results along with the appropriate 
identifiers or links to the appropriate identifiers. 
Sample A subset of a defined population 
Scenario A scenario is an instance of a use case that includes step-by-step 
descriptions of how an actor uses the system to accomplish a 
goal. Scenarios are drawn from real-life examples of how the 
system will be used. The steps for the “ideal” way to perform a 
use case are called the main success scenario. Alternate scenarios 
identify ways that the goal can fail or other ways that the actor 
can accomplish the goal. 
Sequence Method A method associated with a single set of samples. 
System The system consists of software, personnel, and procedures. 
System 
Requirement 
Non-Functional and Functional requirements associated at the 
system level that are not appropriate to be described with a Use 
Case scenario approach.  
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Term Definition 
Use Case A Use Case is a requirements model that specifies the system’s 
requirements from a user-centric point of view.  
An individual Use Case contains a high-level statement that 
describes a general task an actor can accomplish using a system.  
The use case name identifies the actor’s goal, in plain English. 
Typically, they are in the format “Verb, noun”, or “Do an action 
to/for something”. 
Use Case Model A model for depicting requirements by showing relationships 
between Use Cases, Scenarios, Actors, Functional Requirements, 
and other supplementary requirements. 
Use Case Model 
Diagram 
A diagram that illustrates the relationship between Use Cases 
and Actors within a computer system. 
GMP and Business Policies 
The CDS will comply with the following government, industry, and corporate guidance: 
Regulations 
FDA:  
• 21 CFR part 11(Electronic Records, Electronic Signatures) 
• 21 CFR part 210 and 211 (current Good Manufacturing Practices) 
Guidelines  
Business Area Guidelines 
• European Pharmacopoeia 
• International Conference on Harmonisation of Technical Requirements for 
Registration of Pharmaceuticals for Human Use (ICH) Quality Guidelines 
• Japanese Pharmacopoeia 
• United States Pharmacopoeia 
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System Requirements  
This table describes the system requirements of the CDS. 
Table 4 System Requirements 
Requirement 
Number 
Requirement Description 
FR12 Whenever revisions to a record are made, the original entries must not 
be obscured. 
FR13 The system must have the ability to discern invalid records for raw data, 
result, security, audit trail, and configuration records. 
FR48 Electronic signatures and handwritten signatures executed to electronic 
records shall be linked to their respective electronic records to ensure 
that the signatures cannot be excised, copied, or otherwise transferred to 
falsify an electronic record by ordinary means. 
FR72 The system must include the following components as part of the 
signature on the electronic record: 
• Printed name of the signer,  
• Date and time of the execution of the signature, and  
• Meaning associated with the signing. 
FR208 When an electronic record that has been signed is displayed or printed, 
the signature elements must be viewable.   
FR229 Each electronic signature shall be unique to one individual and shall not 
be reused by, or reassigned to, anyone else.  System must prevent 
duplication/reuse/reassignment of user ID.   
FR249 The system must be able to display, print and create electronic copies of 
all electronic records and their associated audit trails.   
FR263 At least one of the system user interface presentations must prevent 
multiple users from establishing concurrent sessions from a single 
terminal. 
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Requirement 
Number 
Requirement Description 
FR266 The system must require that a user does not reuse a password that they 
have previously used. 
FR267 The system must close or lock all open windows when a user logs off 
the system. 
FR268 A user must perform first person verification before second person 
verification can be completed where two person verification is required 
by the laboratory. 
FR269 The system must provide the capability to create logical groups to 
logically group/separate data to determine users’ accessibility to data. 
FR270 Printed name of the signer, date and time when the signature was 
executed, and meaning associated with the signing must be subject to 
the same controls as electronic records. 
FR280 The system must allow for remote backups and support. 
FR290 The system shall be able to store default selections for the user to select 
when making a change. 
FR294 The system must not permit the deletion of raw data files. 
FR295 The system must not permit the modification of raw data files. 
FR296 The system must expire passwords automatically every 60 days. 
FR308 Stored passwords must be encrypted and not readable. 
FR312 Reactivation of a suspended account must require system administrator 
intervention. 
FR313 Active system sessions must automatically end after 30 minutes of 
continuous inactivity. 
FR315 Time stamps must be at least to the nearest second. 
FR316 Date/time stamps must be in a format that clearly reveals the month, 
day, year, and time zone. 
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Requirement 
Number 
Requirement Description 
FR317 All date and time values must have leading zeroes where appropriate, 
e.g. 05:07:02. 
FR318 The hour must be expressed in 24-hour format. 
FR319 Time stamps must use the time zone in which the acquisition server is 
located. 
FR320 The ability to set/reset system time must only be permitted by system 
administrators. 
FR321 The system must provide the capability to verify the time periodically 
with an external source to maintain synchronization. 
FR333 The system must provide a buffer used to retain raw data prior to 
writing to the acquisition server to prevent the loss of data if the 
acquisition server becomes unavailable.  
FR337 Any audit trail record must contain user id, date and time, full name, 
and the action taken of the user creating, modifying or deleting of raw 
data, result, security, and configuration records.  
FR338 The system shall not permit users to modify any audit trail. 
FR339 Creation, modification, or deletion of raw data, result, security, and 
configuration records will require an audit trail.  
Use Cases 
Additional CDS requirements are captured in Use Cases described below.  
Table 5 Use Cases 
Use 
Case # 
Use Case 
Name 
Use Case Description 
UC01 Manage 
Method 
Use case describes the functionality for creating, editing, 
printing and copying methods.  Methods are used for data 
acquisition, data processing, exporting and result reporting. 
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UC02 Manage 
Sample Set 
Use case describes the functionality for creating, editing, 
reviewing and searching sample sets. 
UC03 Manage 
Sample Set 
Queue 
Use case describes the functionality for managing the 
sample set queue.  This includes the starting, aborting, 
pausing, resuming and sequencing the sample set queue.  
The sample sets are queued for acquisition on an 
instrument. 
UC04 Acquire Data Use case describes the functionality for data acquisition 
from a laboratory instrument. 
UC05 Process Data Use case describes the functionality for processing of 
sample set data once data acquisition has completed 
successfully. 
UC06 Report Data Use case describes the functionality for reporting data, 
whether to a screen or to a printer.  
UC07 Release Data Use case describes the functionality for releasing data.  
Data release is the activity by which data is given a 
disposition status appropriate to its content based on 
predefined business rules and procedures. This release 
process can involve sending data to another system 
(LIMS). 
UC08 Export Data Use case describes the functionality for outputting data 
from the system via the export functions. 
UC09 Manage 
Instrument 
Use case describes the functionality for configuring the 
laboratory instrument required for acquisition of a sample 
set. 
UC10 Manage 
Accounts 
Use case describes the functionality for user and system-
level processes related to account management. 
UC11 Manage Data Use case describes the functionality for managing data 
within the CDS. 
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Detailed Use Case Descriptions 
Each Use Case has detailed scenarios which define additional Functional Requirements 
(requirements) unique to that particular Use Case as detailed below.  
Detailed Scenario Information 
Scenario A user creates a method 
Scenario Number Sc05 
Use Case Number UC01 
Description/Objective 
This scenario proves that a user is able to create a method 
within defined business rules. 
Primary Actor(s) Power User, Master User 
Secondary Actor(s) Not applicable 
Resources Needed Laboratory instrument 
Privilege Levels Master Method Edit 
Req Number(s) Functional Requirement Content 
FR04 
Methods must include an assay specific default run template 
including: default placement of samples, standards, blanks, and 
control samples within a sequence; default standard 
concentrations 
FR07 Method creation must require privilege 
FR08 Methods must be definable at the laboratory level 
FR151 
A user must be able to create a method without system 
suitability limits 
FR152 
A user must be able to create a method without control sample 
limits 
FR153 
A user must be able to create a method with control sample 
result limits 
FR327 
A user must be able to create a method with check standard 
result limits 
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Scenario The user removes a method from use 
Scenario Number Sc06 
Use Case Number UC01 
Description/Objective 
This scenario proves that a user is able to remove a method 
from use within defined business rules. 
Primary Actor(s) Power User 
Secondary Actor(s) Not applicable 
Resources Needed Master Method 
Privilege Levels Manage Master Method 
Req Number(s) Functional Requirement Content 
FR16 Method removal must require privilege 
FR28 Method audit trails must not be physically deleted. 
 
Scenario A user copies a method 
Scenario Number Sc07 
Use Case Number UC01 
Description/Objective 
This scenario proves that a user is able to copy a method 
within defined business rules. 
Primary Actor(s) Power User, Master User 
Secondary Actor(s) Not applicable 
Resources Needed Master Method 
Privilege Levels Master Method Edit 
Req Number(s) Functional Requirement Content 
FR17 Method copying must require privilege 
FR36 
A user must be able to copy a method from one server on the 
network to another 
FR37 
The original system of a copied method must be identifiable 
after copying from one server to another 
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Scenario A user edits a method 
Scenario Number Sc08 
Use Case Number UC01 
Description/Objective 
This scenario proves that a user is able to edit a method within 
defined business rules. 
Primary Actor(s) Power User, Master User 
Secondary Actor(s) Not applicable 
Resources Needed Master Method 
Privilege Levels Master Method Edit 
Req Number(s) Functional Requirement Content 
FR05 
Revisions to all methods must have a sequential revision 
number stored in the audit trail 
FR06 All revisions of all methods must have a unique identifier 
FR09 
Revisions to all methods must have a sequential revision 
number stored in the audit trail 
FR18 Method editing must require privilege 
 
Scenario A user edits a Sequence method 
Scenario Number Sc09 
Use Case Number UC01 
Description/Objective 
This scenario proves that a user is able to edit a sequence 
method within defined business rules. 
Primary Actor(s) Power User, Master User, User, Support 
Secondary Actor(s) Not applicable 
Resources Needed Sequence Method 
Privilege Levels Sequence Method Edit 
Req Number(s) Functional Requirement Content 
FR11 
Changes to the sequence method must be included in the 
sequence's audit trail 
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FR20 Sequence method editing must require privilege 
FR44 
An audit trail must be maintained for changes made to method 
parameters during sequence creation 
FR95 
A user must be able to edit the non-acquisition portion of the 
method after sequence acquisition has started 
FR97 
A user must be able to edit the sequence method before 
sequence acquisition has started 
FR144 
A user must be able to modify the system suitability limits for 
a selected compound in a method 
FR145 
A user must be able to modify the calibration curve limits for a 
selected compound in a method  
FR147 
A user must be able to select at the sequence level whether 
limits are checked for samples or standards or both 
 
Scenario A user copies a Sequence method 
Scenario Number Sc12 
Use Case Number UC01 
Description/Objective 
This scenario proves that a user is able to copy a sequence 
method within defined business rules. 
Primary Actor(s) Power User, Master User, User, Support 
Secondary Actor(s) Not applicable 
Resources Needed Sequence Method 
Privilege Levels Sequence Method Edit 
Req Number(s) Functional Requirement Content 
FR31 
A user must be able to copy a sequence method to another 
sequence 
 
Scenario The user locks a method 
Scenario Number Sc13 
Use Case Number UC01 
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Description/Objective 
This scenario proves that a user is able to lock a method to 
protect it from change within defined business rules 
Primary Actor(s) Power User, Master User 
Secondary Actor(s) Not applicable 
Resources Needed Master Method 
Privilege Levels Master Method Edit 
Req Number(s) Functional Requirement Content 
FR32 A user must be able to lock a method  
FR33 A user must be able to override the locking of a method. 
FR34 Method locking must require privilege 
 
Scenario A user creates a sample sequence 
Scenario Number Sc15 
Use Case Number UC02 
Description/Objective 
This scenario proves that a user is able to create a sequence 
file within defined business rules. 
Primary Actor(s) Power User, Master User, User, Support 
Secondary Actor(s) Instrument, LIMS Interface 
Resources Needed LIMS Interface; Laboratory instrument 
Privilege Levels Manage Sample Set 
Req Number(s) Functional Requirement Content 
FR38 
A privileged user must be able to retrieve a sequence file from 
an external LIMS and use it to create a CDS sequence file 
FR39 
Changes to data within a sequence file must be synchronized 
between the LIMS and the CDS during transfer from one 
system to the other  
FR40 
A privileged user must be able to create a sample sequence 
without communicating with an external LIMS 
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FR41 
The system must provide the ability to sort preps received 
from an external LIMS by various fields (e.g. Lot Number, 
Item Code) to aid in sample selection as the sequence file is 
being created. 
FR47 
Each sequence must have its own unique identifier for each 
combination of server and data project. 
FR50 
The system must provide grid capabilities to facilitate 
sequence creation and editing (e.g., copy, cut, paste, auto-fill, 
exchange, insert, and delete). 
FR51 
The system must provide a capability to auto-increment 
sample identifiers when creating a sequence. 
FR52 
The system must record the name of the user creating a 
sequence with that sequence 
FR57 
The system must determine the factors and identifiers required 
for a sequence from the method 
FR58 
The system must allow a free text comment field stored with 
each sequence. 
FR60 
The system must permit a user to link transferred weight data 
from a balance system to the corresponding injection factors 
in a sequence 
FR63 A sequence must be able to contain more than one method. 
FR91 
A privileged user must be able to create a sequence identifying 
at least one injection with each of the following injection 
types: blank, control, unknown, standard, check standard, 
suitability, test, and detectability 
FR189 
The system must allow the notebook number and notebook 
page to be stored with each sequence. 
 
Scenario A user modifies a sample sequence 
Scenario Number Sc16 
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Use Case Number UC02 
Description/Objective 
This scenario proves that a user is able to modify a sequence 
file within defined business rules. 
Primary Actor(s) Power User, Master User, User, Support 
Secondary Actor(s) Instrument, LIMS Interface 
Resources Needed LIMS Interface; Laboratory instrument 
Privilege Levels Manage Sample Set 
Req Number(s) Functional Requirement Content 
FR43 
Injections can be identified any time after the sequence is 
created but before results are calculated. 
FR92 
A privileged user must be able to add and delete an injection 
from a sequence before data acquisition starts 
FR93 
A privileged user must be able to add and delete an injection 
from a sequence after data acquisition starts 
FR96 
A privileged user must be able to substitute the non-acquisition 
portion of a method with another method after sequence 
acquisition has started 
FR98 
A privileged user must be able to substitute the sequence 
method before sequence acquisition has started 
FR99 
The system must require a privileged user to abort an active 
sequence before changing the acquisition portion of the 
method 
FR190 
A privileged user must be able to modify the total number of 
injections for an acquiring sequence 
FR193 
A privileged user must be able to modify the run time of a 
non-acquired injection in an acquiring sequence 
 
Scenario A user schedules a sequence on an instrument 
Scenario Number Sc17 
Use Case Number UC03 
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Description/Objective 
This scenario proves that a user is able to schedule a sequence 
on an instrument within defined business rules 
Primary Actor(s) Power User, Master User, User, Support 
Secondary Actor(s) Laboratory Instrument 
Resources Needed Sample sequence; Laboratory Instrument 
Privilege Levels Manage Sample Set, Manage Sample Set Queue 
Req Number(s) Functional Requirement Content 
FR42 
A user must be able to start a sequence by identifying only the 
data acquisition method, instrument number, and number of 
injections. 
FR53 
A user must be able to move a sequence to a different 
instrument with a compatible instrument type 
FR64 
A user must be able to queue multiple sequences on an 
instrument 
FR66 
A user must be able to queue a sequence with a delay of 48 
hours. 
 
Scenario A user aborts a sequence 
Scenario Number Sc19 
Use Case Number UC03 
Description/Objective 
This scenario proves that a user is able to abort a sequence 
within defined business rules 
Primary Actor(s) Power User, Master User, User, Support 
Secondary Actor(s) Laboratory Instrument 
Resources Needed Sample sequence; Laboratory Instrument 
Privilege Levels Manage Sample Set Queue 
Req Number(s) Functional Requirement Content 
FR67 A user must be able to abort an active sequence 
FR68 A user must be able to abort a queued or delayed sequence 
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FR69 
A user must be able to restart an aborted sequence after the last 
acquired injection. 
FR100 
Aborting of a sample set must create an entry in the sequence 
audit trail 
FR187 
A user must be able to abort a sequence after the current 
injection 
FR188 
A user must be able to abort a sequence immediately 
regardless of status 
FR182 
When a sequence is aborted, the system must retain all raw 
data up to the point of aborting. 
 
Scenario A user modifies an instrument queue 
Scenario Number Sc21 
Use Case Number UC03 
Description/Objective 
This scenario proves that a user is able to reorder the 
sequences in an instrument queue within defined business 
rules 
Primary Actor(s) Power User, Master User, User, Support 
Secondary Actor(s) Laboratory Instrument 
Resources Needed Two or more queued sequences; Laboratory Instrument 
Privilege Levels Manage Sample Set Queue 
Req Number(s) Functional Requirement Content 
FR75 A user must be able to reorder queued sequences 
FR85 
A user must be able to change the instrument a sequence is 
assigned to anytime prior to acquisition 
 
Scenario A user pauses an acquiring sequence 
Scenario Number Sc29 
Use Case Number UC03 
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Description/Objective 
This scenario proves that a user is able to pause an acquiring 
sequence within defined business rules 
Primary Actor(s) Power User, Master User, User, Support 
Secondary Actor(s) Laboratory Instrument 
Resources Needed Acquiring sequence; Laboratory Instrument 
Privilege Levels Manage Sample Set Queue 
Req Number(s) Functional Requirement Content 
FR191 
A user must be able to pause an acquiring sequence after the 
current injection is completed. 
FR192 
A user must be able to continue a paused sequence at a later 
time 
 
Scenario The system acquires data from a laboratory instrument 
Scenario Number Sc02 
Use Case Number UC04 
Description/Objective 
This scenario proves that the system permits acquisition of 
raw data from laboratory instruments within defined business 
rules 
Primary Actor(s) Laboratory Instrument 
Secondary Actor(s) Not applicable 
Resources Needed Sequence method; Laboratory instrument 
Privilege Levels Manage Sample Set Queue, Acquire Data 
Req Number(s) Functional Requirement Content 
FR02 
The system must acquire data following user-configured 
parameters 
FR59 
The system must be able to acquire weight data from a balance 
into the CDS. 
FR61 
The system must be able to acquire 3D data from a Photo 
Diode Array detector 
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FR183 
Data must be buffered before it is written to the acquisition 
server. 
FR184 
The system shall support an input range of  -0.25 volts to 
+2.25 volts 
FR185 
The system shall support sampling rates between 0.25 and 100 
Hz inclusively 
FR251 
The system must collect the following data for all samples: 
Sequence number; Assigned analyst 
FR277 The system must allow acquisition during backup procedures 
FR278 
In the case of a power failure, the system must automatically 
recover all data buffered at the instrument 
FR286 
The system must be able to acquire 2D data from a Photo 
Diode Array detector 
FR322 
The System must require that input come from specifically 
authorized devices and perform device checks to verify the 
source.  If the source is invalid, the system must notify the 
user.  
 
Scenario A user processes a sample 
Scenario Number Sc18 
Use Case Number UC05 
Description/Objective 
This scenario proves that a user is able to process a sample to 
obtain results within defined business rules 
Primary Actor(s) Power User, Master User, User 
Secondary Actor(s) Not applicable 
Resources Needed Sample data; processing method 
Privilege Levels Process Data 
Req Number(s) Functional Requirement Content 
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FR14 The system must allow a named peak in a method to be 
defined as the reference standard for any other peak in the 
chromatogram. 
FR15 The system must allow the designation of more than one peak 
in the chromatogram as internal standard(s). 
FR29 The system must permit reprocessing of a sample using a prior 
revision of a master method that has not been marked as 
logically deleted. 
FR62 A user must be able to process 3D Photo Diode Array data. 
FR101 A user must be able to process a component in a sample 
injection from another component's standard curve. 
FR102 A user must be able to process results in a sequence from a 
calibration curve acquired in another sequence. 
FR103 A user must be able to process multiple components in a 
sample using multiple calibration standards from different 
sequences. 
FR104 A user must be able to logically delete a level from a standard 
curve and enter the appropriate audit comment. 
FR105 The system must be able to create a normalized one-point 
standard curve. 
FR106 A normalized one-point standard curve must be able to use the 
averages of the responses and concentrations as one point and 
then include the origin as the second point. 
FR108 The system must be able to create a least squares calibration 
curve as corrected standard weight vs. response. 
FR109 The system must be able to create a least squares calibration 
curve as 1/corrected standard weight vs. response. 
FR110 The system must be able to create a least squares calibration 
curve as 1/corrected standard weight squared vs. response. 
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FR111 The system must be able to create a least squares calibration 
curve as log standard weight squared vs. log response. 
FR112 The system must be able to create a non-linear, point-to-point 
calibration curve. 
FR113 The system must be able to calculate the standard curve RSD 
of a multiple-level calibration curve. 
FR114 The system must be able to create a calibration curve and 
calculate the normalized intercept to slope ratio, maximum % 
deviation, RSD of replicate injections, correlation coefficient, 
coefficient of determination, confidence interval parameters 
(slope, intercept, probability factors), actual intercept, and the 
actual slope. 
FR115 A user must be able to process a single raw data file with 
multiple methods. 
FR116 A user must be able to process a result to calculate the area 
percent of a peak as a percent of the total area of peaks 
integrated (within injection). 
FR118 The system must allow samples which have responses lower 
than the lowest point of the standard curve to be calculated by 
the normal regression line. 
FR119 The system must allow samples which have responses lower 
than the lowest point of the standard curve to be calculated by 
a line drawn from the low standard through the origin. 
FR120 The system must allow samples which have responses lower 
than the lowest point of the standard curve to be calculated by 
a line forcing the regression analysis through the origin. 
FR121 The system must allow samples which have responses lower 
than the lowest point of the standard curve to be calculated by 
a second regression line of low concentration standards for the 
same component. 
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FR122 Sample responses that are greater than the highest response of 
the standard curve or less than the lowest response of the 
standard curve must be flagged as such. 
FR123 The system must be able to create a calibration curve by 
grouping two non-consecutive peaks together. 
FR124 The system must be able to calculate dissolution results. 
FR125 A calculated result must include a data integration revision 
number and time stamp. 
FR126 The time stamp for a calculated result must be the actual time 
the calculation is performed. 
FR129 The system must be able to calculate a result for a peak using a 
response factor relative to another peak in the 
chromatographic run. 
FR132 For a suitability sample, the system must calculate the 
following for a peak: retention time, peak width, theoretical 
plates, tailing, resolution, signal to noise, selectivity, and K-
prime. 
FR133 For a suitability sample, the system must calculate the peak 
resolution for two non-adjacent peaks. 
FR135 For a suitability sample, the system must provide the option of 
calculating system suitability parameters according to the USP 
calculations. 
FR136 For a suitability sample, the system must provide the option of 
calculating system suitability parameters according to the EP 
calculations. 
FR137 For a suitability sample, the system must provide the option of 
calculating system suitability parameters according to the JP 
calculations. 
FR138 A user must be able to select the appropriate suitability 
calculation type to use for limit checking. 
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FR146 The system must flag peaks for all sample types if any of the 
following items are outside the limit: retention time, peak 
width, theoretical plates, tailing, resolution, signal to noise, 
area ratio, selectivity, and K-Prime. 
FR148 The system must flag peaks outside of limits configured in the 
method. 
FR149 The system must flag standards with a multiple-level 
calibration curve if any of the following items are outside the 
limit: the standard curve RSD of the line and the standard 
curve RSD of the normalized points. 
FR150 The system must flag standards if any of the following items 
are outside the limit: the normalized intercept to slope ratio, 
maximum % deviation, RSD of replicate injections, 
correlation coefficient, coefficient of determination, 
confidence interval parameters (slope, intercept, probability 
factors), actual intercept, and the actual slope. 
FR157 The system must flag manually integrated peak areas. 
FR195 The system must provide a graphical way to manually 
integrate peaks. 
FR196 The system must be able to determine integration parameters 
to apply on a series of raw data from the integration 
parameters selected in a manual integration. 
FR197 The system must give the user the option whether or not to 
save manual integrations the user has just created. 
FR198 The system must provide a complete audit trail for any saved 
manual integrations. 
FR199 A user must be able to review the integration history for an 
injection (using the audit trail) and to revert back to an 
previous set of integrations. 
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FR202 During manual and automatic integration, the system must use 
the raw data values to determine the y-coordinates of peak 
integration points. 
FR203 A user must be able to rename the peaks in a result without 
reintegrating. 
FR204 The system must provide a background process for 
automatically integrating peaks. 
FR205 The automatic integration process must be capable of 
integrating peaks at 3 times the noise level. 
FR206 A user must be prompted for an audit trail reason when saving 
a automatic integration. 
FR207 Each integration must have a unique revision number. 
FR209 The system must allow integrations to be performed 
automatically when the injection completes. 
FR210 The system must be able to suggest analysis parameters (peak 
width, threshold, minimum area, minimum height) for a 
method based on a single injection. 
FR211 The system must have the ability to identify peaks based on 
retention time (absolute or relative to a reference peak), 
relative peak position, or size within a window. 
FR212 The system must have the ability to subtract a blank injection 
from a sample injection before automatically integrating 
peaks. 
FR213 The system must mark a blank subtracted result as such. 
FR214 The following peak baseline types must be available: Valley to 
valley fit. 
FR215 The following peak baseline types must be available: Vertical 
drop to a common baseline. 
FR216 The following peak baseline types must be available: Tangent 
skim, backside. 
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FR217 The following peak baseline types must be available: Tangent 
skim, front side. 
FR218 The following peak baseline types must be available: 
Exponential skim. 
FR219 The system must be able to integrate a peak based on a 
specified minimum peak area. 
FR220 The system must be able to integrate a peak based on a 
specified minimum peak height. 
FR221 The system must be able to integrate a peak based on a 
specified noise threshold. 
FR222 When processing a suitability sample, the system must provide 
the following data: EP valley resolution. 
FR223 When processing a peak, the system must provide the 
following data: peak height. 
FR224 When processing a peak, the system must provide the 
following data: peak area. 
FR225 When processing a peak, the system must provide the 
following data: peak start (x,y) and end points (x,y) for each 
peak. 
FR226 When processing a peak, the system must provide the 
following data: baseline start (x,y) and end points (x,y) for 
each peak. 
FR227 When processing a peak, the system must provide the 
following data: difference between the retention and start time 
at the 5% peak height, retention time at full height for a peak.  
FR228 When processing a peak, the system must provide the 
following data: peak width at baseline between resolution 
tangents for a peak. 
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FR240 The system must be able to perform a chromatogram 
subtraction manipulation on two raw data files, saving the 
manipulated data while not changing the original data files. 
FR241 The system must be able to perform a time shift manipulation 
on a raw data file, saving the manipulated data while not 
changing the original data file. 
FR242 The system must be able to perform a scalar addition 
manipulation on a raw data file, saving the manipulated data 
while not changing the original data file. 
FR243 The system must be able to perform a scalar subtraction 
manipulation on a raw data file, saving the manipulated data 
while not changing the original data file. 
FR244 The system must be able to perform a scalar multiplication 
manipulation on a raw data file, saving the manipulated data 
while not changing the original data file. 
FR245 The system must be able to perform a scalar division 
manipulation on a raw data file, saving the manipulated data 
while not changing the original data file. 
FR246 The system must be able to perform a chromatogram addition 
manipulation on two raw data files, saving the manipulated 
data while not changing the original data files. 
FR252 When processing a peak, the system must retain the following 
data: peak name, expected retention time (absolute), expected 
retention time (relative to another peak), and the Baseline type.
FR253 When processing a sample, the system must retain the 
following data: actual acquisition start date and start time. 
FR254 When processing a sample, the system must retain the 
following data: actual acquisition end date and end time. 
FR255 When processing a sample, the system must retain the 
following data: actual injection run time. 
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FR256 When processing a sample, the system must be able to 
calculate the following data: noise amplitude (root mean 
square). 
FR257 When processing a sample, the system must be able to 
calculate the following data: Sample concentration, defined as 
SampleWeight/Dilution 
FR258 When processing a sample, the system must retain the 
following data: Software version of the integrator. 
FR259 When processing a sample, the system must retain the 
following data: actual integration date. 
FR260 When processing a sample, the system must retain the 
following data: actual integration time. 
FR261 When processing a sample, the system must retain the 
following data: Name and system identifier of user who 
integrated the raw data. 
FR265 The system must not allow processing of data that was 
generated from a different machine that had been running a 
newer version of the software. 
FR275 The system must allow data processing during backup 
procedures. 
FR287 A user must be able to process 2D data from a Photo Diode 
Array detector. 
FR289 Every change to peak integration (automatic or manual) must 
be audit trailed. 
FR323 The system must perform the following calculations: Slope of 
the least-squares, linear regression line of the observed peak 
heights versus the expected peak heights, Standard Error of the 
least-squares, linear regression line of the observed peak 
heights versus the expected peak heights, Baseline Noise, and 
Baseline Drift. 
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FR325 The precision for suitability fields must be 6 digits after the 
decimal, including all fields that feed into results except area 
and height which are a precision of 0.   
FR326 The precision for result fields must be 6 digits after the 
decimal, including all fields that feed into results except area 
and height which are a precision of 0. 
FR329 The system must be able to calculate the RSD of the 
normalized points of a multiple-level calibration curve. 
 
Scenario A user formats a report 
Scenario Number Sc03 
Use Case Number UC06 
Description/Objective 
This scenario proves that a user is able to format a report 
within defined business rules 
Primary Actor(s) Power User, Master User, User 
Secondary Actor(s) Not applicable  
Resources Needed Reportable Data 
Privilege Levels Report Data 
Req Number(s) Functional Requirement Content 
FR03 A user must be able to format a plot in a report 
 
Scenario A user creates a report 
Scenario Number Sc11 
Use Case Number UC06 
Description/Objective 
This scenario proves that a user is able to create a report 
within defined business rules 
Primary Actor(s) Power User, Master User 
Secondary Actor(s) Not applicable 
Resources Needed Queued Sequence; Sequence method 
Privilege Levels Master Method Edit 
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Req Number(s) Functional Requirement Content 
FR26 
A user must be able to display in a report a unique sequential 
revision number for a method  
FR49 
A user must be able to display the identifications of the 
injections in a sequence in a report 
FR127 
A user must be able to specify which peaks and which 
attributes will be reported 
FR158 
A user must be able to display each replicate result along with 
the value of the average results 
FR165 
A user must be able to include the following on a result report: 
software version number for data analysis and result 
calculation 
FR166 
A user must be able to include the following on a result report: 
acquisition machine 
FR167 
A user must be able to include the following on a result report: 
processing machine 
FR168 
A user must be able to include the following on a suitability 
result report: suitability calculation used 
FR169 A user must be able to display specified limits on a report 
 
Scenario A user searches for a method 
Scenario Number Sc14 
Use Case Number UC06 
Description/Objective 
This scenario proves that a user is able to search for methods 
within defined business rules 
Primary Actor(s) Power User, Master User, User, Support 
Secondary Actor(s) Not applicable 
Resources Needed Method 
Privilege Levels Report Data 
Req Number(s) Functional Requirement Content 
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FR35 
A user must be able to select methods by typing in the method 
code 
FR55 
A user must be able to retrieve the total number of times a 
method was used by a given user  
FR56 
A user must be able to retrieve the total number of times a 
method was used on a given instrument 
 
Scenario A user displays and/or prints a report 
Scenario Number Sc20 
Use Case Number UC06 
Description/Objective 
This scenario proves that a user is able to display and print a 
report within defined business rules 
Primary Actor(s) Power User, Master User, User 
Secondary Actor(s) Not applicable 
Resources Needed Laboratory Instrument; FR 
Privilege Levels Report Data 
Req Number(s) Functional Requirement Content 
FR21 A user must be able to list a method on paper 
FR70 A user must be able to report the number of sequences in the 
queue. 
FR71 A user must be able to display the number of injections for 
each sequence in the queue 
FR73 A user must be able to display the method code for a sequence 
in a queue 
FR74 A user must be able to display the projected start and end 
times (per sequence) for sequences in the queue. 
FR86 The system must be able to  track the component(s) used by an 
instrument 
FR87 The system must be able to track method usage by instrument 
FR88 The system must be able to track instrument usage by method 
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FR90 The system must be able to display a summary of suitability 
data collected on an instrument for a selected period of time 
FR155 A user must be able to view a result as soon as it can be 
accurately calculated (i.e. before the sequence has completed, 
but after acquisition of any relevant standards). 
FR156 The system must permit reporting of flagged peaks which 
failed chromatographic parameters 
FR159 The system must be able to calculate the RSD of samples from 
the same lot number 
FR160 The system must be able to calculate the RSD of samples from 
the same sample number 
FR161 The system must be able to calculate the RSD of samples from 
the same storage conditions.  
FR164 The system must permit a user to view a report without 
printing it 
FR179 The system must be able to summarize system suitability 
statistics for selected methods in a report. 
FR248 A user must be able to review all the audit trail information for 
a sequence in one location 
FR262 A user must be able to display the external standard run on a 
report for those sequences that use an external standard run 
FR273 The system must permit reporting of flagged peaks which 
were outside of acceptable ranges 
FR276 The system must allow data reporting during backup 
procedures. 
 
FR283 The system reports must have national language support and 
must be able to be implemented in at least the following 
language: English. 
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Scenario A user searches for data 
Scenario Number Sc22 
Use Case Number UC06 
Description/Objective 
This scenario proves that a user is able to search for data 
within defined business rules 
Primary Actor(s) Power User, Master User, User, Support 
Secondary Actor(s) Not applicable 
Resources Needed Searchable Data 
Privilege Levels Report Data 
Req Number(s) Functional Requirement Content 
FR76 A user must be able to retrieve data by the analytical column 
name 
FR82 A user must be able to retrieve the instrument name for a 
sample sequence 
FR83 A user must be able to retrieve the number of injections 
actually made on an instrument 
FR89 A user must be able to identify the instrument used to generate 
system suitability data for a selected sequence of data while 
sorting the data by method 
FR94 The system must inform a user that calibration standards are 
missing from a sequence if none exist in the sequence. 
FR264 A user must be able to retrieve all the sequences that used a 
standard run as an external standard curve run 
FR291 A user must be able to search for audit trails by sequence 
FR292 A user must be able to search for sequence method(s), peak 
integration(s), result calculation(s), and result release audit 
trail(s) by sequence 
FR293 A user must be able to search for master method audit trail(s) 
by master method name 
 
 191
Scenario A user displays data on the screen 
Scenario Number Sc04 
Use Case Number UC06 
Description/Objective 
This scenario proves that a user is able to view data on the 
screen within given business rules 
Primary Actor(s) Power User, Master User, User 
Secondary Actor(s) Not applicable 
Resources Needed Acquired Data 
Privilege Levels Report Data 
Req Number(s) Functional Requirement Content 
FR230 A user must be able to display a stack plot for multiple 
chromatograms from multiple sequences 
FR231 A user must be able to overlay multiple chromatograms from 
multiple sequences 
FR232 A user must be able to generate a sequential display for 
multiple chromatograms from multiple sequences 
FR233 A user must be able to overlay a solvent gradient on a 
chromatogram 
FR234 A user must be able to overlay a temperature gradient on a 
chromatogram 
FR235 A user must be able to display the following with the 
chromatogram on the screen: peak names, heights, areas, 
retention times, and results 
FR236 A user must be able to display the following with the 
chromatogram on a report: peak names, heights, areas, 
retention times, and results 
FR237 A user must be able to set individual preferences for what is 
displayed with the chromatogram on the screen 
FR238 A user must be able to display chromatograms in real-time as 
data are collected from an instrument 
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FR239 A user must be able to zoom within a chromatogram. 
FR247 A user must be able to place a text label on a chromatogram 
FR282 The system presentation must have national language support 
and must be able to be implemented in the following language: 
English. 
FR285 A user must be able to display the status of sequences and a 
sequence result report with injection and peak information 
after logging into the network via an external account provided 
by the company and then logging into the system 
 
Scenario A user dispositions a result 
Scenario Number Sc25 
Use Case Number UC07 
Description/Objective 
This scenario proves that a user is able to disposition a result 
within defined business rules 
Primary Actor(s) Power User, Master User, User 
Secondary Actor(s) LIMS 
Resources Needed Processed results 
Privilege Levels Release Data 
Req Number(s) Functional Requirement Content 
FR130 A user must be able to disposition a suitability result 
FR131 Dispositioning results must generate an audit trail entry 
FR139 The system must permit a user to verify if a result has a status 
of rejected. 
FR140 A user must be able to enter a comment when rejecting results
FR141 A user must be able to release previously rejected results 
FR170 A user must be able to review and disposition results for an 
entire sequence 
FR171 A user must be able to review and disposition results for 
individual samples in a sequence 
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FR172 A user must be able to review and disposition results for 
samples in a sequence while the sequence is still in progress 
FR173 Dispositioning results must be limited to privileged individuals
FR174 The system must provide for up to two levels of verification of 
the results prior to releasing the data. 
FR200 A user must be able to lock integrations after verification 
FR201 A user must be able to unlock integrations 
 
Scenario The system transfers data to a LIMS 
Scenario Number Sc27 
Use Case Number UC07 
Description/Objective 
This scenario proves that the system is able to transfer results 
and associated data to a LIMS within defined business rules 
Primary Actor(s) LIMS 
Secondary Actor(s) Not applicable 
Resources Needed Released Results 
Privilege Levels Release Data 
Req Number(s) Functional Requirement Content 
FR175 
The system must be able to transfer sample result data and 
associated sample identifiers to a LIMS upon a user's request 
FR176 The system must allow only released data to be transferred to 
LIMS 
FR177 The system must verify the integrity of each result prior to 
releasing it to the LIMS 
 
Scenario A user exports a method 
Scenario Number Sc10 
Use Case Number UC08 
Description/Objective 
This scenario proves that a user is able to export a method 
within defined business rules 
 194
Primary Actor(s) Power User, Master User, User 
Secondary Actor(s) Not applicable 
Resources Needed Method 
Privilege Levels Export Data 
Req Number(s) Functional Requirement Content 
FR24 The system must permit a method to be exported to a word 
processing program 
FR25 Method exporting must require privilege 
 
Scenario A user exports data 
Scenario Number Sc26 
Use Case Number UC08 
Description/Objective 
This scenario proves that a user is able to export data within 
defined business rules 
Primary Actor(s) Power User, Master User, User 
Secondary Actor(s) Not applicable 
Resources Needed Sample result(s) 
Privilege Levels Export Data 
Req Number(s) Functional Requirement Content 
FR154 A user must be able to export historical data for control 
samples to an external file 
FR162 A user must be able to export data in a word processor 
compatible format 
FR163 A user must be able to export data in a spreadsheet compatible 
format 
FR178 A user must be able to export data in a format compatible with 
external statistical packages 
FR271 A user must be able to generate an export method that exports 
the following: sample identification information; item codes; 
lot numbers; individual results from final report; 
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concentration; Area %; area/area ratio; standard and sample 
weights; sample raw data points. 
FR281  A user must be able to transfer screen contents from the 
CDS to another application external to the CDS 
 
Scenario The system controls a laboratory instrument 
Scenario Number Sc01 
Use Case Number UC09 
Description/Objective 
This scenario proves that the system is able to control a 
laboratory instrument within defined business rules 
Primary Actor(s) Laboratory Instrument 
Secondary Actor(s) Not applicable 
Resources Needed Sequence method; Laboratory instrument 
Privilege Levels Acquire Data 
Req Number(s) Functional Requirement Content 
FR01 A user must have the capability to pass control parameters to 
an instrument  
FR180 The system must be able to control a laboratory instrument via 
a contact closure that is programmable for each injection. 
FR181 The system must be able to control a laboratory instrument via 
a contact closure that is programmable for over the course of 
an entire sequence, not by injection. 
FR250 The system must retain the following data for all samples: 
Instrument number; Sampling rate; Instrument Control 
Parameters; Voltage range 
 
Scenario A user creates an instrument setup 
Scenario Number Sc23 
Use Case Number UC09 
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Description/Objective 
This scenario proves that a user is able to create an instrument 
setup within defined business rules 
Primary Actor(s) Power User, Master User, Support 
Secondary Actor(s) Not applicable 
Resources Needed Laboratory Instrument 
Privilege Levels Instrument Configuration 
Req Number(s) Functional Requirement Content 
FR77 The analytical column used to acquire data on a 
chromatography instrument must be able to be tracked 
FR78 Instrument components must be permitted to be used in more 
than one instrument 
 
Scenario A user modifies an instrument setup 
Scenario Number Sc24 
Use Case Number UC09 
Description/Objective 
This scenario proves that a user is able to modify an 
instrument setup within defined business rules 
Primary Actor(s) Power User, Master User, Support 
Secondary Actor(s) Not applicable 
Resources Needed Laboratory Instrument 
Privilege Levels Instrument Configuration 
Req Number(s) Functional Requirement Content 
FR79 Modifying instrument components in an instrument setup must 
require privilege 
FR80 A user must be able to inactivate an instrument setup to make 
it unavailable for data acquisition. 
FR84 A user must be able to change the component operating 
parameters in an instrument setup during sequence creation. 
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Scenario A user monitors a baseline 
Scenario Number Sc28 
Use Case Number UC09 
Description/Objective 
This scenario proves that a user is able to monitor a baseline 
within defined business rules 
Primary Actor(s) Power User, Master User, User, Support 
Secondary Actor(s) Not applicable 
Resources Needed Sequence method; Laboratory Instrument 
Privilege Levels Acquire Data 
Req Number(s) Functional Requirement Content 
FR186 A user must be able to monitor a baseline without starting a 
sequence 
 
 
Scenario A user logs into the system. 
Scenario Number Sc30 
Use Case Number UC10 
Description/Objective 
This scenario proves that a user is able to access the system 
within defined business rules. 
Primary Actor(s) Power User, Master User, User, Support 
Secondary Actor(s) Not applicable 
Resources Needed User account 
Privilege Levels Report Data 
Req Number(s) Functional Requirement Content 
FR302 A user must be able to have different roles on separate servers 
as permitted by local management approval. 
FR303 Logging into the system will require unique identification. 
FR304 The system must require that user identification codes be at 
least 7 characters. 
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FR305 The system must require that passwords be at least 6 
characters in length. 
FR306 Users must be able to change their own passwords and be 
prompted to do so upon password expiration. 
FR307 Passwords must not be displayed or printed in a readable 
format. 
FR309 The system must record access violations for future review. 
FR311 The system must suspend user access after three successive 
failed login attempts. 
 
Scenario A support user creates or modifies a user account. 
Scenario Number Sc31 
Use Case Number UC10 
Description/Objective 
This scenario proves that a support user is able to create or 
modify a user account on the system within defined business 
rules. 
Primary Actor(s) Support 
Secondary Actor(s) Not applicable 
Resources Needed User Account 
Privilege Levels System Configuration 
Req Number(s) Functional Requirement Content 
FR298 The system must permit user access to be defined at the 
laboratory level. 
FR300 A user must be able to hold multiple roles on a single server as 
permitted by local management approval. 
FR301 A user must be able to have access to more than one 
laboratory on a server as permitted by local management 
approval. 
   
Scenario A user manages data. 
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Scenario Number Sc32 
Use Case Number UC11 
Description/Objective 
This scenario proves that a user is able to manage data within 
defined business rules. 
Primary Actor(s) Power User, Master User, User 
Secondary Actor(s) Not applicable 
Resources Needed Sample data 
Privilege Levels Manage Data 
Req Number(s) Functional Requirement Content 
FR274 The system must allow a user with privilege to Save/Rename 
spectral libraries and search those libraries. 
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Introduction 
Purpose 
System Description 
Empower is a Chromatography Data Management System designed to collect, analyze, 
and report data from laboratory instruments. 
The Empower system consists of the following components: 
• Empower chromatography data software application 
Refer to the Empower System Overview for additional details. 
Document Overview 
This Validation Plan describes and identifies the organization, resources, activities, and 
procedures required for the validation effort associated with Empower Release 1.0.  A 
description of the deliverables and supporting documents that will be created for Release 
1.0 is included in this Validation Plan. The roles and responsibilities for these activities 
are identified in the Empower Validation Roles and Responsibilities document. 
Scope 
The scope of Empower Release 1.0 encompasses the following: 
• Validation of the Empower application (Build 2154), based on Indiana University’s 
intended use. This includes the Dissolution, Gas Chromatography (GC), Agilent 
A1100, System Suitability, and Photodiode Array (PDA) options of the Empower 
software. 
• Qualification of the LAC/E32 data acquisition servers, instrument control 
connections, and SAT/IN analog/digital signal converters. 
Terms and Acronyms 
Refer to the Indiana University Informatics Acronym and Definition List for a list of 
terms and acronyms used in this document. 
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References 
Refer to the Empower Master Document List (MDL) for the location of all documents 
referenced in this Validation Plan. The official hard copy location of the MDL is the 
Indiana School of Informatics Validation Library. 
Revisions to the Validation Plan 
This Validation Plan will be updated, versioned, and approved as changes occur, up to 
the point of system acceptance and approval of the Validation Report for Release 1.0. 
After the Validation Report is approved, the Validation Plan will become historic and 
will not be updated. 
Any changes to this plan after the initial approved version will be recorded and tracked in 
the Revision History. A documented change request will be issued to initiate changes to 
approved validation documents. Upon completion and approval of the change, the 
original signed hard copy will be filed in the Indiana School of Informatics Validation 
Library. 
Regulatory Status 
The Empower system is used by laboratory organizations that support manufacturing, 
development, and discovery. These organizations are subject to GLP and GMP 
regulations. 
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Validation Approach 
All validation activities will be conducted prospectively and will be completed prior to 
the system’s availability for deployment and implementation.  
The Empower system will be validated in accordance with Regulatory policies and 
procedures. The extent to which Empower will be validated will be based on a justified 
and documented risk assessment. 
Risk Assessment 
A risk assessment for a generic CDS was performed in accordance with GAMP 5 
guidelines. Potential risks and high-level risk control measures are identified in the CDS 
Risk Assessment document. The rationale for any risk-based decisions will be 
documented within the validation deliverables themselves (e.g., Test Plan). Subsequently, 
the Validation Plan will be updated to reflect activities or deliverables identified for risk 
mitigation. 
Applicable Policies and Procedures 
The Empower system development methodology is a risk-based, iterative approach. For 
example, during development, feedback is obtained from stakeholders, which is used to 
develop and refine the requirements and design (configuration) in parallel. Requirements 
and design (configuration) will be approved prior to beginning unit and system level 
testing. All other validation deliverables and supporting documents will be completed 
prior to system acceptance. 
Automated Tools 
No special automated tools will be used to assist with system development, validation, 
and maintenance activities. 
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Project Organizational Structure 
The Empower Validation Roles and Responsibilities document contains a high-level 
overview of the groups and key roles involved with the Empower system. 
Team Training 
Empower personnel are required to complete all training by the assigned due date and 
complete proof of training as defined in each individual’s training plan. Employee 
resumes or curriculum vitae are maintained on file. 
Document Storage and Retention 
Upon final approval of validation documentation and materials, all hard copies will be 
stored in the Indiana School of Informatics Validation Library will be retained according 
to the appropriate Records Retention Schedule.  
All final electronic copies will also be retained. Electronic document access is described 
in the Empower Security Plan. 
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Validation Package 
Validation Activities and Deliverables 
Validation Planning 
The Validation Plan defines the validation strategy for the Empower system and 
describes the validation documentation that will be created. The Validation Plan serves as 
the set of criteria for accepting the system and approving the Validation Report during the 
system acceptance activity. 
The Roles and Responsibilities document provides a list of the roles and corresponding 
responsibilities that are involved in validation activities associated with the development, 
deployment, and maintenance of Empower. 
The CDS Risk Assessment deliverable identifies potential risks and risk control measures. 
The rationale for any risk-based decisions will be documented within the validation 
deliverables themselves. The CDS Risk Assessment will be reviewed and updated 
periodically, as risks change and additional risks are identified. 
Deliverables: 
• Empower Validation Plan 
• Empower Validation Roles and Responsibilities 
Requirements 
The Requirements Definition document identifies the System Requirements and Use 
Case requirements for a generic CDS.  The Use Case definition section contains the 
attributes (e.g., Use Case ID, Use Case Description), scenarios, functional requirements, 
actors, and other information that is specific to the individual Use Case. 
Inputs into authoring requirements include, but are not limited to, the following: 
• Review of other CDS requirements examples 
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• Interviews with business area subject matter experts (SMEs) 
A Traceability Matrix will be developed to include all functional requirements and will 
be used to accurately trace requirements to design and testing. If a functional requirement 
is satisfied by standard COTS functionality, the Traceability Matrix should identify that it 
is fulfilled by the vendor. 
Deliverables: 
• CDS Requirements Definition 
• Empower Traceability Matrix (initial development for requirements) 
Vendor Management 
Waters Corporation 
Waters Corporation is the vendor and application developer of the Empower software.  
The Empower team also reviewed and evaluated the action items noted in the May 2003 
vendor audit performed by Watson Pharmaceuticals, available through the Parenteral 
Drug Association Audit Repository Center (ARC). The scope of this audit included the 
following: 
• Quality System 
• Project Management 
• Methodology 
• Testing 
• Configuration Management 
• Manufacturing 
• Documentation and Records Management 
• Security 
• Training and Education 
• Maintenance 
• Date Dependencies 
• Electronic Record Capabilities 
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The Watson auditors found that Waters had a very well organized formal system to 
document the Software Development Life Cycle (SDLC) and that extensive testing was 
completed as part of the development process. Test cases were also reviewed to ensure 
that Waters executed the functionality as described in the Functional Specification and 
the Marketing Requirements document. 
Vendor Management Plans 
Vendor Management Plans will be written to describe the approach that will be used by 
Indiana University to manage the Empower software vendor. 
Vendor Management Deliverables and Activities 
Deliverables: 
• Vendor Evaluation Report (ARC) 
• Empower Vendor Management Plan 
System Design 
A System Overview will be created. Additional design documentation will be created, 
including the following: 
• Security Design – This document identifies the user types that have access to 
Empower and the security privileges configured for each user type. 
• Custom Field Design Definition – These documents identify the specific 
configurations required for creating custom fields within Empower to meet user 
requirements 
The Empower application is purchased configurable COTS software. Application design 
documentation is proprietary and owned by the application vendor. Design information 
was examined during the vendor evaluation, and it was found that system design was 
well documented and implemented. Indiana University will not create detailed 
specifications for standard software functionality that is not configured. However, design 
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definition documents for application configurations (e.g., custom fields, template 
projects, and report groups) will be created and maintained by Indiana University.  
Design will be traced to requirements in the Traceability Matrix. 
Deliverables: 
• Empower System Overview 
• Empower Security Design 
• Custom Field Design Definition documents 
Software Development and Source Code Review 
The Empower application is a purchased COTS software product, and all source code is 
owned and maintained by the vendor. There will be no Indiana University-developed 
custom code for the Empower software.  
The application vendor’s software development methodology, design specifications 
(including design and coding standards), and source code review documentation were 
reviewed during the vendor evaluation. No issues related to coding standards or source 
code reviews were found during the audit. 
The application vendor is responsible for conducting and documenting source code 
reviews. Refer to the Vendor Management Plans for a description of vendor software 
development responsibilities. 
Deliverable: 
No deliverables for software development will be created. 
Testing 
The Empower testing documentation addresses test planning, execution, and result 
reporting. The following test strategy will be used for testing of the Empower system: 
• The extent of testing to be performed by Indiana University is based on the results of 
vendor evaluations. 
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• Indiana University relies on vendor testing of the COTS software. The Indiana 
University testing effort is primarily directed toward the configuration tasks 
performed by Indiana University that have a direct bearing on data integrity (i.e., 
assay results). 
• Indiana University will perform unit testing on custom fields and application 
configurations. 
• Integration level testing will be conducted during system testing. 
• System level testing will include end-to-end testing of the Empower system. 
• Acceptance testing will be conducted and will include a demonstration of required 
system functionality to key business partners. 
Refer to the Empower Test Strategy document for more detail. 
 
Test Plan and Test Summary Report 
The Empower Test Plan describes the test approach (including risks) for unit and system 
level testing. The Empower Test Summary Report will summarize the results of the 
testing effort for unit and system level testing and will include a list of the test cases and 
test scripts executed and final statuses. 
Traceability 
Test cases and test scripts will be identified in the Traceability Matrix and traced to 
requirements and design. 
Client Acceptance Testing 
The Empower Test Plan describes the test approach for acceptance testing and identifies 
the testing activities that will be executed in order to obtain formal acknowledgement 
from the System Owner that Empower meets the business objectives as described by the 
requirements documentation. 
The results of the testing activities described in the Empower Test Plan will be 
documented in the Empower Test Summary Report. 
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Installation Qualification 
The application vendor’s Installation, Installation Qualification, and Operational 
Qualification process documents were evaluated, and it was determined that they would 
be usable in the Indiana University environment as written.  
This review will be documented in a QAR. If additional requirements or special needs are 
identified, this will be resolved prior to system acceptance. 
Testing Deliverables and Activities 
Deliverables: 
• Empower Test Plan 
• Empower Test Strategy 
• Empower Test Cases and Test Scripts 
• Empower Test Summary Report 
• QAR document for vendor’s Installation, Installation Qualification, and Operational 
Qualification documents 
System Acceptance 
A Validation Report will be created to summarize the completion of all validation 
activities and resulting deliverables and supporting documentation. Approval of the 
Validation Report attests that the Empower system is validated and ready for deployment. 
A Release Description document will be created that describes: 
• Release identification 
• The functionality included in the release 
• Any outstanding bugs and known workarounds 
• Any required training for users or support personnel 
Deliverables: 
• Empower Validation Report 
• Release Description document 
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Supporting Documentation 
Security 
The Security Plan describes the physical and logical security to protect the Empower 
application and the integrity of the data within the system.  
Deliverables: 
• Empower Security Plan 
Backup and Restoration 
The application vendor’s Backup and Restoration process documents were evaluated, and 
it was determined that they would be usable in the IU environment as written. 
This review will be documented in a QAR. If additional requirements or special needs are 
identified, this will be resolved prior to system acceptance. 
Deliverable: 
• QAR document for review of vendor’s backup and restoration documents 
Disaster Recovery  
A Disaster Recovery Plan (DRP) will be created to document the steps that will be taken 
in order to restore the availability of an Empower system in the event of a disaster (e.g., 
prolonged server and/or network outage). 
Deliverables: 
• Empower Disaster Recovery Plan 
Business Continuity  
An Empower Business Continuity Plan (BCP) will be written to address how Indiana 
University School of Informatics business operations will continue in the event of a 
disaster. 
Deliverable: 
• Empower BCP  
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System Administration and Support 
An Empower System Administration Guide will be written to address how Indiana 
University School of Informatics will maintain and use the Empower system.  Procedures 
for the following will be included: 
• User Account Administration –Describes process for creating, modifying, 
deactivating, and auditing user accounts and addresses password management for 
user accounts. 
• Laboratory Administration –Describes process for laboratory creation, modification, 
deactivation 
• Instrument Administration – Describes process for approving the addition of 
instruments or deactivation of instruments 
• Data Project Administration – Describes process for managing a data project, 
including requesting, creating, locking, and unlocking data projects 
• Empower Data Release and Review – Describes process for releasing and reviewing 
data from Empower 
Deliverables: 
• Empower System Administration Guide 
Training 
The application vendor’s training documents were evaluated, and it was determined that 
they would be usable in the Indiana University environment as written. 
This review will be documented in the Training Plan. 
The Training Plan addresses training requirements for system users and project-specific 
training for Empower team members. This document also provides information on the 
training materials that will be developed and describes how training records are 
maintained. 
Deliverables: 
• Empower Training Plan 
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• QAR document for review of vendor’s training documents 
Periodic Review 
Periodic reviews of the Empower system will be conducted annually. No separate 
Empower Periodic Review SOP will be created. 
Master Document List 
A MDL containing a list and the location of all documents that constitute the validation 
package and other documents that support the Empower system will be maintained. 
Deliverable: 
• Empower MDL 
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Introduction 
Purpose 
System Description 
Empower is a Chromatography Data Management System designed to collect, analyze, 
and report data from laboratory instruments.  
Document Overview 
This document identifies the various roles involved in validation activities associated 
with the development, deployment, and maintenance of the Empower system. 
This document also includes: 
• Responsibilities assigned to the roles 
• Roles responsible for reviewing and approving validation deliverables and 
supporting documents 
Scope 
In-Scope 
Roles and responsibilities of individuals involved in validation activities are in scope for 
this document.  
This document is the primary Roles and Responsibilities document for the Empower 
system.  This document lists the approvers for documents.  
Out-of-Scope 
Personnel assigned to the roles defined in this document and the dates of assignment are 
out-of-scope. The names of the individuals assigned to the roles will be maintained in a 
separate roles list. Refer to the Empower Master Document List (MDL) for the location 
of this list. 
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Terms and Acronyms 
Refer to the Indiana University Informatics Acronym and Definition List for a list of 
terms and acronyms used in this document. 
References 
Refer to the Empower Master Document List (MDL) for the location of all documents 
referenced in this Validation Plan. The official hard copy location of the MDL is the 
Indiana School of Informatics Validation Library. 
Delegation of Approval Authority 
Temporary 
It is possible for the same person to be involved in multiple roles. It is also possible for a 
role to be temporarily delegated to another individual, if this delegation is documented 
and approved. 
Permanent 
Permanent delegation of authority is not permitted. 
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Roles and Responsibilities 
Project Organizational Structure 
The following chart represents a high level overview of the groups and key roles involved 
with the Empower System.  
Central
System Owner
Local *
Quality
System 
Custodian
Validation 
(Tier 3)
Project 
Management
Testing 
(Tier 3)
Deployment 
(Tier 3)
Local 
Business QA
CSQ
* Represents typical organization at local site. Organizational structure at local sites may vary.
Central 
Support 
Leader
GCCB Coordinator 
(Tier 3)
Training
Mentors/
Business 
Integrators
LCCB (Optional)
Local GCCB 
Rep
Local System 
Owner
Local System 
Custodian
Local IT
Lab Data 
Owner
Local Project 
Validation 
Advocate
System User
Configuration 
Team 
Member
Power User
 
Project Support Structure 
Initial application support can be obtained from a Power User in the laboratory. 
Tier 2 Application support is reached by contacting the vendor, Waters Corporation. 
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Roles and Responsibilities 
The following table defines roles and responsibilities and consists of the following: 
• Key:   An abbreviation assigned to each role 
• Role:   Identifies a role involved in validation activities for Empower  
• Responsibilities: Identifies the responsibilities assigned to the role 
Table 1. Roles and Responsibilities 
Key Role Responsibilities 
BSME Business SME • Provides high-level user requirements 
• Provides overall business knowledge for 
requirements gathering and deployment impact 
assessment 
Waters Vendor • Develops all code 
• Provides support resolution 
QA Quality 
Assurance 
Representative 
• Review validation deliverables for quality verification
 
CCB Change Control 
Board (CCB) 
• Administers the functions necessary to effectively 
manage centralized change control on the system 
• Evaluates and approves/rejects change requests 
• Actively participates in CCB activities 
• Review and prioritize local site Empower trouble 
tickets and change requests 
• Establish release scope 
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Key Role Responsibilities 
ITECH Instrument 
Technician 
• Qualifies instruments and troubleshoots laboratory 
instrument issues 
• May assist LIT with installation and qualification of 
LAC/E32s, SAT/INs, and instrument control 
connections. 
LDO Lab Data Owner • Responsible for approving and revoking access 
security of a specific Empower project laboratory’s 
data 
• Responsible for verifying training prior to account 
requests 
• Approves specified local Empower documents (e.g., 
System Request Form) 
LIT Local IT Support • Provides account management 
• Responsible for the ongoing installation, 
qualification, and testing of LAC/E32s, Instrument 
Control connections, and SAT/INs  
LM Lab Manager • Responsible for lab management for a specific 
Empower laboratory 
• Approves specified local Empower documents (e.g., 
System Request Form) 
PWR Power User • Provides Tier 1 support  
• Provides local configuration support 
• Provides local method management 
• Responsible for verification of method migration 
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Key Role Responsibilities 
SC System Custodian The System Custodian also has the following 
responsibilities: 
• Ensures that vendor evaluations are performed 
• Approves specified Empower validation deliverables 
and other Empower system-related documents 
• Determine an Empower release type and number 
• Release back-off decisions 
• Project communications 
SO System Owner The System Owner also has the following 
responsibilities: 
• Evaluates and approves/rejects system requirements 
• Approves and prioritizes content of scheduled change 
requests 
• Approves Vendor Evaluation Reports and proposed 
follow-up action items 
• Approves specified Empower validation deliverables 
and other Empower system-related documents 
• Approving the scope for an Empower release 
SPV Second Person 
Verifier 
• Reviews testing and qualification documentation 
executed by another person for accuracy, 
completeness, and compliance with established 
standards 
• Verify the accuracy of completed actions in 
documentation as specified by a procedure.  
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Key Role Responsibilities 
TA Test Analyst • Responsible for creating and executing test cases and 
test scripts 
• Logs test defects 
• Responsible for compiling Traceability Matrix 
• Provides Test Lead with test results for inclusion in 
the Test Summary Report 
TC Training 
Coordinator/ 
Training Lead 
• Coordinates the scheduling of the users of the system 
into training sessions 
• Develops training materials 
• Performs initial training 
• Certifies all trainers 
• Maintains all training records  
• Creates and reviews specified Empower 
documentation 
• Facilitating configuration and maintenance of the 
training environment 
TECH Technical Lead • Serves as main point of contact for technical 
questions 
• Serves as technical liaison with any vendors 
• Reviews SOPs, where appropriate  
• Reviews test scripts directly related to system 
components 
• Responsible for system architectural design 
• Creates and provides technical review of specified 
Empower documentation 
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Key Role Responsibilities 
TL Test Lead • Defines the test strategy 
• Defines testing tasks, estimated hours, and required 
resources 
• Responsible for reviewing requirements as they are 
developed and assuring that the requirements are 
testable and verifiable 
• Provides Test Analyst with the information necessary 
to generate Traceability Matrix 
• Compiles/creates the Test Summary Report 
• Creates and reviews specified Empower 
documentation 
TSME Technical SME • Reviews SOPs, where appropriate  
• May reviews test scripts directly related to system 
components 
• Responds to technical questions and issues from 
internal and external sources 
• Executes and/or reviews the execution of 
installation/qualification SOPs 
• Provides ongoing support of all system components 
for all environments (i.e., Production, Test, Training, 
Development) 
• Creates or provides technical review of specified 
Empower documentation 
• Verify instrument integration information 
periodically from the vendor 
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Key Role Responsibilities 
VL Validation Lead • Provides the direction, clarification, and review 
necessary for validation documents and the overall 
validation process to assure that the validation 
deliverables comply with policies and procedures 
• Prioritizes validation tasks 
• Responsible for establishment of quality processes 
and continuous improvement related to systems 
development and Computer System Validation 
• Determines the level of security needed for electronic 
version of validation documents 
VSME Validation SME • Responsible for ensuring that the validation 
documents and validation process follow corporate 
and departmental policies and procedures 
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Documentation Responsibilities 
The following table defines the minimal roles required to sign each validation deliverable 
and consists of the following information:  
• Activity Identifies the validation activity associated with the validation 
deliverable or supporting document 
• Document: Identifies the validation deliverable or supporting document being 
addressed 
• Reviewer(s): Uses the key assigned in the Roles and Responsibilities section to 
identify the roles required to review and sign the document 
• Approver(s): Uses the key assigned in Roles and Responsibilities section to identify 
the roles responsible for approving the document 
Table 2. Documentation Responsibilities 
*If the Validation Lead or Test Lead authors the document, they are not required to 
review the document. 
Activity Document Reviewer(s) Approver(s) 
Validation Plan TSME 
VL* 
SC 
SO 
QA 
Validation Roles and 
Responsibilities 
VL* SC 
SO 
QA 
Validation 
Planning 
Risk Assessment TSME 
VL* 
SC 
SO 
QA 
Requirements Definition TL* 
VL* 
SC 
SO 
QA 
Requirements 
Definition 
Requirements Traceability 
Matrix 
TSME SC 
 
ARC Audit Report N/A N/A Vendor 
Management Waters Vendor Management 
Plan  
TSME 
VL* 
SC 
SO 
QA 
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Activity Document Reviewer(s) Approver(s) 
System Overview TECH 
VSME 
SC, SO 
QA 
Security Design TSME 
VSME 
SC 
SO 
QA 
System Design 
Custom Field Design 
Definitions 
TSME SC 
Test Strategy TL* 
VL* 
SC 
SO 
QA 
Test Plan TL* 
VL* 
SC 
SO 
QA 
Test Cases and Test Scripts Case/Script Creation 
TA 
Case/Script 
Execution 
TA 
Pre-Execution 
Review 
TL, TSME 
Executed 
Cases/Scripts 
TL 
Test Summary Report TL* 
VL* 
SC 
SO 
QA 
Testing 
Installation Process QAR TSME SC 
Validation Report TSME 
VL* 
SC 
SO 
QA 
System 
Acceptance 
Release Description 
Document 
TSME 
VL* 
SC 
SO 
QA 
Security Security Plan TSME  
VL* 
 
SC 
SO 
QA 
Disaster 
Recovery 
Disaster Recovery Plan TSME 
VSME 
SC 
QA 
System 
Administration 
System Administration 
Document 
TSME SC, SO 
QA 
Training Plan TC 
VSME 
SL 
SC 
SO 
QA 
Training 
Training Materials QAR TSME SL 
SO 
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Introduction 
Purpose 
The System Overview provides high-level information about the system design. It 
includes: 
• Basic functions and features of the Empower system, 
• Application options in the Empower system, and  
• Interfaces in the Empower system.  
Scope 
This System Overview is limited to components that make up the Empower 
chromatography software application. 
Terms/Acronyms 
Refer to the Indiana University Informatics Acronym and Definition List for a list of 
terms and acronyms used in this document. 
References 
Refer to the Empower Master Document List (MDL) for the location of all documents 
referenced in this System Overview. 
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System Overview 
System Description 
Empower is a chromatography data management system designed to collect, analyze, and 
report data from laboratory instruments. 
Basic Functions and Features 
The Empower system allows users to: 
• Provide data acquisition and reporting capabilities from chromatography 
instrumentation; 
• Create processing methods, which contain peak detection and integration 
parameters; 
• Create sample sets to acquire the data; 
• Review and process the data and create reports with the results; and 
• Verify the results. 
Empower Application Options 
The following options are offered by the vendor as additional functionality to the 
Empower application. Each deployment may choose to have the option enabled as 
indicated. 
Table 1. Application Options 
Option Description 
System Suitability • Empower application software option that provides 
suitability result calculations over and above standard 
chromatography results. 
• All Empower deployments will include this option. 
• Installed once per Empower database. 
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Option Description 
Dissolution • Empower application software option that provides 
dissolution analysis using the Empower software. 
• Only labs that do dissolution analysis will require this 
option. 
• Installed once per Empower database. 
Instrument Control 
Option Package (ICOP) 
• Selectable list of instruments that can be controlled by 
the Empower software. 
• All Empower deployments will include this option. 
• Installed on Application and Laboratory Acquisition 
Control Environment (LAC/E) acquisition servers. 
Empower System Components 
The Empower system consists of the following components: 
• Empower chromatography data software application. 
The following diagram provides a high-level illustration of the components and features 
that comprise the Empower system. 
Database 
Server Client PC
LAC/E32 
Acquisition 
Server
RS CS TR RD TD CD
T A LK  / DA TA
TA L K
SAT/IN
Converter
or
Empower
System
 
Instrument 
Control
Dissolution
Instrument 
(PDA)
Laboratory 
Instrument
(GC, A1100)
Client
Control
Empower Base Software
System
Suitability
Array
Photodiode
 
Figure 1. System Components 
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Empower Infrastructure Overview 
The following diagram provides a more detailed illustration of the Empower 
infrastructure. The Empower database server resides on a network and contains the 
Empower application data and server-side application software. The instruments, Satellite 
Interfaces (SAT/Ins), and LAC/Es would reside in laboratories and connect to the servers 
via Ethernet. 
Certain laboratory instruments will be connected directly to the LAC/E acquisition 
servers where they will be controllable by the application. Other uncontrollable 
instruments will be connected to SAT/INs for data signal conversion. The SAT/INs will 
then be connected to the LAC/E. 
Laboratory 
Laboratory Information
Management System
[Out of Scope]
Empower
 Database/File/
Application 
Server(s)
LAC/Es
Instruments
SAT/INs
Instruments
LAC/Es
Ethernet
User
Desktops
Printers
 
Figure 2. System Overview 
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Technical SME Reviewer’s Signature 
Your signature indicates that, as a content expert, you have reviewed this document and 
agree that it accurately and completely describes the design to be implemented in the 
Empower system. 
Reviewed By: 
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Title, Department 
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Your signature indicates that that this document was written and reviewed by the 
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implementation in your organization. 
Approved By: 
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Printed Name  dd-Mmm-yyyy 
Title, Department 
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Revision History 
This Revision History documents changes to validation documents. Any differences 
between this version and previous ones are resolved in favor of the present document. 
Electronic Filename: Empower_Custom_Field_DSG001.doc 
 
Revision Revision Date 
dd-MMM-yyyy 
Revised 
By 
Reason for Revision/ 
Change Request 
1.0 dd-MMM-yyyy Author New document. Ready for signatures. 
 
  248
Empower Custom Field Design Definition: ChromColumn 
The following table defines the details of Custom Field Design Definition: 
ChromColumn. For more information about system pre-defined fields, refer to the 
Empower online help. 
If an attribute does not need to have a value configured, enter “N/A” (Not applicable). 
Attribute Description 
Design Name ChromColumn 
1. Design ID DSG001 
2. Purpose Provide user the opportunity to enter and display 
information associated with the column used for the assay. 
3. Inputs Input 1:  
• Name: ChromColumn 
4. Outputs Sample Table 
5. Requirement(s) Refer to Empower Traceability Matrix 
6. Field Explanation Provide user the opportunity to enter information 
associated with the column used for the assay. The entry is 
optional and there is no default value. The field is text 
only, 30 characters maximum, and the entry has no effect 
on calculations. 
7. Triggers The field is available for entries when creating or 
modifying (Alter Sample) a sample set. The field can be 
displayed in Review and in Preview and well as other 
tables in Empower. 
8. Field Type Sample 
9. Data Type Text 
10. Data Source Keyboard, no required entry 
11. Width 30 
12. Precision System default=Null; not configurable 
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Attribute Description 
13. Minimum/ 
 Maximum Values 
System default=Null; not configurable. 
14. Translation 
Definition 
System default=Null; not configurable. 
15. User Entry Required Null 
16. Custom Field Locked Checked 
17. Default Value Null 
18. Search Order System default=Null; not configurable. 
19. All or Nothing System default=Null; not configurable. 
20. Use As System default=Null; not configurable. 
21. Sample Type System default=All; not configurable. 
22. Peak Type System default=All; not configurable. 
23. Missing Peak System default=Null; not configurable. 
24. Formula System default=Null; not configurable. 
25. Constant Definitions N/A 
26. Notes N/A 
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 Custom Field Design Definition Approval 
Technical SME Reviewer’s Signature 
Your signature indicates that, as a content expert, you have reviewed this document and 
agree that it accurately and completely describes the design to be implemented in the 
Empower system. 
Reviewed By: 
___________________________________________________ Date: _______________  
Printed Name  dd-Mmm-yyyy 
Title, Department 
 
Reviewed By: 
___________________________________________________ Date: _______________  
Printed Name  dd-Mmm-yyyy 
Title, Department 
 
System Custodian Approver’s Signature 
Your signature indicates that that this document was written and reviewed by the 
appropriate subject matter experts, and that you understand and accept responsibility for 
implementation in your organization. 
Approved By: 
___________________________________________________ Date: _______________  
Printed Name  dd-Mmm-yyyy 
Title, Department 
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Revision History 
This Revision History documents changes to validation documents. Any differences 
between this version and previous ones are resolved in favor of the present document. 
Electronic Filename: Empower_Custom_Field_DSG002.doc 
 
Revision Revision Date 
dd-MMM-yyyy 
Revised 
By 
Reason for Revision/ 
Change Request 
1.0 dd-MMM-yyyy Author New document. Ready for signatures. 
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Empower Custom Field Design Definition: ChromComments 
The following table defines the details of Custom Field Design Definition: 
ChromComments. For more information about system pre-defined fields, refer to the 
Empower online help. 
If an attribute does not need to have a value configured, enter “N/A” (Not applicable). 
Attribute Description 
Design Name ChromComments 
1. Design ID DSG002 
2. Purpose Provide user the opportunity to enter and display sample 
information. 
3. Inputs Input 1:  
• Name: ChromComments 
• Where it comes from: user entered 
4. Outputs Sample Table 
5. Requirement(s) Refer to Empower Traceability Matrix 
6. Field Explanation The field is available for entries when creating or 
modifying (Alter Sample) a sample set. The field can be 
displayed in Review, in Preview, and in other tables in 
Empower. Provides user the opportunity to enter and 
display information about the sample. 
7. Triggers The field is available for entries when creating or 
modifying (Alter Sample) a sample set.  After integration 
and quantitation, the contents of the ChromComments 
fields are associated with results. 
8. Field Type Sample 
9. Data Type Text 
10. Data Source Keyboard; no entry required 
11. Width 249 
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Attribute Description 
12. Precision System default=Null; not configurable. 
13. Minimum/ 
 Maximum Values 
System default=Null; not configurable. 
14. Translation 
Definition 
System default=Null; not configurable. 
15. User Entry Required Null 
16. Custom Field Locked Checked 
17. Default Value Null 
18. Search Order System default=Null; not configurable. 
19. All or Nothing System default=Null; not configurable. 
20. Use As System default=Null; not configurable. 
21. Sample Type System default=All; not configurable. 
22. Peak Type System default=All; not configurable. 
23. Missing Peak System default=Null; not configurable. 
24. Formula System default=Null; not configurable. 
25. Constant Definitions N/A 
26. Notes N/A 
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 Custom Field Design Definition Approval 
Technical SME Reviewer’s Signature 
Your signature indicates that, as a content expert, you have reviewed this document and 
agree that it accurately and completely describes the design to be implemented in the 
Empower system. 
Reviewed By: 
___________________________________________________ Date: _______________  
Printed Name  dd-Mmm-yyyy 
Title, Department 
 
Reviewed By: 
___________________________________________________ Date: _______________  
Printed Name  dd-Mmm-yyyy 
Title, Department 
 
System Custodian Approver’s Signature 
Your signature indicates that that this document was written and reviewed by the 
appropriate subject matter experts, and that you understand and accept responsibility for 
implementation in your organization. 
Approved By: 
___________________________________________________ Date: _______________  
Printed Name  dd-Mmm-yyyy 
Title, Department 
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Revision History 
This Revision History documents changes to validation documents. Any differences 
between this version and previous ones are resolved in favor of the present document. 
Electronic Filename: Empower_Custom_Field_DSG003.doc 
 
Revision Revision Date 
dd-MMM-yyyy 
Revised 
By 
Reason for Revision/ 
Change Request 
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Empower Custom Field Design Definition: ChromConcentration 
The following table defines the details of Custom Field Design Definition: 
ChromConcentration. For more information about system pre-defined fields, refer to the 
Empower online help. 
If an attribute does not need to have a value configured, enter “N/A” (Not applicable). 
Attribute Description 
Design Name ChromConcentration 
1. Design ID DSG003 
2. Purpose Calculate and display the concentration of samples 
3. Inputs Input 1: 
• Name:  ChromConcentration 
• SampleWeight divided by Dilution 
4. Outputs Sample Table 
5. Requirement(s) Refer to the Empower Traceability Matrix 
6. Field Explanation Sample weight divided by the Dilution 
7. Triggers The Sample Weights and Dilutions must be entered in 
the Sample Set with correct SampleType and InjType 
entries for the ChromConcentration to be calculated. 
8. Field Type Sample 
9. Data Type Real 
10. Data Source Calculated 
11. Width 15  
12. Precision 6 
13. Minimum/ 
 Maximum Values 
System default= -99999999.999999; not configurable. 
System default=100000000.000000; not configurable. 
14. Translation Definition System default=Null; not configurable. 
15. User Entry Required System default=Null; not configurable. 
16. Custom Field Locked Checked 
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Attribute Description 
17. Default Value System default=Null; not configurable. 
18. Search Order System default=Null; not configurable. 
19. All or Nothing Null 
20. Use As System default=Null; not configurable. 
21. Sample Type Controls and Unknowns 
22. Peak Type System default=All; not configurable. 
23. Missing Peak System default=Null; not configurable. 
24. Formula SampleWeight/Dilution 
25. Constant Definitions N/A 
26. Notes N/A 
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Revision History 
This Revision History documents changes to validation documents. Any differences 
between this version and previous ones are resolved in favor of the present document. 
Electronic Filename: Empower_Custom_Field_DSG004.doc 
 
Revision Revision Date 
dd-MMM-yyyy 
Revised 
By 
Reason for Revision/ 
Change Request 
1.0 dd-MMM-yyyy Author New document. Ready for signatures. 
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Empower Custom Field Design Definition: InjType 
The following table defines the details of Custom Field Design Definition: InjType. For 
more information about system pre-defined fields, refer to the Empower online help. 
If an attribute does not need to have a value configured, enter “N/A” (Not applicable). 
Attribute Description 
Design Name InjType 
1. Design ID DSG004 
2. Purpose Allow user to select from one of five predefined choices 
3. Inputs Input 1:  
• Name: InjType 
• Where it comes from: user selected 
4. Outputs Sample Table 
5. Requirement(s) Refer to the Empower Traceability Matrix 
6. Field Explanation Provide user the opportunity to enter injection type to be 
associated with the sample. The choices available are: 
Unknown, Control, Blank, Standard, and Suitability. Some 
custom field calculations use the InjType to determine if 
results are to be calculated or not. For instance, Blank, 
Standard, and Suitability samples do not get Concentration 
calculations. 
7. Triggers The field is available for entries when creating or 
modifying (Alter Sample) a sample set. The field can be 
displayed in Review and in Preview and well as other 
tables in Empower. A sample must be processed for 
InjType to be utilized. 
8. Field Type Sample 
9. Data Type Enum 
10. Data Source Keyboard; entry is required. 
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Attribute Description 
11. Width System default=18; not configurable. 
12. Precision System default=0; not configurable. 
13. Minimum/ 
 Maximum Values 
System default=1; not configurable\ 
System default=999; not configurable. 
14. Translation 
Definition 
1 Value 0, Translation Unknown; 2 Value 1, Translation 
Control; 3 Value 2, Translation Blank; 4 Value 5, 
Translation Standard;  
5 Value 6, Translation Suitability 
15. User Entry Required Checked 
16. Custom Field Locked Checked 
17. Default Value Null 
18. Search Order System default=Null; not configurable. 
19. All or Nothing System default=Null; not configurable. 
20. Use As Position 
21. Sample Type System default=All; not configurable. 
22. Peak Type System default=All; not configurable. 
23. Missing Peak System default=Null; not configurable. 
24. Formula System default=Null; not configurable. 
25. Constant Definitions N/A 
26. Notes N/A 
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 Custom Field Design Definition Approval 
Technical SME Reviewer’s Signature 
Your signature indicates that, as a content expert, you have reviewed this document and 
agree that it accurately and completely describes the design to be implemented in the 
Empower system. 
Reviewed By: 
___________________________________________________ Date: _______________  
Printed Name  dd-Mmm-yyyy 
Title, Department 
 
Reviewed By: 
___________________________________________________ Date: _______________  
Printed Name  dd-Mmm-yyyy 
Title, Department 
 
System Custodian Approver’s Signature 
Your signature indicates that that this document was written and reviewed by the 
appropriate subject matter experts, and that you understand and accept responsibility for 
implementation in your organization. 
Approved By: 
___________________________________________________ Date: _______________  
Printed Name  dd-Mmm-yyyy 
Title, Department 
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This Revision History documents changes to validation documents. Any differences 
between this version and previous ones are resolved in favor of the present document. 
Electronic Filename: Empower_Custom_Field_DSG005.doc 
 
Revision Revision Date 
dd-MMM-yyyy 
Revised 
By 
Reason for Revision/ 
Change Request 
1.0 dd-MMM-yyyy Author New document. Ready for signatures. 
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Empower Custom Field Design Definition: Lot 
The following table defines the details of Custom Field Design Definition: Lot. For more 
information about system pre-defined fields, refer to the Empower online help. 
If an attribute does not need to have a value configured, enter “N/A” (Not applicable). 
Attribute Description 
Design Name Lot 
1. Design ID DSG005 
2. Purpose Provide user the opportunity to enter lot numbers to be 
associated with corresponding injections. 
3. Inputs Input 1:  
• Name: Lot  
• Where it comes from: LIMS interface or user entered 
4. Outputs Sample Table 
5. Requirement(s) Refer to Empower Traceability Matrix 
6. Field Explanation The field is available for entries when creating or 
modifying (Alter Sample) a sample set. The field can be 
displayed in Review and in Preview and well as other 
tables in Empower. Allow general use custom tables, such 
as pulling together samples with the same lot number in 
order to generate statistics, to be created in Report 
Methods. 
7. Triggers After integration and quantitation, lot (numbers) are 
associated with results. 
8. Field Type Sample 
9. Data Type Text 
10. Data Source Keyboard; entry not required 
11. Width 20 
12. Precision System default=Null; not configurable. 
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Attribute Description 
13. Minimum/ 
 Maximum Values 
System default=Null; not configurable. 
14. Translation 
Definition 
System default=Null; not configurable. 
15. User Entry Required Null 
16. Custom Field Locked Checked 
17. Default Value Null 
18. Search Order System default=Null; not configurable. 
19. All or Nothing System default=Null; not configurable. 
20. Use As System default=Null; not configurable. 
21. Sample Type System default=All; not configurable. 
22. Peak Type System default=All; not configurable. 
23. Missing Peak System default=Null; not configurable. 
24. Formula System default=Null; not configurable. 
25. Constant Definitions N/A 
26. Notes N/A 
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 Custom Field Design Definition Approval 
Technical SME Reviewer’s Signature 
Your signature indicates that, as a content expert, you have reviewed this document and 
agree that it accurately and completely describes the design to be implemented in the 
Empower system. 
Reviewed By: 
___________________________________________________ Date: _______________  
Printed Name  dd-Mmm-yyyy 
Title, Department 
 
Reviewed By: 
___________________________________________________ Date: _______________  
Printed Name  dd-Mmm-yyyy 
Title, Department 
 
System Custodian Approver’s Signature 
Your signature indicates that that this document was written and reviewed by the 
appropriate subject matter experts, and that you understand and accept responsibility for 
implementation in your organization. 
Approved By: 
___________________________________________________ Date: _______________  
Printed Name  dd-Mmm-yyyy 
Title, Department 
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This Revision History documents changes to validation documents. Any differences 
between this version and previous ones are resolved in favor of the present document. 
Electronic Filename: Empower_Custom_Field_DSG006.doc 
 
Revision Revision Date 
dd-MMM-yyyy 
Revised 
By 
Reason for Revision/ 
Change Request 
1.0 dd-MMM-yyyy Author New document. Ready for signatures. 
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Empower Custom Field Design Definition: Notebook 
The following table defines the details of Custom Field Design Definition: Notebook. For 
more information about system pre-defined fields, refer to the Empower online help. 
If an attribute does not need to have a value configured, enter “N/A” (Not applicable). 
Attribute Description 
Design Name Notebook 
1. Design ID DSG006 
2. Purpose Provide user the opportunity to enter and display notebook 
identifier 
3. Inputs Input 1:  
• Name: Notebook 
• Where it comes from: user entered 
4. Outputs Sample Table 
5. Requirement(s) Refer to the Empower Traceability Matrix 
6. Field Explanation The field is available for entries when creating or 
modifying (Alter Sample) a sample set.  The field can be 
displayed in Review and in Preview and well as other 
tables in Empower. 
7. Triggers After integration and quantitation, the content of the field 
Notebook is associated with results. 
8. Field Type Sample 
9. Data Type Text 
10. Data Source Keyboard; no entry required 
11. Width 50 
12. Precision System default=Null; not configurable. 
13. Minimum/ 
 Maximum Values 
System default=Null; not configurable. 
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Attribute Description 
14. Translation 
Definition 
System default=Null; not configurable. 
15. User Entry Required Null 
16. Custom Field Locked Checked 
17. Default Value Null 
18. Search Order System default=Null; not configurable. 
19. All or Nothing System default=Null; not configurable. 
20. Use As System default=Null; not configurable. 
21. Sample Type System default=All; not configurable. 
22. Peak Type System default=All; not configurable. 
23. Missing Peak System default=Null; not configurable. 
24. Formula System default=Null; not configurable. 
25. Constant Definitions N/A 
26. Notes N/A 
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 Custom Field Design Definition Approval 
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Reviewed By: 
____________________________________________________  Date: ______________  
Printed Name  dd-Mmm-yyyy 
Title, Department 
 
System Custodian Approver’s Signature 
Your signature indicates that that this document was written and reviewed by the 
appropriate subject matter experts, and that you understand and accept responsibility for 
implementation in your organization. 
Approved By: 
____________________________________________________  Date: ______________  
Printed Name  dd-Mmm-yyyy 
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Empower Custom Field Design Definition: NotebookPage 
The following table defines the details of Custom Field Design Definition: 
NotebookPage. For more information about system pre-defined fields, refer to the 
Empower online help. 
If an attribute does not need to have a value configured, enter “N/A” (Not applicable). 
Attribute Description 
Design Name NotebookPage 
1. Design ID DSG007 
2. Purpose Provide user the opportunity to enter and display the 
Notebook Page Number. 
3. Inputs Input 1:  
• Name: NotebookPage 
• Where it comes from: user entered 
4. Outputs Sample Table 
5. Requirement(s) Refer to Empower Traceability Matrix 
6. Field Explanation The field is available for entries when creating or 
modifying (Alter Sample) a sample set.  The field can be 
displayed in Review and in Preview and well as other 
tables in Empower. 
7. Triggers After integration and quantitation, the contents in the 
NotebookPage field are associated with results. 
8. Field Type Sample 
9. Data Type Text 
10. Data Source Keyboard; no entry required 
11. Width 20 
12. Precision System default=Null; not configurable. 
13. Minimum/ 
 Maximum Values 
System default=Null; not configurable. 
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Attribute Description 
14. Translation 
Definition 
System default=Null; not configurable. 
15. User Entry Required Null 
16. Custom Field Locked Checked 
17. Default Value Null 
18. Search Order System default=Null; not configurable. 
19. All or Nothing System default=Null; not configurable. 
20. Use As System default=Null; not configurable. 
21. Sample Type System default=All; not configurable. 
22. Peak Type System default=All; not configurable. 
23. Missing Peak System default=Null; not configurable. 
24. Formula System default=Null; not configurable. 
25. Constant Definitions N/A 
26. Notes N/A 
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Introduction 
Purpose 
This deliverable provides the following information regarding Empower. 
• Empower Laboratory User Types 
• Empower Support Personnel User Types 
• Empower Management Privileges 
• Empower Methods Privileges 
• Empower Data Acquisition Privileges 
Scope 
In-Scope 
The following are in scope for this document: 
• Empower application security configurations 
Out-of-Scope 
The following are out of scope for this document: 
• Laboratory Information Management System (LIMS) interface security 
configurations 
• Physical security 
• Infrastructure security 
• Account administration procedures 
• Local security configurations 
Terms/Acronyms 
The following table defines some of the design-specific terms used in this document. 
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Table 1 Terms and Acronyms 
Term Definition 
User Group A system object used to define groupings of user accounts.  These User 
Groups, in conjunction with the Project Access Properties, determine 
which users have read and/or write access to specific instruments, data, 
and methods on a database server. 
User Type A system object used to define and name unique sets of user privileges.  
User Types dictate which functionalities are available to each user in 
the areas of System Management, Methods and Data Acquisition. 
References 
See the Empower Master Document List for documents referenced in this document: 
Revisions 
Any changes to approved versions of this Plan will be done in accordance with a change 
control.   
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Security Design 
Empower User Types 
The primary function of User Types in Empower is to dictate which functionalities are 
available to users in the areas of System Management, Methods, and Data Acquisition.  
For system configurations at IU, the User Types have been designed to specifically meet 
requirements for performing different job functions at the support and lab levels. 
Support User Types include: 
• Administrator 
• Support 
Laboratory User Types include: 
• BasicUser 
• MasterUser 
• PowerUser 
• Guest 
Empower User Type Privileges 
The following tables identify the security privileges to be configured for each user type in 
the Empower application. A configuration team member will use this information to 
configure the Empower application. 
Table 2 Empower Management Privileges 
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Administrator  x       
Archive and Remove Sample/Project Archives x       
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View Audit Trails x x  x x x  
Archive System Audit Trails x x      
Clear/Restore Offline System Audit Trails x       
Clear/Restore Offline Project/Sample Archives x       
Restore AutoArchived Projects x       
Paste Shallow Copies x       
Lock Channels x   x x   
Unlock Channels x x  x x   
Alter Custom Fields x       
Create Custom Field x       
Delete Custom Field x       
Lock Custom Field x       
Unlock Custom Field x       
Alter Default Strings x   x    
Create Default Strings x   x    
Delete Default Strings x   x    
Alter Plate Type x       
Create Plate Type x       
Delete Plate Type x       
Alter System Policies x       
Alter Any Project x x      
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Backup Projects x x      
Create Projects x x  x    
Create Projects at the Root x x  x    
Delete Projects x       
Restore Projects x x      
Change Project Parent x x  x    
Lock Projects x x  x    
Unlock Projects x x  x    
Change Project Owner x x  x    
Change Project Quota x x      
Create Project Path x x      
Change Project Path x x      
Specify Project Path x x      
View Multiple Projects x x  x x x  
Alter Users x x      
Create Users x x      
Delete Users x x      
Alter User Type x       
Create User Type x       
Delete User Type x       
Alter User Groups x x      
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Create User Groups x       
Delete User Groups x       
Allow Shallow Copies of FAT Projects x       
View Quantitation Peak Fields in Review x x  x x x x 
Allow Calibration & Quantitation in Review x   x x x  
Alter Customized Time Zone List x       
Run Empower AQT x x      
Validation Administrator x   x    
Alter Project Type x   x    
 
Table 3 Empower Methods Privileges 
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Delete Data x       
Export Data x x  x x x  
Import Data x       
Delete Libraries x       
Save Libraries x   x x   
Rename Libraries x   x x   
Delete Export Methods x   x    
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Save Export Methods x   x x   
Delete Instrument Methods x   x    
Save Instrument Methods x x  x x x  
Delete Locked Methods x   x    
Lock Methods x   x x   
Delete Processing Methods x   x    
Save Processing Methods x   x x   
Modify Integration Parameters x x    x  
Modify Component Times x     x  
Modify Component Constants/Default 
Amounts 
x       
Delete Reporting Methods x   x    
Save Reporting Methods x x  x x   
Modify Report Scaling Only x     x  
Modify Default Report Methods x       
Modify Default Report Groups x       
Clear Read Only Methods x x  x x   
Save Methods as Current x   x x   
Delete Sample Set Methods x   x    
Save Sample Set Methods x x  x x x  
Delete Sample Set Mth Templates x   x    
Save Sample Set Mth Templates x   x x   
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Delete Method Sets x   x    
Save Method Sets x   x x   
Delete Validation Protocol Methods x       
Save Validation Protocol Methods x       
Delete Tune Methods x       
Save Tune Methods x       
Delete MS Calibration Methods x       
Save MS Calibration Methods x       
Delete 3D After Processing x       
Copy To Projects x x  x x   
Delete Calibration Curves x       
Save Calibration Curves x   x x x  
Delete Results x       
Save Results x   x x x  
Save Results and Calibrations in Review x   x x x  
Delete Validation Studies x       
Save Validation Studies x       
Clear Read Only Validation Studies x       
Sign Off Results 1 x   x x   
Sign Off Results 2 x   x x   
Approve Validation Protocol Methods x       
Approve Validation Study Data x       
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Override Validation Data Checks x       
Specify Report Methods for Sign Off x   x    
Alter Sample x x  x x x  
Save View Filters x x  x x x  
Make View Filters Public x x  x    
Table 4 Empower Data Acquisition Privileges 
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Acquire Samples x x  x x x  
Edit Sample Sets x x  x x x  
Reinject Samples x       
Allow Interactive Sys Changes x x      
Alter Running Sample Sets x x  x x x  
Access Real Time Plot from Open Access x       
Alter Any Queue x x  x x x  
Alter My Queue x       
Warn on Service Limit x       
Use Wizard Templates x x  x x x  
Allow Remote LAC/E Reboot x x  x    
Access Real Time Review From Run Samples x x  x x x  
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Verify Incomplete Data in Raw Data Files x   x    
Empower User Groups 
The User Groups, in conjunction with the LAC/E, Chromatographic System, and Project 
Access Properties, define which instruments and projects the user may access. User 
Groups are created according to a logical structure that designates which users will need 
access to the same instruments or data.  
Empower Support User Groups 
The User Groups for Support personnel are created during server installation. Support 
User Groups include: 
• Administrators (Vendor default; not configured by IU) 
• Support 
The following apply to the configuration of User Groups in the Empower application: 
• Leave the Group Admin box empty 
• Select System in the Users in Group box 
An additional User Group on all servers, Guests, is a vendor default User Group. This 
group is not assigned to Support personnel. 
Empower Laboratory User Groups 
When a laboratory is configured within Empower, the following Laboratory User Groups 
will be created to designate which users will be granted access to the instruments and 
data within the laboratory.  These groups are as follows: 
  295
• Lab_Power 
• Lab_User 
Where Lab is the laboratory name, as designated by the local laboratory management. 
The appropriate laboratory user group(s) will be selected to restrict access to data projects 
and Chromatographic Systems.  
LAC/E Access Properties 
Limiting the control of laboratory user access to instruments on a server will be 
accomplished by configuring security on the LAC/E acquisition servers.  The original 
settings that are selected at the initial installation of a LAC/E must be as follows: 
• The LAC/E must be set to Share Instruments with Other Network User. 
• The Owner must be set to System. 
• The Allowed Access must be set to Owner and Group(s). 
• The Support User Groups that must have access to all LAC/Es on a server are: 
a. Administrators 
b. Support 
• The Laboratory User Groups that must have access to some LAC/Es on a server 
are: 
c. Lab_Power, assigning Power Users to only those LAC/Es associated with their 
laboratory 
• The LAC/E will have no password required. 
Laboratory user access to LAC/Es will be restricted through laboratory user groups as 
noted above. No laboratory User Groups other than Power User are given LAC/E access. 
Chromatographic System Access Properties 
Limiting the control of laboratory user access to instruments on a server will be 
accomplished by configuring security on each Chromatographic System.  The original 
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settings that are selected at the initial installation of a Chromatographic System must be 
as follows: 
• The Chromatographic System must be set to Share System with Other Network 
Users. 
• The Owner must be set to System. 
• The Allowed Access must be set to Owner and Group(s). 
• The Support User Groups that must have access to all Chromatographic Systems on 
a server are: 
 Administrators 
 Support 
• The Chromatographic System will have no password required. 
Laboratory user access to a Chromatographic System will be controlled through 
laboratory user groups. For each Lab, only the Lab_User and Lab_Power User Groups 
associated with the Chromatographic System will be added to each system. 
Project Access Properties 
A template project will be used to create projects for laboratory users.  Laboratory user 
access to local projects will be controlled through laboratory user groups.  For each Lab, 
only the Lab_User and Lab_Power User Groups associated with the data project will be 
added to each project. 
Empower System Policies 
There are server-level policies applied at the time of installing the Empower Application 
on a server.  These policies are as follows: 
User Account Policies Tabbed Page 
Check all boxes in the Accounts and Passwords section, with the following details: 
• Passwords Expire every 60 days 
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• Limit # of Entry Attempts to 3 tries 
• Enforce Minimum Password Length of 7 characters 
Check all boxes in the Login Window Policies section, with the following details: 
• Global Default User Interface is QuickStart 
New Project Policies Tabbed Page 
Check the following options in the Default Full Audit Trail Settings section: 
• Full Audit Trail Support 
Select the following options for the table in the Default Full Audit Trail Settings Section: 
Project Object Comment Confirm Identity
Method Unrestricted  
Result Unrestricted  
Sample Unrestricted  
Deletion Unrestricted  
Check the following options in the Full Audit Trail Settings Section: 
• Don’t allow user to change default Full Audit Trail Support Setting 
• Don’t allow user to change default ‘Require User Comments On’ Setting 
• Don’t allow user to copy from non-FAT projects into FAT projects 
Note:  Do NOT check ‘Allow Shallow Copies Between FAT Projects’ 
System Audit Trail Policies Tabbed Page 
Select the following options for the table in the System Audit Trail Policies Section: 
System Object Comment Confirm Identity 
Project Unrestricted  
Empower Nodes Unrestricted  
System Unrestricted  
Library Unrestricted  
User Unrestricted  
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System Object Comment Confirm Identity 
User Group Unrestricted  
User Type Unrestricted  
Plate Type Unrestricted  
System Audit Trail Unrestricted  
Offline System Audit Trail Silent  
Project/Sample Archives Silent  
Offline Project/Sample Archives Silent  
Default Strings Silent  
Database Properties Silent  
AutoArchive Properties Silent  
System Policy Unrestricted  
SDMS Archive Properties Silent  
Data Processing Policies Tabbed Page 
Check all boxes in the Data Processing Policies section, with the following details: 
• Do NOT check Use v2.XX Style Retention Time Calculations 
Check all boxes in the Data Processing Technique section, with the following details: 
• Default Integration Algorithm is Traditional 
Other Policies Tabbed Page 
Check all boxes in the Result Sign Off Policies section, with the following details: 
• Sign Off Inactivity Delay of 30 minutes 
• Multiple signoff behavior:  Allow the Same Reasons 
• Do NOT check any boxes in the Valid Sign Off 1 Reason(s) section 
Check all boxes in the Other Policies section, with the following details: 
• Applications Timeout after 30 minutes 
• Do NOT check Disallow Use of Annotation Tools 
Select the following details in the Date Display Policies: 
• Show Region Abbreviation 
• Use “long” date formats 
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E-Mail Policies Tabbed Page  
Do not make any changes to this section. 
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 Template Project Design Specification 
Reviewers’ Signatures 
Technical SME Signature 
Your signature indicates that, as a content expert, you have reviewed this document and 
agree that it accurately and completely describes the design for this template project to be 
implemented in the Empower system. 
Reviewed By: 
 
____________________________________________________  Date: ______________  
Printed Name  dd-Mmm-yyyy 
Title, Department 
 
System Custodian Approver’s Signature 
Your signature indicates that the design specifications identified in this document were 
written and reviewed by the appropriate subject matter experts, and that you understand 
and accept responsibility for implementation in your organization. 
Approved By: 
 
____________________________________________________  Date: ______________  
Printed Name  dd-Mmm-yyyy 
Title, Department 
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This Revision History documents changes to validation documents. Any differences 
between this version and previous ones are resolved in favor of the present document. 
Electronic Filename: Empower_Template_Project_DSG008 
 
Revision Revision Date 
dd-MMM-yyyy 
Revised 
By 
Reason for Revision/ 
Change Request 
1.0 dd-MMM-yyyy Author New document. Ready for signatures. 
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Empower Template Project Design Specification 
The following sections describe the configurations to be applied to the template project. 
Note: System-supplied default values are not included in this configuration spec. 
Template Project Attributes 
The following table defines the details of Template Project Design Specification. For 
more information about configuring Empower, refer to the Empower online help. 
If an attribute does not need to have a value configured, enter “N/A” (Not applicable). 
Attribute Description 
Design Name Template 
1. Design ID DSG008 
2. Purpose To provide a template project to be cloned for use in production 
laboratories. The cloned project will store methods and data that 
require all configured custom fields. 
3. Outputs The output will be data projects created in laboratories. 
4. Functional 
Requirement(s) 
Refer to Empower Traceability Matrix 
5. Notes N/A 
General Properties 
Attribute Value 
Owner System 
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Attribute Value 
Enabled Options Photo Diode Array: Yes 
System Suitability: Yes 
Mass Spectrometry: No 
CE/CIA: No 
Dissolution: Yes (Only when installed on server) 
Database Tablespace 50 MB 
Data Processing 
Techniques 
Enable ApexTrack Integration: Yes 
Default Algorithm: Traditional 
Number of Digits of 
Precision Displayed for 
Area and Height 
0 
Security 
The following table identifies the security access applied to this template project. 
Attribute Value 
Allowed Access Owner and Group 
Group User Type Guest 
Allow Access to Groups Administrators 
Support 
Custom Fields 
The following table identifies the custom fields used in this template project. 
Design ID Custom Field Name 
DSG001 ChromColumn 
DSG002 ChromComments 
DSG003 ChromConcentration 
DSG004 InjType 
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Design ID Custom Field Name 
DSG005 Lot 
DSG006 Notebook 
DSG007 NotebookPage 
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Introduction 
Purpose 
This test strategy document supersedes any previous Empower test plans and serves as 
the foundation for all future Empower test plans.  This document outlines the Empower 
testing strategy by identifying: 
• Overall Test Strategy 
- Strategy Overview 
- Test Levels 
- Data Requirements 
• Testing Tools 
• Prerequisites  
• Traceability 
• Test Scripts  
• Testing Execution 
• Test Problem Reporting  
• Exit Criteria  
• Test Summary Report 
Roles and Responsibilities are as defined in the Empower Validation Roles and 
Responsibilities.   
Scope 
The scope of this document addresses the strategy for all software testing levels. For any 
given Indiana University Empower software release, a companion test plan or series of 
test plans will be written to identify the details of the testing to be performed for that 
release. The test plan may be a stand-alone document or included in the text of an 
appropriate electronic change control record.   
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For information regarding the structure and documentation produced for Empower server 
application software installation, configuration, qualification, and verification, refer to the 
Empower System Overview document. 
Terms and Acronyms 
Refer to the Indiana University Informatics Acronym and Definition List for a list of the 
terms and acronyms used in this document. The location of this list is available in the 
Empower Master Document List (MDL). The official hard copy of the Empower MDL is 
located in the Indiana University Validation Library. 
Reference Documents 
Refer to the Empower MDL for the location of all Empower documents and procedures 
referenced in this document. 
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Test Strategy 
Strategy Overview 
For Commercial Off-the-Shelf (COTS) software, the vendor is responsible for 
performing Unit, Integration, and System level testing. Indiana University relies on the 
vendor testing based on the outcome of a comprehensive vendor audit to assess the 
vendor quality systems and software development business practices. The conclusions 
drawn from the audit are summarized in the vendor-specific management plan and 
vendor audit report. The vendor management plan contains a provision for follow-up if 
any on-going operational experience differs from expectations. Refer to the Empower 
MDL for the location of the audit report and vendor management plan 
For any release, Indiana University will rely on the test results of prior Empower 
release(s) as the starting point for determining the scope of testing on the current release. 
Each Empower software release will have a corresponding test plan. 
Risk-Based Testing Approach 
The Indiana University testing effort is primarily directed toward the complex Empower 
configuration tasks performed by Indiana University that have a direct bearing on data 
integrity, i.e., assay results. Due to their inherent complexity, these tasks also have more 
risk of error in either design or implementation. Establishing the Empower custom fields 
that contain calculations is an example in this category. Design elements that are created 
by Indiana University and contain conditional logic statements and/or compound 
arithmetic will be subject to comprehensive unit tests by Indiana University.   
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No application testing is planned for changes made to the components that are not 
included in the Empower System, e.g., routine infrastructure maintenance operations such 
as replacing a server disk drive. 
Formal Testing 
Custom fields without calculations and other system configuration tasks, such as 
establishing the application user security roles or establishing a view filter, are much less 
complex and therefore have a reduced risk of data impact or errors in design or 
implementation. These straightforward configuration tasks will be subject to inspectional 
unit tests by Indiana University. The inspectional unit tests will serve to confirm the 
second person verification performed during the configuration setup process and also 
confirm that the application configuration migration process is operating as planned. 
Integration testing may be warranted in some test plans to ensure that the interaction 
between the vendor packages or between other systems and Empower is operating as 
planned.   
The system testing consists of one end-to-end test, which covers the testing on the 
Indiana University business functionality of business scenarios and is conducted in the 
Indiana University test environment.  In this context, end-to-end means that, functionality 
is exercised for each of the Use Cases. Since Indiana University relies on the vendor tests 
as stated above, the end-to-end test is only exercising a representative sample of system 
functionality to ensure that all components are working together.  
In the event of a Indiana University Empower release strictly consisting of updates to 
vendor functionality (i.e., no changes to the Indiana University design elements), the test 
plan will identify the extent of Indiana University regression testing to be conducted in 
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the Indiana University test environment. The regression test may consist of re-executing 
all or some portion of existing test scripts to confirm basic system operation with the 
vendor updates installed. 
Infrastructure Changes 
In some cases, supplemental Empower testing may also be conducted outside the scope 
of an Empower software release. This situation applies where there is some infrastructure 
change that potentially affects Empower operations but there are no changed Empower 
application elements. The most common example is a Microsoft Security vulnerability 
fix. The Indiana University infrastructure group will test the security vulnerability fixes 
to ensure the patches install and uninstall successfully in the Indiana University 
environment.   
Additionally, the Indiana University Empower team will review Microsoft release 
information for security vulnerability fixes and respond to this information with the 
appropriate risk-based approach. Based on this assessment, the Indiana University 
Empower team will determine whether to perform an application verification or 
execution of regression tests. At a minimum, application verification will consist of 
logging into Empower, connecting to a LAC/E and processing and reporting data from a 
sample. 
Formal Testing Process and Requirements 
Test Levels 
There are five levels of testing identified for this project: Unit, Integration, System, 
Regression and Acceptance.  The following table provides detail for each of these levels 
of testing: 
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Test Level 
Identification 
Description 
Unit • Custom Fields 
Indiana University will perform unit testing on any custom fields 
introduced or modified in a release. 
The type of custom field will determine the type of testing, with 
two fields types identified: Data Entry and Calculation. 
o Data entry fields are defined as fields that have no 
arithmetic formula identified in the Empower Custom Field 
Design Definition, such as keyboard entries or data copied.  
Data Entry fields will be visually verified against the 
pertinent system design document.   
o Calculation fields are defined as fields that have an 
arithmetic formula identified in the Empower Custom Field 
Design Specification.  
Calculation fields will be fully functionally tested versus 
the logical conditions specified. 
• Application Configurations 
Indiana University specific configurations of the Empower system 
will be visually verified versus the corresponding system design 
document(s). This class includes application security 
configurations. The application configurations will be tested on a 
server (not project) basis.   
All Unit Test scripts must be successfully and completely executed 
and reviewed prior to the execution of higher-level tests. 
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Test Level 
Identification 
Description 
Integration Integration level testing should primarily be conducted during system 
testing when Empower owns an automated data transfer interface to 
another system.  When applicable, the ownership of the interface 
should be documented in the test plan of a given release of Empower. 
If applicable, additional integration tests may optionally be created 
and conducted to verify operational details of interactions and data 
transaction status between Empower – Interface Engine – The 
System Transferring Data to/from Empower without executing the 
entire end-to-end system tests.   
If present, the Integration Tests must be successfully and completely 
executed and reviewed prior to the execution of higher-level tests.   
System  System level testing will consist of a series of tests designed to verify 
that all components utilized/impacted by the Empower application 
are working together correctly in the Indiana University environment. 
The System Test must be successfully and completely executed and 
reviewed prior to the execution of higher-level tests. 
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Test Level 
Identification 
Description 
Regression Indiana University relies on the software vendors to perform 
regression testing for their software.  
For an Indiana University Empower release that only contains vendor 
software modification(s), the test plan will define the regression test 
to confirm basic system operation with the vendor updates installed. 
For all Indiana University Empower releases, an impact assessment 
will be conducted to determine which Empower Unit, Integration, 
and System level tests will be executed as the Regression suite. 
For the changes to the Indiana University design elements, in 
particular the calculation custom fields, the calculation dependencies 
will be analyzed to determine which custom fields depend on the 
results produced by a modified custom field. All custom fields 
dependent on a modified custom field will be subject to a regression 
test (re-executing the unit test script for the dependent custom field).  
Acceptance Acceptance testing will be conducted for each major release.   
The Acceptance test consists of:  
• Demonstration of new or changed functionality   
• Presentation of system requirements not fulfilled by the release 
Key Business Partners will grant approval on the release.   
The Acceptance Testing is a demonstration of functionality.  Any 
issues determined during Acceptance testing will be corrected during 
System Testing.   
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Data Requirements 
Technical SMEs and/or the test team will develop an Empower data project to be used for 
testing. This data project will have predefined sample data, acquired raw data, and 
processing methods. The project data may be newly acquired in the test environment or 
derived from data previously used for chromatography testing or from data copied and 
converted from the prior chromatography production environment.  
Each test script or case will identify prerequisite data characteristics and may identify 
suitable suggested samples, chromatograms, or methods from the test project.   
Testing Tools 
Test scripts for the application configuration unit tests and the system test case will be 
developed in Microsoft Word. 
Test scripts for custom field unit tests will be Microsoft Excel workbooks to test the 
calculations defined in a single custom field. A workbook will be created to verify 
Empower calculation results versus the Excel generated calculation results. Each 
workbook will be subject to a quality assurance review including review of all 
calculations.  The calculation custom field test script execution will be verified by a 
second user, including all calculations.   
Test Execution Prerequisites 
Documentation 
Prior to the start of any formal test execution, the following documents must be 
completed and reviewed/approved: 
• Validation Plan (if applicable) 
• Requirements Documents 
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• Security Design (if applicable) 
• Design Specifications  (if applicable) 
• Test Plan(s) 
• Test Readiness Checklist 
• Qualification of the Test environment platform and application as per approved 
installation/verification instructions. 
The following must be completed and approved prior to the starting of each test level: 
• Unit Test scripts 
• Integration Test Scripts if applicable 
• System Test Scripts 
The system custodian or designee will ensure that the documentation status complies with 
the above criteria by verifying the approval of the documentation sign-off page(s), QAR 
forms, and Test Readiness Checklist. 
Hardware and Software 
The test environment setup is documented and reviewed.  Explicit verification of these 
activities is not included in this test strategy. The setup verification is limited to 
confirming that the executed installation and configuration documentation has been 
reviewed and approved in partial satisfaction of the documentation prerequisites in the 
Documentation section.   
The following resources must be available for test execution:  
• Indiana University Network access 
• Empower Database Server and Database configured in accordance with the 
Empower System Overview 
• Application Server configured in accordance with the Empower System 
Overview 
• LAC/E Server configured in accordance with the Empower System Overview 
• SAT/IN 
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• Peak generator  
• Client PC with appropriate Empower Build 
The system custodian or designee will ensure that the test hardware and software 
complies with the above criteria by reviewing the installation records and recording 
which workstations, peak generators, and SAT/INs are used for testing. This will be 
recorded in the Test Readiness Checklist.  
Test Analyst Qualification 
Before a Test Analyst begins formal execution of unit, integration, regression, and system 
level testing, he or she must: 
• Sign the departmental signature log. 
• Read and acknowledge the Empower Test Strategy. 
• Read and acknowledge the Empower Test Plan for the current Empower release. 
• Complete the following training:  
Name 
Waters Empower Basic Training  
Waters Empower Advanced Training 
 
The Test Lead will ensure that all test analysts comply with the above qualification 
requirements. 
Test Analyst Application User Account Security 
The test analyst’s Empower user account will be set up with PowerUser privileges in 
accordance with the Empower System Administration Guide.  If a test script activity 
requires administrator access, the script will be written to submit a detailed service 
request in the form of a trouble ticket to the server administrator and wait for the executor 
to provide the needed activity performance evidence.   
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The Test Lead will ensure that test analyst Empower user accounts meet these criteria 
prior to commencing testing. The Test Lead will also conduct a post-test user account 
audit for the Empower Test server to ensure that only the expected user accounts have 
accessed the server during the test period. This information is documented in the Test 
Readiness Checklist.   
Traceability 
Indiana University Empower release testing must be traceable back to the design 
specifications and Empower system requirements. Conversely, the Indiana University 
Empower system requirements are traceable forward to vendor provided functionality or 
design elements created by Indiana University. As stated above, for vendor functionality, 
the vendor performs the testing.  Design elements created by Indiana University are 
tested by Indiana University. For testing that Indiana University performs, the tests are 
cataloged in the Empower traceability matrix. Testing performed by the vendor is not 
tracked in the Indiana University Empower traceability matrix.   
The Empower traceability matrix will be updated to reflect the Indiana University test 
cases introduced for an Empower Release. The traceability matrix must be approved prior 
to formal testing. 
Test Execution Documentation  
The Empower team will document test execution in the Empower Test Summary Report. 
Testing Execution 
Unit tests on the custom fields will involve using Excel spreadsheets to verify 
calculations with first person execution and second person verification.  Note that the 
arithmetic precision of Excel and Empower calculation algorithm implementations may 
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differ.  Therefore, small differences between the expected result and the actual result are 
allowed as follows: 
The precision for which the custom fields will be tested is taken from the precision and 
field width attributes in the corresponding Empower Custom Field Design Definition. 
1. Any values extracted from Empower for input to the calculation will be entered on 
the workbook using the precision defined in the Empower Custom Field Design 
Definition for the source data field. 
2. The calculation result precision will be entered in each workbook as defined in the 
Empower Custom Field Design Definition for the target field. 
3. The test will be considered successful if the difference between the Empower 
calculation result and the test workbook calculation result taken at the result 
precision recorded on the workbook is less than or equal to 0.001% according to 
this formula:   
ABS[(Empower_result - Workbook_result ) / Empower_result] <= 0.00001 
Pre-Execution Review 
A pre-execution review and test script readiness check will be conducted. 
Post-Execution Review 
A member of the Empower team will conduct the post-execution review after test 
executions are complete. 
Retention 
All executed test documentation and supporting documentation including documentation 
of failed test runs will be stored with the Empower validation package in the Indiana 
University Library. Refer to the Empower Validation Plan for document retention policy.  
  325
Test Problem Reporting  
Test problem reports will be recorded and addressed, either during testing or in the Test 
Summary Report. 
Exit Criteria  
Overall exit criteria are detailed below: 
• All planned unit tests are executed, second person reviewed, signed, and dated 
• All planned integration tests are executed, second person reviewed, signed, and 
dated 
• All planned regression tests are executed, second person reviewed, signed, and dated 
• All system tests are executed, second person reviewed, signed, and dated 
• All planned acceptance tests are executed, second person reviewed, signed, and 
dated 
• All issues found in the informal testing were properly managed and documented per 
the problem reporting process referenced in the Test Problem Reporting section of 
this Test Strategy.  .  
• Empower Traceability Matrix is updated and approved 
• All test failures have been resolved either during testing or addressed in the Test 
Summary Report. 
Test Summary Report 
The Test Lead will write a Test Summary Report when all planned testing activities are 
completed.  The Test Summary Report may be a stand-alone document or included in the 
text of an appropriate electronic change control record.   
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Introduction 
Purpose 
System Description 
Empower is a Chromatography Data Management System designed to collect, analyze, 
and report data from laboratory instruments. 
The Empower system consists of Empower chromatography data software application. 
Refer to the Empower System Overview for additional details. 
Document Overview 
This Training Plan describes and identifies the organization, resources, activities, and 
procedures required for the training effort associated with Empower Release 1.0.  A 
description of the training deliverables and supporting documents that will be used for 
Release 1.0 is included in this Training Plan. The roles and responsibilities are identified 
in the Empower Validation Roles and Responsibilities document. 
Scope 
This Training Plan dictates the minimum training requirements for the use of the 
Empower software for all Empower Support personnel and Empower laboratory 
personnel which include the application System Owner(s) and System Custodian. 
Terms and Acronyms 
Refer to the Indiana University Informatics Acronym and Definition List for a list of 
terms and acronyms used in this document. 
References 
Refer to the Empower Master Document List (MDL) for the location of all documents 
referenced in this Validation Plan. 
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Training Courses 
The courses included in the Empower training program are provided externally by the 
Empower Software vendor, Waters Corporation 
This section identifies each Empower course. 
Course Name Topics 
Delivery 
Method Length Prerequisites 
Empower 
Software 
Acquisition, 
Processing, and 
Reviewing 
Results 
• Data Acquisition and 
Sample Set Methods 
• Bringing data into 
Review  
• Developing a Processing 
Method 
• Altering Samples  
• Batch Processing 
• Manual Integration 
• Reviewing Results 
• Detector Noise and Drift 
• System Suitability 
Leader-
Led 
1 day N/A 
Empower 
Software Using 
Administrative 
Features for 
Productivity 
• Use of System Policies 
• Acquisition Servers & 
Chromatographic 
Systems 
• The Project Window 
• Copying Data and 
Methods 
• Method Properties  
• Lock/Unlock Channels 
• Multi-Project Mode 
• View Filters 
Leader-
Led 
1 days N/A 
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Course Name Topics 
Delivery 
Method Length Prerequisites 
Empower 
Software Custom 
Fields and 
Reports 
• Custom Field Types 
• Creating a Custom Field 
• Creating Individual 
Reports 
• Sign Off Reports 
• Creating a Summary 
Report 
• Automating Printing of 
Summary Reports in 
Run Samples 
Leader-
Led 
1 days N/A 
Empower 
Software 
Hardware and 
Troubleshooting 
Training  
• Practical Windows NT 
Networking Review 
• Empower Technical 
Overview & Basics 
Operations (Hardware & 
Software) 
• Empower Installation 
(Client, LAC/E32(PCI 
& ISA Buslace), & 
SAT/IN) 
• Connecting of Hardware 
(LAC/E32, SAT/IN & 
instruments) 
• Troubleshooting 
(Hardware & Software) 
• Empower Acquisition 
Theory of Operation 
• Remote Acquisition 
Theory of Operation 
Leader-
Led 
3 days N/A 
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Laboratory Training 
A series of classes has been defined for the various functions within the Empower 
system.  A minimum set of classes is required based on the role of the user.   
Laboratory Roles 
Generic roles have been identified in this document for defining training needs.  These 
roles are general in nature.  These generic roles are: 
• Power User 
• Master User 
• Basic User  
Note: Empower Support personnel are considered ‘support’ not ‘laboratory,’ and are 
addressed in the “Support Training” section. 
Minimum Training Requirements - Laboratory 
This section identifies training requirements for Empower laboratories based upon the 
generic user roles listed above. 
Training Courses Required 
The following table identifies the required training for Empower laboratory personnel.  
  
(Generic) User 
Role 
Minimum Required Training 
Power User • Empower Software Acquisition, Processing, and Reviewing 
Results  
• Empower Software Custom Fields and Reports 
Master User • Empower Software Acquisition, Processing, and Reviewing 
Results  
Basic User • Empower Software Acquisition, Processing, and Reviewing 
Results  
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Support Training 
Empower Support personnel provide training, installation, system support, and helpdesk 
assistance.  This group must have a thorough understanding of Empower and its 
individual applications, as related to their role.  Training on general chromatography and 
the Empower Software, provided externally by the Waters Corporation, is mandatory.   
Support Roles 
Generic roles have been identified in this document for defining training needs.  These 
roles are general in nature.  These generic roles are: 
• Administrator 
• Support  
Minimum Training Requirements - Support 
This section identifies training requirements for Empower laboratories based upon the 
generic user roles listed above. 
Training Courses Required 
The following table identifies the required training for Empower support personnel.  
 (Generic) User 
Role 
Minimum Required Training 
Administrator 
 
• Empower Software Acquisition, Processing, and 
Reviewing Results  
• Empower Software Custom Fields and Reports 
• Empower Software Hardware and Troubleshooting 
Training 
Support • Empower Software Acquisition, Processing, and 
Reviewing Results  
• Empower Software Custom Fields and Reports 
• Empower Software Hardware and Troubleshooting 
Training 
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Training Records 
Training records for Empower personnel are maintained as controlled training 
documents.  It is the responsibility of each supervisor to ensure that Empower personnel 
have completed the minimum training required for their role. 
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Training Materials 
All vendor training materials shall undergo a documented Quality Assurance Review 
(QAR).  At a minimum, a content expert (SME) and the System Owner must sign all new 
or updated QARs for training materials.  
Course Material 
The Empower vendor develops and maintains the training materials.  Empower courses 
may be taught for any version of the Empower software in use by Indiana University. 
Changes or Updates to Training Materials  
When determining the scope of the changes, the Empower Support personnel have two 
modes for communicating changes or updates to Empower training materials:   
 
• Release Description Document (RDD)   
• Empower Training Email Update 
RDD  
Each version and revision release of Empower requires the creation of a RDD.  The RDD 
conveys the system changes implemented in the release and the impact of these changes 
on Empower system users.  The Impacts and Implementation section of the RDD conveys 
training information that is specifically associated with an Empower release.  The RDD is 
distributed to the appropriate Empower personnel for presentation and communication to 
their respective users.   
Empower Training Email Update  
Empower Support personnel can also choose to communicate Empower training material 
changes via a simple email to Empower users.  The System Owner will also receive all 
such emails. 
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Introduction 
Purpose 
This document identifies the plan for managing the relationship with Waters Corporation 
in regards to its obligation for supplying and supporting the Empower application, herein 
referred to as Empower.  
The Empower application is a chromatography data management system designed to 
collect, analyze, and report data from laboratory instruments.  The Empower project 
utilizes a configurable COTS vendor solution. 
Scope 
This document covers the use of Waters Corporation as the supplier of the Empower 
application within the parameters of Indiana University’s intended use of the application.  
Acronyms / Definitions 
Refer to the Indiana University Informatics Acronym and Definition List for a list of the 
terms and acronyms used in this document.  
Reference 
Refer to the Empower MDL for the location of all documents referenced in this 
document.  
History of relationship with vendor 
Indiana University has maintained a successful working relationship with Waters 
Corporation at all times since selecting this vendor in 2005 to supply their Empower 
application. Waters Corporation provides IU a specific customer support representative to 
handle all support calls.   
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This relationship also involves at least annual interactions between the IU Empower 
system owner team and management-level associates at Waters Corporation.  Waters 
Corporation takes into consideration all requests submitted by customers, including IU, 
and determines the best way to handle the request.  This interaction could result in an IU 
request being incorporated into a future release, or Waters might defer or not accept an 
IU request. 
Vendor’s Background 
Waters principal activity is to design, manufacture and distribute high performance liquid 
chromatography and mass spectrometry instrument systems and associated service and 
support products, including chromatography columns and other consumable products. 
Waters also develops and supplies software products that interface with Waters 
instruments and are typically purchased by customers as part of the instrument system. 
The products of Waters are used by pharmaceutical, life science, biochemical, industrial, 
academic and government customers working in research and development, quality 
assurance and other laboratory applications.   
Refer to ARC Audit No.0074 for additional supporting evidence of Waters Corporations 
quality practices surrounding the Empower Chromatography software. 
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Risks 
Indiana University has implemented the following compensating controls to help mitigate 
the risks associated with this vendor, as well as facilitate issue resolution: 
• Quarterly reviews of the Waters web-site (as described in a subsequent section) 
• Annual Vendor Evaluations 
There have been no findings that have the potential to impact data integrity.  See Waters 
ARC Audit for specific finding information.   If Waters determines they will not address 
some or all issues identified by IU, the IU System Owner will institute additional 
compensating controls. 
The risks described in this section are specific risks that have been identified as having a 
high impact to business operations and data integrity and have been or are being 
mitigated by the Empower Team.  These risks are associated with the use of Waters 
Corporation to supply the Empower Chromatography software.  This plan does not 
address general inherent risks with the use of any vendor or COTS product. 
The following table describes the risks and mitigation approach the project team and 
business areas have identified and implemented: 
Risk Mitigation 
Waters testing of selected 
requirements that IU deems critical 
may not meet IU’s expectations.  
Rely preferentially on vendor testing 
wherever possible.  Mitigate with local testing 
if necessary.   
Waters may not communicate changes 
in their quality system.  
Frequent review of Waters certifications via 
review of public records and Waters 
publications.  If significant changes occur, 
perform additional evaluation. 
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Risk Mitigation 
Waters may not address defects or 
enhancements deemed critical by IU 
in a time frame acceptable to IU. 
Communicate any critical issues to Waters 
support immediately.  Communicate timelines 
to users to permit them to adjust processes as 
needed. 
Waters may delay delivery of new 
versions, releases, and service packs. 
Communicate any critical timelines to Waters 
support immediately.  Communicate timelines 
to users to permit them to adjust processes as 
needed. 
Waters does not communicate defects 
that are found during internal testing. 
Assumption is that internal defects are small 
if they have not been noted during IU usage.  
If a defect is noted at IU, prompt reporting to 
Waters will be completed.  
IU is unaware of a critical defect Waters communicates defects on their web-
site in a timely manner.  IU will monitor the 
Waters web-site as part of system 
management activities, performing 
assessments of defect impacts deemed 
necessary. 
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Vendor Management 
Roles and Responsibilities 
Refer to the Empower Validation Roles and Responsibilities document for a complete 
listing of the project and vendor roles associated with vendor management and vendor 
evaluations.  
Reliance on Vendor’s Quality Practices 
Through vendor evaluations, IU will rely on aspects of Waters Corporations software 
development practices, including but not limited to planning, requirements gathering, 
design, code and code reviews, testing, and release management.  Refer to Waters ARC 
Audit report for supporting evidence. 
Agreements 
Legally binding licensing and service contracts are negotiated through IU Financial with 
input from the System Owner. IU Financial maintains the controlled copies of vendor 
contracts, such as licensing and service agreements.  
Contact Information 
Waters Corporation contact information can be obtained by accessing the following 
website: http://www.waters.info/.    The Empower System Owner is responsible for 
maintaining a list of key Waters contacts for IU. 
Vendor Interactions 
User Symposium 
Representatives from IU may attend the annual Waters Software Users Symposium. This 
global meeting provides an opportunity for IU to interact with other customers of Waters, 
including other large pharmaceutical corporations. This venue permits IU to further 
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assess the performance of Waters with customers that have interests similar to that of IU.   
Key subject matter experts from Waters Corporation also participate in the symposium. 
Vendor Evaluations 
Watson Pharmaceuticals conducted an evaluation of Waters Corporation to assess Waters 
quality system, software development, and testing practices.  Refer to the ARC Audit for 
details.  There have been no observations that would prevent IU from using this vendor 
and software.    
Follow-up Evaluations 
The System Owner will determine if additional evaluations are necessary based on the 
following situations: 
• Significant changes to Waters quality practices occur, including implementation 
of a new quality system or substantial changes to an existing quality system 
• Major application release or upgrade 
• Major bug discoveries and fixes 
The System Owner will determine the scope of each follow-up evaluation. 
Software Release Notes and Defect Notification 
The vendor provides software release notes for each release of the software.   These 
release notes provide details around features included and defects corrected in the release.  
Vendor defect and issue information can be obtained through Waters’ website. 
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Introduction 
Purpose 
This Release Description Document (RDD) provides information regarding Release 1.0 
of Empower and serves as the official communication of the release and its contents to 
laboratories and key business partners. 
Terms and Acronyms 
Refer to the Indiana University Informatics Acronym and Definition List for a list of 
terms and acronyms used in this document. 
References 
Refer to the Empower Master Document List (MDL) for the location of all documents 
referenced in this Validation Plan. 
  358
Release Definition 
Release Identification 
System Name: Empower 
Release Number: Version 1.0 
Release Date: Date of final approval on RDD 
Release Description 
The scope of this release includes the following: 
• Deployment of Empower 2154 configured for laboratory requirements 
• Deployment of seven custom fields 
Known Issues and Workarounds 
Gas Chromatography Control 
Empower control of Gas Chromatography (GC) equipment requires a user be sure to 
select the proper GC Syringe parameters.  A defect presently in Empower shows these 
parameters as ‘gray’ even though the parameters are applied.  Selecting the correct 
parameters will generate the correct injection volumes. 
Testing 
The test plan and test summary report is available upon request to the System Owner. 
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Laboratory Impacts and Implementation 
Laboratory Impact 
Laboratories will need to evaluate how Empower deployment will impact operations. 
Training for Laboratory Users 
Minimum user training requirements for Empower Release 1.0 are identified in the 
Empower Training Plan.  
Key Contacts 
Implementation of Empower Release 1.0 in the laboratory must be coordinated with the 
System Owner. 
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Support Impacts and Implementation 
Support 
The support team has been trained for Release 1.0. There are no additional impacts to the 
support team. 
Validation 
The following table identifies the validation products included in Release 1.0. The table 
consists of the following information: 
• Validation Document – Identifies the validation document impacted 
• Description of Change – Briefly describes the change to the validation document 
The document version number of the impacted validation document is identified in the 
Empower MDL. 
Table 1. Changes to Validation Documents 
Validation Document Description of Change 
Empower Release Description Document for 
Release 1.0 
New document. 
Empower Requirements Definition New document. 
Empower Use Case Definition – UC01 New document. 
Empower Use Case Definition – UC02 New document. 
Empower Use Case Definition – UC03 New document. 
Empower Use Case Definition – UC04 New document. 
Empower Use Case Definition – UC05 New document. 
Empower Use Case Definition – UC06 New document. 
Empower Use Case Definition – UC07 New document. 
Empower Use Case Definition – UC08 New document. 
Empower Use Case Definition – UC09 New document. 
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Validation Document Description of Change 
Empower Use Case Definition – UC10 New document. 
Empower Use Case Definition – UC11 New document. 
Empower Requirements Traceability Matrix New document. 
Empower Security Design New document. 
Empower System Overview New document. 
Empower Custom Field Design Specification: 
ChromColumn 
New document. 
Empower Custom Field Design Specification: 
ChromComment 
New document. 
Empower Custom Field Design Specification: 
ChromConcentration 
New document. 
Empower Custom Field Design Specification: 
InjType 
New document. 
Empower Custom Field Design Specification: Lot New document. 
Empower Custom Field Design Specification: 
Notebook 
New document. 
Empower Custom Field Design Specification: 
NotebookPage 
New document. 
Empower Template Project Design Specification New document. 
Empower Test Strategy New document. 
Empower Test Plan New document. 
Empower Test Script UT-DSG001 (ChromColumn) New document. 
Empower Test Script UT-DSG002 
(ChromComment) 
New document. 
Empower Test Script UT-DSG003 
(ChromConcentration) 
New document. 
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Validation Document Description of Change 
Empower Test Script UT-DSG004 (InjType) New document. 
Empower Test Script UT-DSG005 (Lot) New document. 
Empower Test Script UT-DSG006 (Notebook) New document. 
Empower Test Script UT-DSG007 (NotebookPage) New document. 
Empower Test Script UT-DSG008 (Template 
Project) 
New document. 
Empower System Test Script New document. 
Empower Acceptance Test Script New document. 
Empower Test Summary Report New document. 
Disaster Recovery Plan New document. 
Business Continuity Plan New document. 
Empower System Administration Guide New document. 
Waters Vendor Management Plan New document. 
Empower Training Plan New document. 
Empower Master Document List Updated with new documents 
and revisions to documents. 
 
Training for Support Personnel 
Empower-specific training requirements for support personnel are addressed in the 
Empower Training Plan. Support personnel will be given the appropriate individual 
training map based on the Empower Training Plan and their assigned role(s). 
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